[
    "This phase 1 trial is testing the efficacy of regorafenib in combination with cisplatin and pemetrexed for patients with metastatic Stage IV or locally advanced, unresectable confirmed Stage IIIB nonsquamous Non-Small Cell Lung Cancer (NSCLC) who meet certain eligibility criteria and do not have any exclusion criteria.",
    "The sample is a phase 1 trial for cancer patients with rare tumors, testing the efficacy of imatinib mesylate and cyclophosphamide at different dosing levels, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of canagliflozin in patients with type 2 diabetes mellitus who have inadequate glycemic control on metformin monotherapy or in dual combination with other glucose lowering agents, with a list of inclusion and exclusion criteria.",
    "This trial is testing the effectiveness of trastuzumab, paclitaxel, and myocet in treating HER2 overexpressing metastatic or locally advanced breast cancer in women aged 18-70 with measurable lesions, while excluding those with prior treatment for advanced breast cancer or Herceptin, bone or central nervous system metastasis as the only site of disease, and history of another malignancy within 5 years of study.",
    "The sample is a clinical trial for early phase 1 testing of papaverine or placebo on patients with schizophrenia and cognitive deficits, with specific inclusion and exclusion criteria, and the diseases are identified by their ICD-10 codes.",
    "The sample is a phase 1 trial for Japanese patients with advanced solid malignancies, testing the drug azd4547, with inclusion criteria of patients over 25 years old and relatively good overall health, and exclusion criteria of poor bone marrow, liver or kidney function, refractory nausea and vomiting, chronic gastrointestinal diseases, inability to swallow the IP or previous significant bowel resection.",
    "This phase 1 trial is testing the efficacy of doxorubicin, pazopanib, and epirubicin in treating advanced solid tumors that have failed standard therapy or for which there is no standard therapy and is indicated for treatment with anthracyclines, with eligibility criteria including age greater than or equal to 18 years, adequate organ system function, ECOG performance value of 0 or 1, and measurable or evaluable disease.",
    "This phase 1 trial is testing the efficacy of XL281 and famotidine in treating metastatic or unresectable solid tumors, including non-small-cell lung cancer, colorectal cancer, papillary thyroid cancer, and melanoma, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 1 clinical trial for patients with progressive prostate cancer, testing the efficacy of docetaxel and epirubicin hydrochloride, with eligibility criteria including confirmed adenocarcinoma of the prostate, measurable or non-measurable disease with PSA \u2265 5 ng/mL, and progressive systemic disease despite prior standard endocrine therapy.",
    "This trial is a phase 1/phase 2 study for breast cancer patients with tumors overexpressing HER2neu, testing the efficacy of myocet, taxotere, and herceptin, with eligibility criteria including age, performance status, and adequate organ function.",
    "This phase 1 trial is testing the drugs pemetrexed and topotecan on patients with advanced solid tumors, including ovarian, endometrial, cervical, and lung cancer, who meet certain eligibility criteria.",
    "The sample is a phase 1/2 trial for patients with pancreatic cancer, testing the efficacy of vismodegib and gemcitabine hydrochloride, with eligibility criteria including histologically confirmed adenocarcinoma of the pancreas, measurable disease, and Karnofsky performance status >= 80%.",
    "The sample is a phase 1 clinical trial for healthy male volunteers testing the effects of bisoprolol and rosuvastatin on individuals with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the combination of PD 0332991 and bortezomib in patients with mantle cell lymphoma who have received prior chemotherapy and rituximab-containing regimens, and have measurable disease, with eligibility criteria including normal organ and marrow function, and willingness to use contraception.",
    "This phase 1 trial is testing the efficacy of dasatinib, bortezomib, and dexamethasone in treating relapsed or refractory multiple myeloma patients who have had at least 2 prior therapies, with specific inclusion and exclusion criteria.",
    "This trial is for diabetic macular edema and involves the drug ranibizumab, with eligibility criteria including a diagnosis of diabetes mellitus and evidence of retinal thickening due to macular edema.",
    "The sample is a phase 1 trial for patients with type 2 diabetes, testing the drug canagliflozin, with inclusion criteria of no prior anti-hyperglycemic treatment or stable metformin monotherapy, and exclusion criteria of Type 1 diabetes, severe hypoglycemic episodes, and clinically significant diabetic complications or illnesses.",
    "This sample is a phase 1/phase 2 trial for type 1 diabetes using etanercept and placebo drugs, with inclusion criteria such as positive GAD 65 and/or islet cell antibody, HbA1c at diagnosis above 6%, and insulin regimen with 3 injections of insulin daily, and exclusion criteria such as infection requiring IV antibiotics at diagnosis or within past 14 days from study entry, BMI over 85th percentile for age and gender, and evidence of psychiatric disease in the potential study subject and/or primary care taker.",
    "This clinical trial is for patients with refractory or relapsed multiple myeloma and will test the drug hll1-dox, which is the doxorubicin conjugate of milatuzumab, with eligibility criteria including measurable disease and adequate hematologic, renal, and hepatic function.",
    "This trial is testing the drug tandutinib on patients with recurrent adult brain tumors, who meet specific eligibility criteria, including having measurable disease and a Karnofsky performance status of 60-100%.",
    "The sample is a phase 1/2 trial for non small cell lung cancer and lung cancer patients, testing the efficacy of abt-751 and carboplatin, with eligibility criteria including advanced stage of disease, adequate hematologic, renal and hepatic function, and adequate performance status.",
    "The sample is a phase 1/phase 2 trial for metastatic colorectal cancer, testing the efficacy of azd2171, folfox, and placebo cediranib, with specific inclusion and exclusion criteria listed.",
    "This phase 1 trial is testing the efficacy of the drug MK-0893, in various doses and a placebo, on patients with type 2 diabetes mellitus who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for patients with chronic lymphocytic leukemia and small lymphocytic leukemia, testing the efficacy of lenalidomide, fludarabine, and rituximab, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 1 trial aims to test the efficacy of rectal and vaginal formulations of tenofovir 1% gel and universal hec placebo gel formulation in preventing HIV transmission in individuals who are at risk, and the eligibility criteria includes being HIV-1 uninfected, vaccinated for or have natural immunity to Hepatitis B, and willing to abstain from RAI and practices involving insertion of anything in rectum for 72 hours before and 72 hours after each flexible sigmoidoscopy and study product exposure.",
    "This phase 1 trial is testing the combination of lonafarnib and paclitaxel in patients with HER2/neu overexpressing breast cancer, with specific eligibility criteria for disease stage, treatment history, and patient characteristics.",
    "This phase 1 trial is testing the drug 2-deoxy-d-glucose (2dg) on patients with various types of advanced or metastatic solid malignancies who have previously been treated with at least one chemotherapy regimen or have no curative standard treatment available, and meet certain eligibility criteria.",
    "This phase 1 trial is testing the effectiveness of multiple drugs, including trametinib and erlotinib, on solid tumors in patients who have had prior standard therapy or no standard therapy exists, and have adequate organ and blood cell counts, while excluding those with brain tumors, uncontrolled systemic disease, and positive for Hepatitis B, Hepatitis C, or HIV.",
    "This phase 1 trial is testing the efficacy of ranibizumab (lucentis) in treating central retinal vein occlusion, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 1 trial is testing the efficacy of exenatide once weekly and placebo in patients with type 2 diabetes who have suboptimal glycemic control and have been treated with diet modification and exercise alone or in combination with a stable regimen of oral antidiabetic drugs for at least 2 months prior to study start.",
    "This phase 1 trial is testing the drug pazopanib on patients with age-related macular degeneration and subfoveal choroidal neovascularization, with specific eligibility criteria including visual acuity score, age, and absence of certain eye diseases or conditions.",
    "The sample is a phase 1 trial with healthy male subjects, testing the drug glpg0492 and placebo, with inclusion criteria of age and BMI range, and exclusion criteria of elevated PSA and drug/alcohol abuse.",
    "The sample is a phase 1/phase 2 trial for non-small-cell lung cancer using pemetrexed, cisplatin, and carboplatin as drugs, with eligibility criteria including inoperable cancer, no significant weight loss, and adequate organ function.",
    "The sample is a phase 1/phase 2 trial for patients with recurring or metastatic pancreatic adenocarcinoma, testing the efficacy of gemcitabine and etanercept, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 1/phase 2 trial for patients with Type 1 Diabetes Mellitus, testing the efficacy of Viaject\u00ae25, Viaject\u00ae7, and insulin lispro, with inclusion criteria including age, BMI, and insulin antibody levels, and exclusion criteria including Type 2 Diabetes Mellitus, C-peptide and HbA1c values, and history of severe allergies or drug/alcohol abuse.",
    "The sample is a phase 1 trial for patients with metastatic malignant melanoma, testing the drug cc-5013, with eligibility criteria including age, performance status, laboratory tests, and prior treatment history.",
    "This trial is testing the efficacy of capecitabine and PHY906 in treating locally advanced or metastatic pancreatic adenocarcinoma, with specific eligibility criteria including prior gemcitabine therapy and adequate hepatic and renal function.",
    "This is a phase 1/phase 2 clinical trial for patients with recurrent epithelial ovarian cancer, primary peritoneal carcinomatosis or fallopian tube cancer, testing the drug decitabine, with eligibility criteria including platinum-resistant or platinum refractory disease, measurable or detectable disease, and acceptable organ function.",
    "This phase 1 trial is testing the efficacy of ertugliflozin, a drug for type 2 diabetes, with various dosages and administration methods, versus placebo, in participants who are either treatment-na\u00efve or on up to 2 acceptable oral anti-diabetes drugs for at least 8 weeks prior to the study, and with exclusion criteria including type 1 diabetes mellitus, stroke, unstable angina, heart attack in last 6 months, and uncontrolled blood pressure.",
    "This phase 1 trial is testing the drug imatinib mesylate on healthy individuals with a BMI < 31 kg/m2, and the eligibility criteria includes negative pregnancy tests for female patients of childbearing potential and exclusion of patients with abnormal marrow function, renal dysfunction, or impaired hepatic function.",
    "This is a phase 1/phase 2 trial for kidney transplant patients with anti-HLA antibody, testing the efficacy of IVIG and rituximab in inhibiting cytotoxic anti-HLA antibody activity, with inclusion and exclusion criteria listed.",
    "The sample is a phase 1/phase 2 trial for patients with HER2+ ve metastatic breast cancer, testing the efficacy of panobinostat and trastuzumab, with eligibility criteria including prior treatment and progression on trastuzumab, adequate laboratory values, and an ECOG performance status of <2.",
    "The sample is a phase 1 clinical trial for ulcerative colitis, testing the efficacy of placebo and rhumab beta7 drugs, with eligibility criteria including diagnosis of ulcerative colitis, disease duration of >=12 weeks, and eligibility to receive biologic therapy.",
    "The sample is a phase 1 clinical trial for Alzheimer's disease, testing the efficacy of a placebo drug on Japanese males and females aged 50-85 with probable Alzheimer's disease, and includes specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the combination of bortezomib and interferon alfa-2b in patients with cutaneous melanoma and metastatic, non-resectable regional lymphatic, or extensive in transit recurrent disease, who have normal organ and marrow function and meet other eligibility criteria.",
    "This clinical trial is testing the effectiveness of everolimus, cetuximab, irinotecan, and capecitabine, oxaliplatine in treating non-resectable or metastatic pancreatic cancer patients who have previously been treated with gemcitabine.",
    "The sample is a phase 1/2 trial for patients with androgen-independent prostate cancer, testing the efficacy of taxotere and doxil chemotherapy drugs, with eligibility criteria including adequate bone marrow, liver, and renal function, and a life expectancy of greater than 12 weeks.",
    "The sample is a phase 1 trial for patients with myelodysplastic syndromes, testing the efficacy of arsenic trioxide and azacitidine, with eligibility criteria including confirmed diagnosis of MDS, adequate marrow iron stores, and age over 18.",
    "This sample is a phase 1 trial for respiratory syncytial virus, testing the drugs placebo and medi-557, with eligibility criteria including age, weight, and medical history.",
    "The sample is a phase 1 trial for patients with CD33 positive acute myeloid leukemia who did not respond to first line induction therapy, testing the efficacy of gemtuzumab ozogamicin, mitoxantrone, and etoposide, with inclusion and exclusion criteria listed.",
    "The sample is a phase 1 trial testing the efficacy of sertraline and simvastatin in treating mild depression and coronary artery disease, with specific inclusion and exclusion criteria, and using ICD-10 codes to identify the diseases.",
    "This trial is testing the efficacy of doxorubicin-eluting beads and everolimus in treating hepatocellular carcinoma in patients who meet specific eligibility criteria, including having a Child-Pugh score < 8 and no tumor involvement > 50% of the whole liver.",
    "This phase 1 trial is testing the efficacy of lenalidomide, rituximab, and cyclophosphamide in treating relapsed/refractory B-cell CLL or SLL, with eligibility criteria including prior therapy and meeting NCI WG criteria, while exclusion criteria include prior use of lenalidomide and concurrent use of other anti-cancer agents or treatments.",
    "The sample is a phase 1/phase 2 trial testing the drug docetaxel on patients with various types of cancer, including recurrent non-small cell lung cancer and recurrent prostate cancer, who meet specific eligibility criteria.",
    "This phase 1 trial is testing the combination of velcade and vorinostat in patients with non-small cell lung cancer who are eligible for surgical resection, and the eligibility criteria include specific disease stage, organ function, and absence of prior exposure to the study drugs.",
    "The sample is a phase 1/phase 2 trial for patients with refractory metastatic melanoma, testing the efficacy of dmf5 melanoma reactive til, cyclophosphamide, fludarabine, and aldesleukin, with specific eligibility criteria including measurable metastatic melanoma, HLA-A 0201 positivity, and normal serology and chemistry levels.",
    "This phase 1 trial is testing the efficacy of aripiprazole im depot and aripiprazole tablets in treating schizophrenia, with inclusion and exclusion criteria including diagnosis of schizophrenia, good physical health, and restrictions on alcohol consumption and medication use.",
    "The sample is a phase 1/phase 2 trial for patients with metastatic breast cancer, testing the drug amrubicin, with eligibility criteria including confirmation of HER2-negative breast cancer, prior chemotherapy regimens, and adequate organ function.",
    "This trial is testing the use of cetuximab, a drug, in patients with squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx or larynx, and the eligibility criteria includes age, histological proof of cancer, and no distant metastases.",
    "This trial is for patients with chronic myeloid leukemia who have resistance or suboptimal response to imatinib, dasatinib, or nilotinib and no known T315I/A Abl-kinase mutation, and will test the efficacy of dasatinib and bms-833923.",
    "This phase 1 trial is testing the efficacy of autologous tumor cell vaccine and therapeutic autologous dendritic cells in treating newly diagnosed acute myeloid leukemia patients with adequate dendritic cells and AML blasts isolated from bone marrow and/or peripheral blood.",
    "This phase 1 trial is testing the drug ly2584702 on patients with advanced and/or metastatic cancer that is refractory to standard therapy and/or therapies known to provide clinical benefit, or for which no standard therapy exists, and who meet specific eligibility criteria.",
    "This phase 1 trial is testing the drug 1-methyl-d-tryptophan on patients with metastatic or unresectable solid malignancies, with specific eligibility criteria including performance status, blood counts, and absence of brain metastases, among others.",
    "This phase 1 trial is testing the efficacy of riociguat in patients with pulmonary hypertension due to COPD, with inclusion and exclusion criteria listed, and the drug names and disease names provided.",
    "This phase 1 trial is testing the drug rad001 on patients with lung cancer and metastatic cancer who have radiographically confirmed brain metastases and stable extracranial disease, and meet a list of patient characteristics and prior concurrent therapy criteria.",
    "The sample is a phase 1 trial for athletes with exercise-triggered asthma and gastroesophageal reflux, testing the efficacy of Nexium and placebo in reducing symptoms during exercise, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the drug mp-424 (telaprevir) on patients with genotype 1b chronic hepatitis C, with inclusion criteria of being naive to interferon concomitant medications and exclusion criteria of having decompensated cirrhosis or positive HBs antigen.",
    "This is a phase 1 trial for patients with metastatic or inoperable neoplasms, testing the drug PT-523 for injection, with eligibility criteria including age, ECOG performance status, and adequate organ function.",
    "This trial is for patients with recurrent glioblastoma multiforme, glioma, astrocytoma, or brain tumor who have failed initial surgical resection followed by standard adjuvant therapy, and will test the efficacy of itv depocyt + temozolomide as a treatment option.",
    "The sample is a phase 1 clinical trial for irritable bowel syndrome, testing the effectiveness of lubiprostone and placebo drugs on patients who meet specific inclusion and exclusion criteria, with a list of diseases and their corresponding icd-10 codes provided.",
    "The sample is a phase 1 trial for breast cancer patients with unresectable, locally recurrent or metastatic disease, testing the efficacy of sunitinib and taxotere, with specific inclusion and exclusion criteria, and icd-10 codes for the disease.",
    "The sample is a phase 1/phase 2 trial for the treatment of malignant melanoma using the drug pivanex, with eligibility criteria including confirmed melanoma, measurable disease, and adequate organ function, while exclusion criteria include receipt of more than three systemic treatment regimens for malignant melanoma and untreated brain metastases.",
    "The sample is a phase 1 trial for pancreatic adenocarcinoma testing the efficacy of imexon and gemcitabine, with eligibility criteria including inoperable cancer of the pancreas and a projected life expectancy of at least 2 months.",
    "The sample is a phase 1 trial for advanced solid tumors and cancer, testing the effectiveness of azd7762 and irinotecan, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for pulmonary disease, chronic obstructive, with the drug uk-369,003, and eligibility criteria including GOLD criteria 2 to 4 and a 10 pack year history of smoking.",
    "The sample is a phase 1 trial for patients with metastatic or unresectable melanoma, testing the efficacy of bortezomib and sorafenib, with eligibility criteria including measurable disease, prior treatments, and adequate organ function.",
    "The sample is a phase 1 clinical trial for ravpal-peg in patients with phenylketonuria, with inclusion and exclusion criteria listed, and the important values include the drug ravpal-peg and the disease phenylketonuria.",
    "This phase 1 trial is testing the efficacy of bi 2536 and pemetrexed in treating non-small-cell lung carcinoma patients who have progressed following 1 prior chemotherapy regimen for advanced disease, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for patients with advanced, non-resectable and/or metastatic solid tumors, testing the drug bi 2536 bs, intravenous, with eligibility criteria including evaluable tumor deposits, age of 18 years or older, and Eastern Cooperative Oncology Group (ECOG) performance score \u2264 2.",
    "The sample is a phase 1/2 trial testing the use of the drug amd3100 in patients with various types of leukemia, lymphoma, myelodysplastic syndromes, and multiple myeloma, with specific eligibility criteria for both donors and recipients.",
    "This phase 1 trial is testing the safety and efficacy of ilaprazole and esomeprazole in healthy subjects with negative H pylori breath test results, who are using double-barrier birth control, and have a BMI between 18 to 30 kg/m2.",
    "The sample is a phase 1/phase 2 trial for glioblastoma multiforme, testing the efficacy of bcnu wafer, irinotecan, and bevacizumab, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 1/phase 2 trial for previously untreated diffuse large B-cell lymphoma patients, testing the efficacy of bortezomib, cyclophosphamide, doxorubicin, vincristine, prednisolone, and lenograstim, with specific eligibility criteria and exclusion criteria.",
    "This trial is testing the efficacy of cabazitaxel plus bavituximab in treating castration-resistant prostate cancer patients who have only received one prior chemotherapy regimen containing docetaxel, and meet specific eligibility criteria.",
    "The sample is a phase 1 clinical trial testing the drug bi 6727 on patients with advanced, non-resectable and/or metastatic solid tumors who have failed conventional treatment, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the use of busulfan in patients with recurrent or progressive CNS tumors who have undergone prior therapies, with specific eligibility criteria including organ function requirements and medication restrictions.",
    "The sample is a phase 1 trial for patients with advanced pancreatic cancer, testing the combination of romidepsin and gemcitabine, with specific inclusion and exclusion criteria, and a list of organ function requirements and medical conditions that would make a patient ineligible for the study.",
    "This is a phase 1 trial for type 2 diabetes patients or otherwise healthy cigarette smokers, testing the effects of srt2104 and placebo, with specific eligibility criteria including HbA1c levels, BMI, and absence of certain medical conditions.",
    "This sample is a phase 1 trial testing the drug azd4877 on patients with relapsed or refractory acute myelogenous leukemia, with specific inclusion and exclusion criteria listed.",
    "This phase 1 trial is testing the combination of 1-methyl-d-tryptophan and docetaxel in patients with metastatic solid malignancy, who meet specific eligibility criteria including having measurable disease, normal blood counts and liver function, and no active autoimmune disease or other concurrent illness.",
    "The sample is a phase I clinical trial for pancreatic cancer patients with metastatic disease, testing the efficacy of pioglitazone hydrochloride as a second-line treatment, with specific eligibility criteria for patient characteristics and prior concurrent therapy.",
    "The sample is a phase 1 clinical trial for a weight loss drug, canagliflozin, and placebo, with inclusion criteria of BMI between 30.0 to 39.9 kg/m2 and non-diabetic status, and exclusion criteria of significant illness, recent use of anti-obesity medications, and history of gastric-reduction surgery or eating disorder.",
    "This trial is a phase 1/phase 2 study testing the drug ly2886721 and placebo on participants with Alzheimer's disease or mild cognitive impairment due to Alzheimer's disease, with specific inclusion and exclusion criteria, and requiring a positive scan for the presence of amyloid beta.",
    "This phase 1 trial is testing the efficacy of asp1941 and metformin compared to placebo in treating type 2 diabetes mellitus patients who are stable under metformin monotherapy or dual therapy with metformin and a Sulfonylureum Derivative, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for lung cancer patients with measurable disease, using docetaxel and oxaliplatin as drugs, and with specific eligibility criteria including performance status, blood counts, and organ function.",
    "This is a phase 1 trial testing the drugs sb705498 and placebo on healthy Caucasian volunteers with dermatitis, atopic, who meet specific eligibility criteria.",
    "The sample is a phase 1 trial for peripheral arterial disease, testing the effects of atorvastatin, ascorbic acid, and placebo on patients undergoing non-emergent vascular surgery, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 1 trial for metastatic melanoma using rituximab as a drug, with specific eligibility criteria and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of grn163l in combination with trastuzumab for patients with HER2+ breast cancer who are resistant to trastuzumab, and have locally recurrent or metastatic disease that is not amenable to surgery or radiation with curative intent.",
    "This phase 1 trial is testing the drug triciribine on patients with relapsed/refractory leukemias, including hematologic malignancies and leukemia, who have exhausted standard therapies, and have an ECOG performance status of 0-3, with the goal of achieving a durable remission.",
    "This phase 1 trial is testing the efficacy of lapatinib ditosylate and tamoxifen citrate in treating advanced or metastatic breast cancer patients with hormone receptor-positive tumors who have had progressive disease after aromatase inhibitor therapy, and meet specific eligibility criteria.",
    "The sample is a phase 1/phase 2 clinical trial for the treatment of multiple myeloma using bortezomib, lenalidomide, and dexamethasone, with eligibility criteria including a diagnosis of multiple myeloma, no prior systemic therapy, and a Karnofsky performance status of greater or equal to 60.",
    "This phase 1 trial is testing the efficacy of lenalidomide and dexamethasone in treating previously treated multiple myeloma patients with specific eligibility criteria.",
    "This phase 1 trial is testing the drug abt-348, alone or in combination with azacitidine, for the treatment of various types of leukemia and myelodysplasia, with specific eligibility criteria for subjects, including age, disease type, and certain laboratory values.",
    "This phase 1 trial will test the effectiveness of lopinavir/ritonavir, an antiretroviral drug, in treating HIV-infected infants with certain eligibility criteria and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of azacitidine and cisplatin in treating metastatic or recurrent squamous cell carcinoma that is not amenable to salvage surgical resection, with eligibility criteria including normal organ and marrow function, at least one lesion amenable to serial biopsy, and completion of prior treatments at least 28 days before entering the study.",
    "The sample is a phase 1 trial for advanced non-resectable solid tumors, using the drug combination bez235 + mek162, with specific inclusion and exclusion criteria, and a list of icd-10 codes and disease names.",
    "The sample is a phase 1 trial for patients with advanced or metastatic solid tumors, testing the drug bms-907351 (xl184), with inclusion criteria including a life expectancy of at least 3 months and Eastern Cooperative Oncology Group performance 0-2, and exclusion criteria including uncontrolled intercurrent illness. The diseases being studied are neoplasms, with associated icd-10 codes provided.",
    "This phase 1 trial is testing the drug everolimus (rad001) on patients with HER-2 overexpressing metastatic breast cancer, with a list of inclusion and exclusion criteria, and a list of diseases and icd-10 codes.",
    "The sample is a phase 1/phase 2 trial for patients with leukemia or lymphoma, testing the drug laromustine, with eligibility criteria including ECOG performance status, renal and liver function, and no uncontrolled illness or psychiatric illness.",
    "This is a phase 1 trial for patients with Chronic Obstructive Pulmonary Disease (COPD) testing the effectiveness of salbutamol and ipratropium, with eligibility criteria including a post-bronchodilator FEV1 to FVC ratio (FEV1/FVC) < 0.7 and a cigarette smoking history of \u226510 pack years.",
    "This phase 1 trial is testing triciribine phosphate monohydrate on patients with p-Akt positive cancer who are refractory to established therapy, and requires biopsies before and after treatment initiation, as well as a negative pregnancy test for women of childbearing potential.",
    "This sample is a phase 1/phase 2 trial for the treatment of diffuse and systemic scleroderma using abatacept and placebo, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 1 trial for men with prostate cancer, testing the drug mdv3100, with inclusion criteria including confirmed adenocarcinoma of the prostate and ongoing androgen deprivation therapy, and exclusion criteria including severe concurrent disease and prior treatment with docetaxel-based chemotherapy.",
    "The sample is a phase 1 trial testing denosumab on subjects with severe CKD and requiring hemodialysis, who have renal impairment with specific ICD-10 codes, and the eligibility criteria includes appropriate calcium, phosphate, and magnesium levels, while the exclusion criteria includes uncontrolled co-morbidities.",
    "The sample is a phase 1/phase 2 trial for postmenopausal women with estrogen and/or progesterone receptor positive adenocarcinoma of the breast, testing the efficacy of exemestane and sunitinib malate, with inclusion and exclusion criteria listed.",
    "This phase 1 trial is testing the efficacy of avx 470 and placebo in treating ulcerative colitis patients with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial testing topotecan hydrochloride on patients with fallopian tube, ovarian, or peritoneal cavity cancer who have received prior chemotherapy and meet specific eligibility criteria.",
    "This phase 1 trial is testing the combination of zio-201-t and doxorubicin in patients with advanced cancer who meet specific eligibility criteria, including adequate bone marrow, liver, and renal function, while excluding those with certain medical conditions or taking certain medications.",
    "This clinical trial is testing the drug cep-18770 for patients with relapsed multiple myeloma that has progressed following therapies that included bortezomib and an IMiD, either alone or in any combination, and is refractory to the most recent therapy or the patient did not tolerate and discontinued the most recent therapy for multiple myeloma but has recovered from its toxic effects.",
    "This is a phase 1 trial for the drug sibutramine in obese adults with a BMI between 30.0 to 40.0 kg/m2 inclusive, and the eligibility criteria includes previous weight loss sustained for a minimum of one month and complete abstinence from intercourse for pre-menopausal female subjects of child bearing potential who are not pregnant or breast feeding.",
    "This trial is testing the efficacy of bez235, prednisone, and abiraterone acetate in treating castrate-resistant prostate cancer patients who meet specific eligibility criteria.",
    "This trial is testing the combination of hydroxychloroquine and gemcitabine for patients with biopsy-proven adenocarcinoma of the pancreas, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for diabetes mellitus type 2, testing the drugs placebo and ly2409021, with eligibility criteria including HbA1c value, BMI, and glucose levels, and exclusion criteria including medical history and alcohol intake.",
    "This phase 1 trial is testing the efficacy of nab-paclitaxel, gemcitabine, and capecitabine in treating metastatic pancreatic adenocarcinoma, with eligibility criteria including histologically-confirmed pancreatic adenocarcinoma, stage IV disease, and no prior systemic therapy.",
    "The sample is a phase 1/phase 2 trial for advanced breast cancer patients with HER2 positive breast cancer, testing the efficacy of hki-272 and trastuzumab, with eligibility criteria including progression following at least one Herceptin-containing cytotoxic chemotherapy regimen and adequate performance status.",
    "This phase 1 trial is testing a placebo vaccine for papillomavirus in healthy females aged 9-25, with various exclusion criteria, and no other drugs listed.",
    "This clinical trial is testing the efficacy of PB1023, a GLP-1 receptor agonist, in treating type 2 diabetes mellitus in patients who meet specific inclusion and exclusion criteria. The trial involves both single and multiple subcutaneous injections of PB1023 or placebo.",
    "This is a phase 1/phase 2 clinical trial for ulcerative colitis, testing the efficacy of he3286 compared to placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 1 trial is testing the efficacy of polatuzumab vedotin and rituximab in treating indolent non-Hodgkin's lymphoma, Grade 3b follicular lymphoma, diffuse large B-cell lymphoma, mantle cell lymphoma, or chronic lymphocytic leukemia, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of bi 207127 na and placebo in treating chronic hepatitis C in adults aged 18-70 with HCV genotype 1 and a confirmed HCV RNA load > 100,000 IU RNA per ml serum at screening, with specific inclusion and exclusion criteria.",
    "This trial is testing the combination of azd0530 and gemcitabine hydrochloride for patients with unresectable pancreatic adenocarcinoma, with eligibility criteria including ECOG 0-2 performance status, normal hematopoietic, hepatic, renal, and pulmonary function, and no other serious medical conditions or illnesses that would preclude study participation.",
    "This phase 1 trial is testing the efficacy of topotecan hydrochloride in treating neoplastic meningitis secondary to leukemia, lymphoma, or solid tumors, with specific eligibility criteria for patients including age, performance status, and prior concurrent therapy.",
    "This sample is a phase 1/phase 2 trial testing the drug imatinib on healthy male non-smokers with seasonal allergic rhinitis caused by Timothy grass pollen allergy, with specific inclusion and exclusion criteria.",
    "This trial is testing the effectiveness of carfilzomib, lenalidomide plus dexamethasone in treating newly diagnosed, previously untreated Stage I, II, or III multiple myeloma patients with measurable disease, and who meet certain eligibility criteria.",
    "The sample is a phase 1/phase 2 trial for patients with progressive hormone-refractory prostate cancer, testing the efficacy of docetaxel, prednisone, and su011248, with inclusion criteria including confirmed adenocarcinoma of the prostate and measurable or non-measurable disease with elevated PSA, and exclusion criteria including prior chemotherapy and history of cardiac dysfunction.",
    "This phase 1 trial is testing the efficacy of fenretinide and SCH66336 in patients with histologically proven squamous cell carcinoma of the head and neck who are not considered curable by standard measures, and have received no more than 2 prior chemotherapeutic regimens for recurrent or metastatic disease.",
    "The sample is a phase 1 trial testing the efficacy of trv130 and morphine for acute pain relief in healthy adult males, with a list of inclusion and exclusion criteria, and icd-10 codes for pain.",
    "This phase 1 trial is testing the efficacy of efalizumab and ranibizumab in treating diabetic macular edema, with specific inclusion and exclusion criteria, and eligibility requirements for female participants.",
    "The sample is a phase 1/phase 2 trial for patients with myelodysplastic syndromes and leukemia, testing the efficacy of azacitidine and lenalidomide as treatment, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 1/2 trial for newly diagnosed acute myeloid leukemia patients who meet specific eligibility criteria, and will test the efficacy of clofarabine, cytarabine, and idarubicin as treatment options.",
    "This trial is testing the effectiveness of BNP and placebo in treating left ventricular diastolic dysfunction in patients with certain eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for HIV infected patients with genotypic or phenotypic resistance to protease inhibitors, testing the efficacy of lopinavir/ritonavir and saquinavir as drugs, with inclusion and exclusion criteria listed.",
    "The sample is a phase 1/phase 2 trial for patients with various hematologic malignancies, testing the efficacy of busulfan, cyclophosphamide, methotrexate, and tacrolimus as a conditioning regimen for allogeneic hematopoietic stem cell transplantation, with eligibility criteria including specific disease characteristics and HLA matching requirements for donors.",
    "This sample is a phase 1/phase 2 trial for the drug tki258 in patients with locally advanced or metastatic melanoma that is refractory to standard therapy, with inclusion criteria including measurable disease and ECOG performance status 0 or 1, and exclusion criteria including concurrent therapy with any other investigational agent and uncontrolled central nervous system metastases.",
    "The sample is a phase 1/phase 2 trial testing the drug gs-9219 on patients with relapsed or refractory non-hodgkin's lymphoma, chronic lymphocytic leukemia, or multiple myeloma, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of various doses of dasatinib, lenalidomide, and dexamethasone in treating relapsed or refractory multiple myeloma, with eligibility criteria including confirmed diagnosis of MM, measurable disease, and ECOG Performance Status of 0-2.",
    "This phase 1 trial is testing the efficacy of ABT-888 and temozolomide in treating metastatic prostate cancer that has progressed despite prior therapies, with eligibility criteria including PSA progression, normal organ function, and use of adequate contraception.",
    "The sample is a phase 1 trial for patients with advanced non-hematologic malignancy, including breast, lung, colon, pancreatic, prostate, head and neck, or sarcoma, who have failed or become intolerant to prior standard therapy and are no longer likely to respond to such therapy, and will be treated with cisplatin, pemetrexed disodium, and sorafenib, with specific eligibility criteria.",
    "This phase 1 trial will test the combination of bortezomib, cetuximab, and cisplatin for the treatment of previously untreated stage IV squamous cell carcinoma, including variants, or undifferentiated/poorly differentiated carcinoma of the head and neck, with eligibility criteria including normal organ and marrow function, ECOG performance status 0-1, and adequate cognitive and neurologic function.",
    "This clinical trial is testing the effectiveness of cyclophosphamide and fludarabine phosphate in treating non-Hodgkin Lymphoma or chronic lymphocytic leukemia patients who have failed at least 2 prior chemotherapy regimens, and have an available related HLA-haploidentical natural killer cell adult donor.",
    "This phase 1 trial is testing the efficacy of oral topotecan and temodar in treating glioblastoma, gliosarcoma, and anaplastic astrocytoma, with inclusion criteria including age over 18, Karnofsky Performance Status over 60%, and serum creatinine less than 1.5 mg/dl or creatinine clearance greater than 60 ml/dL.",
    "This trial is testing the effectiveness of sodium nitrite injection in treating vaso-occlusive crisis in sickle cell disease patients who meet specific eligibility criteria.",
    "This is a phase 1 trial for patients with refractory solid tumor malignancy, testing the efficacy of hsp90 inhibitor auy922, with specific eligibility criteria including measurable lesions, ECOG performance status, and normal blood counts and organ function.",
    "This phase 1 trial is testing the drug compound 506u78 on patients with various hematologic malignancies that have failed standard therapy, with specific eligibility criteria for age, performance status, life expectancy, and various medical histories.",
    "The sample is a phase 1/phase 2 trial for patients with recurrent malignant glioma, testing the efficacy of ixabepilone and anticonvulsant drugs, with eligibility criteria including prior therapy recovery, performance status, blood counts, and stable corticosteroid regimen.",
    "This phase 1 trial is testing nanoparticulate paclitaxel for patients with peritoneal neoplasms who have failed all potentially curative therapy and have no other systemic treatment options available for extra-peritoneal disease.",
    "The sample is a phase 1 trial for stomach neoplasms, testing the drugs cisplatin, s-1, and sunitinib, with eligibility criteria including chemonaive patients with adequate organ function and exclusion criteria including prior chemotherapy failure and contra-indications of S-1 and Cisplatin.",
    "This phase 1 trial is testing the efficacy of e7389 and carboplatin in treating advanced solid tumors, including cancer, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for ovarian, peritoneal, and fallopian tube cancer patients, testing the efficacy of dasatinib, paclitaxel, and carboplatin, with specific eligibility criteria including prior treatment history and adequate organ function.",
    "This phase 1 trial is testing the efficacy of cisplatin in treating recurrent ovarian carcinoma with specific eligibility criteria, including prior platinum-based chemotherapy and a second cytoreductive surgery, and patients must have or plan to have an IP catheter.",
    "This phase 1 trial is testing the efficacy of xl147 and erlotinib in treating non-small cell lung cancer patients who have not responded to standard therapies, and have been previously or currently treated with EGFR/VEGFR tyrosine kinase inhibitors, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for advanced cancer patients with measurable lesions in the thorax, abdomen or pelvis, testing the drug sorafenib, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 1 trial for the drug zgn-440 and its sterile diluent in obese but otherwise healthy females with a BMI between 30 and 45 kg/m2, with inclusion and exclusion criteria specified, and the disease being studied is obesity.",
    "This phase 1 trial is testing the drug panobinostat on patients with recurrent glioma, high-grade meningioma, or brain metastasis, with specific eligibility criteria including laboratory and cardiac function requirements, and exclusion criteria such as prior HDAC or DAC inhibitors, uncontrolled hypertension, and unresolved diarrhea.",
    "This is a phase 1 clinical trial for non-small-cell lung carcinoma, testing the drug celecoxib, with eligibility criteria including confirmed and surgically resectable cancer and ineligibility for neoadjuvant therapy.",
    "The sample is a phase 1/phase 2 trial for follicular lymphoma using rituximab, bortezomib, and ibritumomab tiuxetan, with eligibility criteria including confirmed diagnosis, CD20+ status, and exclusion criteria including prior stem cell transplantation and known hypersensitivity to the drugs.",
    "This phase 1 trial is testing the efficacy of ibritumomab tiuxetan, rituximab, melphalan, and vinorelbine tartrate/g-csf in treating CD20-positive non-Hodgkin's lymphoma patients who have achieved partial or complete response to salvage treatment and have an indication for autologous stem cell transplantation, with specific eligibility criteria for patient characteristics and prior concurrent therapy.",
    "This phase 1 trial is testing the effectiveness of vinorelbine oral and capecitabine in treating metastatic breast cancer patients who meet specific eligibility criteria, including age, measurable disease, liver and renal function, and written informed consent.",
    "This sample is a phase 1/phase 2 trial for HIV infected children weighing between 6 and 30 kilograms, testing the efficacy of gpo-vir z30 tablet, lamivudine, nevirapine, and zidovudine, with eligibility criteria including HAART regimen of NVP and 2 NRTIs, ability to swallow study drugs, and willingness to be hospitalized for 12-hour intensive PK study.",
    "The sample is a phase 1/phase 2 trial for metastatic bladder cancer using pemetrexed, gemcitabine, and platinol, with eligibility criteria including biopsy-proven cancer and exclusion criteria including brain metastases and clinically relevant fluid collection.",
    "This phase 1 trial is testing the combination of ogx-427 and docetaxel in patients with metastatic neoplasms, who have failed potentially curative therapies, and have a possibility of responding to docetaxel, with various inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of ipilimumab, paclitaxel, and carboplatin in treating non-small cell lung cancer patients who have not received prior chemotherapy, hormonal therapy, immunotherapy, or targeted-therapy-containing regimens, and meet certain eligibility criteria.",
    "This phase 1 trial is testing the combination of cisplatin and erlotinib hydrochloride in patients with squamous cell carcinoma of the cervix who are scheduled to undergo standard radiotherapy, and have met the inclusion criteria, while excluding patients with certain medical conditions or who have received certain treatments.",
    "This phase 1 trial is testing the efficacy of temodar (temozolomide) in treating glioblastoma multiforme, with eligibility criteria including prior radiotherapy completion, Karnofsky performance status of > or = 60, and adequate bone marrow, liver, and renal function.",
    "The sample is a phase 1 trial for neoplasms with the drug pf-00299804, and the eligibility criteria includes having no currently approved treatment for the tumor and adequate bone marrow, liver, cardiac, and kidney function.",
    "The sample is a phase 1 clinical trial for liposomal daunorubicin citrate in patients with Kaposi's sarcoma, with eligibility criteria including histologically confirmed KS, serologically confirmed HIV positivity, and no prior anthracycline therapy.",
    "This trial is for patients with graft failure and will test the effectiveness of fludarabine, campath 1h, and fk506 in combination with a healthy donor for engraftment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for previously treated, relapsed or refractory acute lymphoblastic leukemia using vincristine sulfate liposomes injection and dexamethasone, with eligibility criteria including measurable disease, adequate liver and renal function, and negative pregnancy test.",
    "The sample is a phase 1/phase 2 trial for rheumatoid arthritis using rituximab as a drug, with inclusion criteria including a diagnosis of RA and positive RF and/or CCP, and exclusion criteria including allergy to MTX and previous exposure to anti-CD20 monoclonal antibody therapy.",
    "This sample is a phase 1/phase 2 trial testing the drug mifepristone on HIV-1 infected patients with specific eligibility criteria, including a CD4 count of 350 cells/mm3 or more and a willingness to use acceptable forms of contraception during the study and for 30 days after stopping study medication.",
    "The sample is a phase 1 trial for healthy subjects testing the safety and efficacy of maraviroc, fosamprenavir/ritonavir, and their combination, with inclusion criteria of BMI between 17.5 and 30.5 kg/m2 and exclusion criteria of regular alcohol consumption, tobacco use, recent investigational drug treatment, and sulfonamide allergy.",
    "The sample is a phase 1 trial for advanced cutaneous T-cell lymphoma, testing the efficacy of vorinostat and bexarotene as a comparator drug, with eligibility criteria including failure of at least one systemic therapy and ECOG status less than or equal to 2.",
    "The sample is a phase 1/phase 2 clinical trial for patients with multiple myeloma, testing the drug simvastatine, with inclusion and exclusion criteria listed.",
    "The sample is a phase 1/phase 2 trial for Parkinson's disease, testing the efficacy of levodopa and carbidopa solution for sc administration and placebo, with specific inclusion and exclusion criteria for subjects.",
    "This phase 1 trial is testing the drug sb939 on patients with recurrent or refractory solid tumors, lymphoma, CNS tumors, or leukemia, and requires patients to have no known curative therapy or therapy proven to prolong survival with an acceptable quality of life.",
    "This phase 1 trial is testing the efficacy of tivozanib (av-951) plus folfox6 in treating metastatic colorectal cancer and other gastrointestinal malignancies, with strict eligibility criteria including prior treatment history and laboratory values.",
    "The sample is a phase 1 trial for heart failure patients with NYHA Classification II or III, chronic kidney disease, and cardiac ejection fraction <40%, testing the efficacy of clp and spironolactone, with inclusion and exclusion criteria listed.",
    "This phase 1 trial is testing the efficacy of carboplatin and pazopanib in treating metastatic cancer patients who meet specific eligibility criteria, including age, organ function, and absence of certain medical conditions.",
    "The sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the drug asp1941, with inclusion criteria including a fasting plasma glucose level of <240 mg/dL and a BMI of 20.0-35.0kg/m2, and exclusion criteria including type 1 diabetes mellitus and significant renal, hepatic or cardiovascular diseases.",
    "The sample is a phase 1/phase 2 trial for small cell lung cancer, testing the efficacy of topotecan and vorinostat in patients who have relapsed after first-line chemotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with chronic systolic heart failure, testing the efficacy of the drug CXL-1020 and its various doses, with strict inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of cyclophosphamide, cyclosporine, fludarabine phosphate, and mycophenolate mofetil in treating various hematological malignancies, including leukemia, lymphoma, and myelodysplastic syndromes, in patients who meet specific eligibility criteria.",
    "This phase 1 trial is testing the efficacy of doravirine and placebo in treating HIV-1 infection, with eligibility criteria including ART-na\u00efve participants and exclusion criteria including a history of neoplastic disease and chronic Hepatitis C virus.",
    "The clinical trial is testing the efficacy of HKI-272 and paclitaxel in treating advanced breast cancer and malignant solid tumors with specific eligibility criteria, including HER2 positive tumor and prior treatment with Herceptin, while excluding subjects with bone or skin as the only site of disease and those with significant cardiac or gastrointestinal disorders.",
    "This phase 1 trial is testing the efficacy of dasatinib, a drug used to treat chronic myelogenous leukemia, in patients with various solid tumors or imatinib mesylate-resistant leukemia, who have no known curative therapy or survival-prolonging therapy with an acceptable quality of life, and meet a range of eligibility criteria.",
    "The sample is a phase 1/phase 2 trial for kidney transplantation with primary cadaveric or non-HLA-identical living donor kidney, using drugs such as alemtuzumab, sirolimus, and tacrolimus, and with eligibility criteria including no previous kidney transplant, no concomitant systemic corticosteroid therapy, and no known hypersensitivity to the drugs used.",
    "The sample is a phase 1 trial for patients with hematologic neoplasms, testing the drug snx-5422, with inclusion criteria including confirmed hematological malignancy and refractory to available therapy, and exclusion criteria including CNS malignancy and significant GI/liver disease.",
    "This phase 1 trial is testing the efficacy of TMC649128, a HCV polymerase inhibitor, on treatment-naive volunteers with chronic genotype 1a or 1b Hepatitis C virus infection, who have never received a HCV polymerase inhibitor and have HCV plasma RNA levels of > 100,000 IU/mL at screening.",
    "This phase 1 trial is testing the drugs gs-5885 and placebo on patients with HCV infection who meet specific eligibility criteria, including being treatment-na\u00efve and having a viral load of at least 100,000 IU/mL.",
    "The sample is a phase 1/2 trial for patients with metastatic or chest wall recurrent breast cancer who overexpress HER-2 gene, and will test the combination of vorinostat and trastuzumab, with eligibility criteria including no active infection, no history of allergic reaction to compounds of similar chemical or biologic composition to vorinostat or other agents used in study, and normal cardiac function.",
    "This phase 1 trial is testing the efficacy of CUDC-101 and cisplatin in treating locally advanced squamous cell carcinoma of the head and neck, with specific inclusion and exclusion criteria for eligible subjects.",
    "The sample is a phase 1 trial testing the drug bazedoxifene and bazedoxifene/conjugated estrogens on generally healthy postmenopausal women with a BMI between 18.0 to 35.0 kg/m2 and body weight >= 50 kg, and the exclusion criteria includes pregnant or nursing females and females of childbearing potential.",
    "This phase 1 trial is testing the src kinase inhibitor KX2-391 on patients with advanced solid tumors or lymphoma, with eligibility criteria including confirmed diagnosis, ECOG performance status, and various blood count and organ function requirements.",
    "This trial is for patients with metastatic solid tumor malignancy, including prostate cancer, and will test the drug 2-deoxyglucose, with eligibility criteria including age, performance status, and previous treatment, and exclusion criteria including infection, diabetes, and cardiovascular disease.",
    "The sample is a phase 1 trial with healthy volunteers testing the drugs achn-975 and placebo, with inclusion criteria including body weight, contraception use, and negative tests for alcohol, tobacco, and drugs of abuse, and exclusion criteria including a history of clinically significant disease and pregnancy.",
    "This phase 1 trial is testing the efficacy of imatinib mesylate and docetaxel in treating prostate cancer patients who have progressed on conventional hormonal therapy and have bone metastases, with specific eligibility criteria outlined.",
    "This phase 1 trial is testing the efficacy of gemcitabine hydrochloride and topotecan hydrochloride in treating refractory or recurrent ovarian epithelial or fallopian tube cancer patients who have received at least 1 prior platinum- and paclitaxel-based regimen, and have no other active malignancy or underlying medical problem that would prevent compliance.",
    "The sample is a phase 1 clinical trial for alcohol dependence, testing the efficacy of an opioid receptor kappa antagonist drug, with inclusion and exclusion criteria listed.",
    "This phase 1 trial is testing the efficacy of erlotinib and sunitinib in treating non-small cell lung cancer patients who have had one prior chemotherapy regimen, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of erlotinib hydrochloride, pemetrexed disodium, and vinflunine in treating advanced or metastatic solid tumors that are refractory to standard therapy or have no standard therapy available, with specific eligibility criteria for patients.",
    "The sample is a phase 1 trial testing the drug AZD8418 and placebo on healthy male and female volunteers with inclusion and exclusion criteria, and the icd-10 codes for the disease are Z76.3 and Z76.2.",
    "The sample is a phase 1/phase 2 trial for vildagliptin in patients with type 2 diabetes, with inclusion criteria including non-smoking, Caucasian and African American, male and female subjects between 30 and 65 years of age, and exclusion criteria including history of type 1 diabetes or insulin use, coagulation abnormalities, abnormal heart conditions, pregnancy or breastfeeding.",
    "The sample is a phase 1 trial for lung cancer patients with specific disease characteristics and patient characteristics, testing the drug docetaxel, with eligibility criteria including no prior chemotherapy or curative surgery for this cancer, and no prior therapy which specifically targets the EGFR pathway.",
    "The sample is a phase 1 trial testing the effects of placebo, pioglitazone, and hyperinsulinemic euglycemic clamp on overweight and obese individuals with specific inclusion and exclusion criteria, including BMI and medical history.",
    "The sample is a phase 1 trial for patients with malignant solid tumor, biliary cancer, and pancreatic cancer, testing the efficacy of gemcitabine, capecitabine, and zd6474, with inclusion and exclusion criteria for eligibility.",
    "This phase 1 trial is testing the efficacy of kw-2450 in combination with lapatinib and letrozole for patients with advanced or metastatic breast cancer that is ER+ and/or PgR+ and has documented ErbB2 overexpression, with a focus on eligibility criteria and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of sitagliptin, saxagliptin, vildagliptin, and placebo in treating type 2 diabetes mellitus, with strict inclusion and exclusion criteria.",
    "This trial is testing the drug combretastatin a-4 phosphate on patients with age-related macular degeneration and choroidal neovascularization, with strict eligibility criteria including age, visual acuity, lesion size, and medical history.",
    "The sample is a phase 1 trial for low dose cyclophosphamide in patients with ovarian, fallopian tube, or peritoneal cancer who have completed adjuvant treatment, and the eligibility criteria includes previous courses of investigational biologic therapy and exclusion criteria includes concurrent chemotherapy, radiation therapy, and autoimmune disease.",
    "The sample is a phase 1 trial for colorectal cancer using capecitabine as the drug, with eligibility criteria including confirmed primary adenocarcinoma of the rectum, no evidence of metastatic disease, and various medical and age-related requirements.",
    "The sample is a phase 1 trial for type 2 diabetes mellitus, testing the drugs asp1941 and placebo, with inclusion criteria including HbA1c value between 7.0 and 10.0% and fasting plasma glucose \u2265 126mg/dL and < 240mg/dL, and exclusion criteria including type 1 diabetes mellitus and significant renal, hepatic or cardiovascular diseases.",
    "This phase 1 trial is testing the drug E7820 on patients with advanced malignant solid tumors or lymphoma for which no standard therapy is available, and who meet certain eligibility criteria.",
    "The sample is a phase 1 clinical trial testing the drug lenalidomide on patients with Diamond-Blackfan anemia who are red blood cell transfusion-dependent, with specific eligibility criteria including laboratory test results and exclusion criteria such as prior use of lenalidomide or concurrent use of other anti-cancer agents or treatments.",
    "The sample is a phase 1/phase 2 trial for metastatic renal cell carcinoma, testing the efficacy of gefitinib and sunitinib, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for depression, testing the efficacy of vortioxetine and placebo, with inclusion and exclusion criteria based on previous treatment and cognitive dysfunction.",
    "This phase 1 trial is testing the efficacy of AZD2820 and placebo in obese but otherwise healthy male subjects aged 18-45 years with a BMI between 27 and 40 kg/m2, with inclusion and exclusion criteria specified, for the treatment of obesity.",
    "This sample is a phase 1 trial for relapsed/refractory acute leukemia in children, testing the efficacy of AC220, cytarabine, etoposide, and methotrexate, with eligibility criteria including age, disease type, and adequate renal and hepatic functions.",
    "This sample is a phase 1/phase 2 trial for the drug nilotinib in patients with chronic myelogenous leukemia or acute lymphoblastic leukemia (philadelphia chromosome positive) who are either relapsed after or refractory to standard therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for patients with TdT positive acute lymphocytic leukemia or blastic chronic myelogenous leukemia, testing the efficacy of cordycepin and deoxycoformycin, with specific eligibility criteria for age, performance status, life expectancy, and other medical conditions.",
    "This phase 1 trial is testing the use of fludeoxyglucose f 18 in patients with recurrent ovarian cancer, peritoneal cancer, or stage IV ovarian cancer who are platinum resistant or refractory, and have acceptable organ and marrow function, with the goal of improving treatment outcomes.",
    "The sample is a phase 1/phase 2 trial for type 1 diabetes, testing the efficacy and safety of sitagliptin and insulin in patients who meet specific inclusion and exclusion criteria.",
    "This early phase 1 trial is testing the efficacy of lenalidomide in treating relapsed and/or refractory peripheral T-cell lymphomas and cutaneous T-cell lymphoma with nodal/visceral disease, with eligibility criteria including a confirmed diagnosis of the disease, measurable lesions, and laboratory test results within certain ranges.",
    "The sample is a phase 1 trial for recurrent and/or metastatic squamous cell carcinoma of the head and neck, testing the efficacy of emd 1201081 + 5-fu + cisplatin + cetuximab, with specific inclusion and exclusion criteria.",
    "The sample is a clinical trial for patients with nonischemic dilated cardiomyopathy and congestive heart failure, testing the effectiveness of sitagliptin, with inclusion and exclusion criteria listed.",
    "This phase 1 trial is testing the combination of gemcitabine and paclitaxel in patients with metastatic or recurrent head and neck cancer who have failed at least one prior chemotherapeutic regimen, with specific eligibility criteria including ANC, platelet count, hepatic function, and Zubrod Performance Status.",
    "The sample is a phase 1/phase 2 trial for type II diabetes, testing the drugs placebo, sitagliptin, and lez763, with eligibility criteria including age, weight, BMI, and HbA1c levels, and exclusion criteria including smoking and history of drug or alcohol abuse.",
    "This phase 1 trial is testing the drug auy922 on patients with advanced solid tumors, with specific eligibility criteria and exclusion criteria.",
    "This trial is testing the combination of belinostat and erlotinib for patients with non-small cell lung cancer, with specific eligibility criteria including acceptable liver, kidney, and bone marrow function, and exclusion criteria such as active infection or significant cardiovascular disease.",
    "The sample is a phase 1/2 trial for the treatment of castrate-resistant prostate cancer using temsirolimus and casodex, with eligibility criteria including rising PSA levels, failure of previous therapies, and performance status requirements.",
    "The sample is a phase 1/2 trial for patients with gastrointestinal cancer, testing the efficacy of everolimus and tivozanib, with eligibility criteria including age, disease confirmation, ECOG performance status, and adequate organ function, while excluding patients with prior therapy with inhibitors of mTOR or VEGFR, clinically significant cardiovascular disease, and other medical conditions.",
    "The sample is a phase 1 trial for patients with metastatic or locally advanced transitional cell carcinoma of the urothelial tract, testing the efficacy of cisplatin, gemcitabine hydrochloride, and lapatinib ditosylate, with eligibility criteria including measurable disease, overexpression of HER1 and/or HER2 receptors, and specific patient characteristics.",
    "This clinical trial is for newly diagnosed multiple myeloma patients who are ineligible for autologous stem cell transplantation and will test the effectiveness of carfilzomib, cyclophosphamide, and dexamethasone as treatment options.",
    "This phase 1 trial is testing the safety and tolerability of tipranavir and ritonavir in combination with norethindrone-ethinyl estradiol in healthy female subjects, with strict inclusion and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for the drug pirfenidone in patients with diabetes mellitus and diabetic nephropathy, with inclusion criteria including abnormal kidney function and history of proteinuria, and exclusion criteria including cancer, heart disease, and pregnancy.",
    "This phase 1 trial is testing the effectiveness of paclitaxel in treating platinum-resistant or platinum-refractory recurrent epithelial ovarian cancer or primary peritoneal cancer patients with a treatment-free interval of at least three weeks for cytotoxic therapies, radiation therapy, or other experimental drugs prior to first treatment on this protocol.",
    "This phase 1 trial is testing the effectiveness of rad001 and erlotinib on advanced non small cell lung cancer patients who have not responded to chemotherapy treatment, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of ribavirin and ribavirin + pegylated interferon-alpha in treating genotype 1 hepatitis C patients with chronic hepatitis but without cirrhosis, and includes eligibility criteria such as liver biopsy, platelet count, and reliable contraception methods.",
    "The sample is a phase 1 trial for patients with neoplasms, testing the use of mitoxantrone hydrochloride liposome and mitoxantrone drugs, with eligibility criteria including failure of standard chemotherapy and expected survival time \u2265 3 months.",
    "The sample is a phase 1/phase 2 trial for heart failure, testing the drugs trv120027 and placebo, with inclusion criteria including a diagnosis of congestive heart failure and NYHA Class III or IV heart failure.",
    "This phase 1 trial is testing the efficacy of ezatiostat hydrochloride and lenalidomide in treating myelodysplastic syndrome patients with non-del(5q) low or Intermediate-1risk MDS, who have significant cytopenia and have discontinued growth factors for at least 21 days prior to study entry.",
    "This is a phase 1/phase 2 trial for patients with previously treated lymphoma, testing the drug pci-24781, with inclusion and exclusion criteria listed.",
    "The sample is a phase 1 trial for HER2+ cancer patients, testing the drug arry-380, an oral HER2 inhibitor, with eligibility criteria including previous therapy and ECOG performance status, and exclusion criteria including brain metastases and recent chemotherapy or surgery.",
    "The sample is a phase 1 clinical trial for non-dependent, recreational opioid users, testing the effects of alo-02 and crushed oxycodone ir 30 mg on healthy subjects who have experience with intranasal opioid administration, with inclusion and exclusion criteria listed.",
    "The sample is a phase 1 trial for HCV infection testing the drugs ana773 and placebo, with inclusion and exclusion criteria for both Part A and Part B, and icd-10 codes including K94.02, K94.12, K94.22, K94.32, N99.511, A02.9, and A31.0.",
    "This phase 1 trial is testing the safety and tolerability of a combination of aleglitazar, aspirin, and placebo in healthy volunteers, with specific inclusion and exclusion criteria.",
    "This trial is testing the efficacy of voraxaze and placebo in patients with solid tumors and hematologic malignancies who have delayed methotrexate clearance, with inclusion criteria including ECOG performance status 0-2 and exclusion criteria including medications that may interfere with MTX excretion or enhance MTX toxicity.",
    "The sample is a phase 1/phase 2 trial testing the drug Exjade on patients with non-alcoholic steatohepatitis and increased iron storage/disturbed distribution, with specific inclusion and exclusion criteria listed.",
    "This clinical trial is testing the efficacy of docetaxel and everolimus in treating patients with locally advanced or metastatic squamous cell carcinoma of the head and neck who have received one line of prior chemotherapy, and meet specific eligibility criteria.",
    "The sample is a phase 1 trial for cystic fibrosis patients with Burkholderia dolosa lung infection, testing the efficacy of amiloride solution for inhalation, with specific inclusion and exclusion criteria.",
    "This trial is testing the effectiveness of azacytidine and vorinostat, two drugs, in treating relapsed or resistant diffuse large B cell lymphoma, with specific eligibility criteria for patients.",
    "The sample is a phase 1/phase 2 trial testing the efficacy of lapatinib, carboplatin, and paclitaxel in treating relapsed ovarian and metastatic breast cancer patients who have failed previous chemotherapies, with specific inclusion and exclusion criteria. The trial includes patients with ovarian epithelial cancer stage III, stage IV ovarian cancer, and stage IV breast cancer, and the icd-10 codes for the diseases are provided.",
    "The sample is a phase 1/phase 2 trial for gk1-399 and placebo in patients with type 2 diabetes mellitus, with inclusion criteria including stable background medication and BMI between 20-40 kg/m2, and exclusion criteria including type 1 diabetes, recent heart attack or stroke, uncontrolled blood pressure, and significant kidney disease.",
    "The sample is a phase 1/phase 2 clinical trial for atopic dermatitis, testing the efficacy of DPK-060 1% ointment and placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 1 trial for gemcitabine hydrochloride in patients with unresectable or locally advanced pancreatic cancer, with specific eligibility criteria including measurable disease, ECOG performance status, and various laboratory values, and exclusion criteria including prior radiotherapy to the planned field of treatment and prior therapy targeting the EGFR pathway.",
    "The sample is a phase 1 trial for advanced castration-resistant prostate carcinoma with progressive disease, testing the drug ar antagonist (bms-641988), with inclusion criteria including adequate liver and kidney function and exclusion criteria including uncontrolled or significant heart disease and any concurrent cancer.",
    "This phase 1 trial is testing the safety and efficacy of ALS-002200 and placebo in treating chronic hepatitis C, with specific inclusion and exclusion criteria for subjects, such as genotype 1 infection and absence of prior treatment for CHC.",
    "This trial is testing the drug talaporfin sodium on patients with primary hepatocellular carcinoma, with specific eligibility criteria including liver lesions of a certain size and no extrahepatic metastases.",
    "The sample is a phase 1/phase 2 trial for patients with glioblastoma multiforme, testing the efficacy of mpc-6827 + carboplatin, with specific inclusion and exclusion criteria.",
    "This trial is testing the efficacy of temsirolimus and sorafenib in patients with advanced hepatocellular carcinoma who have received sorafenib at 400 mg bid with consecutive dose reduction to 200 mg bid due to intolerance, toxicity or adverse events or patients who are not eligible for full-dose first-line therapy with sorafenib, and meet a range of eligibility criteria.",
    "The sample is a phase 1 clinical trial for obesity, testing the drugs zgn-433 and normal saline, with eligibility criteria including BMI \u2265 30 and \u2264 50 kg/m2, and exclusion criteria including history of eating disorder and gastric bypass surgery.",
    "This phase 1 trial is testing the combination of temsirolimus and gemcitabine for previously untreated metastatic pancreatic adenocarcinoma, with specific eligibility criteria including measurable disease, ECOG performance status 0 or 1, and adequate organ function.",
    "The sample is a phase 1/phase 2 trial for patients with myelofibrosis, polycythemia vera, or thrombocytosis, testing the drug ruxolitinib, with inclusion criteria including diagnosis of PMF or Post-PV/ET MF and adequate bone marrow reserve, and exclusion criteria including receiving anti-cancer medications or investigational therapy in the past 14 days.",
    "The sample is a phase 1 trial for smoking cessation, testing the effectiveness of nicotine (2 mg) and nicotine (4 mg) on healthy smokers with specific inclusion and exclusion criteria, and using a list of icd-10 codes to identify the disease.",
    "This phase 1 trial is testing the efficacy of docetaxel, rad001, and dexamethasone in treating metastatic breast cancer patients who meet certain eligibility criteria.",
    "This clinical trial is testing the safety and efficacy of safinamide and levodopa in treating idiopathic Parkinson's disease, with specific inclusion and exclusion criteria for eligible participants.",
    "The sample is a phase 1 trial for treatment-naive Hodgkin lymphoma, testing the efficacy of a combination of drugs including brentuximab vedotin, doxorubicin, vinblastine, dacarbazine, and bleomycin, with eligibility criteria including measurable disease and Eastern Cooperative Oncology Group performance status <3.",
    "This phase 1 trial is testing the efficacy of carvedilol cr capsules and lisinopril in treating essential hypertension in males and females over 65 years old who are stable on treatment with an ACE inhibitor or angiotensin II receptor antagonist or renin antagonist and no more than one other antihypertensive medication, with eligibility criteria including BMI between 24 and 37 kg/m2 and exclusion criteria including a history of angioedema and treatment with 3 or more antihypertensive medications.",
    "This phase 1 trial will test the efficacy of aliskiren, placebo, and vtp-27999 in healthy adults with renal function, with strict inclusion and exclusion criteria.",
    "This trial is testing the efficacy of abiraterone acetate and prednisone/prednisolone or dexamethasone in treating prostate neoplasms in patients who meet specific inclusion criteria for phase 1 and phase 2, with additional criteria for phase 2 including the presence of target or non-target abnormalities and no prior treatment with ketoconazole for the management of androgen independent prostate cancer.",
    "The sample is a phase 1/phase 2 trial testing the use of fludarabine in patients with severe combined immunodeficiency disease, severe primary immunodeficiency disorder, undefined T cell deficiency disorder, or Wiskott-Aldrich syndrome, who have an HLA mismatched family member or an HLA matched/mismatched unrelated donor, and meet certain eligibility criteria.",
    "This phase 1 trial is testing the drug PCI-32765 on patients with b-cell chronic lymphocytic leukemia or small lymphocytic lymphoma who have had 1-3 prior treatment regimens, and the eligibility criteria includes various symptoms and laboratory values.",
    "The sample is a phase 1 trial for a drug called bi 691751 and placebo on healthy male subjects with specific age and BMI range, and known genotype, with inclusion and exclusion criteria, and the trial involves the study of icd-10 codes Z76.3 and Z76.2.",
    "This is a phase 1 clinical trial for the drug pf 03654746 in patients with schizophrenia, with specific inclusion and exclusion criteria listed, and the diseases and icd-10 codes are also provided.",
    "The sample is a phase 1/phase 2 trial for non-small cell lung cancer patients with stage IIIA or IIIB, testing the drug S-3304, with eligibility criteria including ECOG performance status 0-1 and ability to receive conventional chemoradiation therapy.",
    "This phase 1 trial is testing the efficacy of zopiclone and zolpidem tartrate sublingual tablet for treating insomnia in subjects between the ages of 21 and 64, with a list of exclusion criteria including a history of drug addiction, hypersensitivity to the drugs, and BMI > 29 Kg/M^2.",
    "The sample is a phase 1 trial for patients with recurrent adult brain tumors, testing the efficacy of ziv-aflibercept and temozolomide, with eligibility criteria including various medical conditions and restrictions on prior treatments.",
    "The sample is a phase 1 trial for cancer patients with advanced or refractory solid tumors, testing the efficacy of bay80-6946, with eligibility criteria including Japanese patients over 20 years old with measurable lesions or evaluable disease according to RECIST, and exclusion criteria including patients with active and clinically serious infections or uncontrolled hypertension.",
    "This phase 1 trial is testing the drug bi 10773 on male and postmenopausal or hysterectomised female patients with type 2 diabetes mellitus, who are treated with diet and exercise or a maximum of two oral antidiabetic agents, and have a glycosylated haemoglobin A1 (HbA1c) level of \u00a3 8.5 % at screening.",
    "This trial is testing the drug nkt-01 for the treatment of lupus nephritis in patients who meet specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the safety and tolerability of aleglitazar, ibuprofen, and placebo in healthy volunteers with specific inclusion and exclusion criteria, and the trial is focused on the treatment of lipid disorders.",
    "This early phase 1 trial will test the efficacy of lapatinib, a drug used to treat breast cancer, in patients with bladder carcinoma who are candidates for radical cystectomy and meet specific eligibility criteria.",
    "This sample is a phase 1 trial for eosinophilic esophagitis, testing the efficacy of beclomethasone dipropionate and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for patients with recurrent ovarian or primary peritoneal cancer, testing the efficacy of pemetrexed and carboplatin, with inclusion and exclusion criteria specified.",
    "This phase 1 trial is testing the combination of gemcitabine and sorafenib for locally advanced unresectable or borderline unresectable pancreatic cancer, with eligibility criteria including confirmed diagnosis, measurable disease, and adequate organ function.",
    "This trial is testing the drug vandetanib on patients with platinum-refractory ovarian cancer who have received at least one previous platinum- and taxane-based chemotherapy regimen, and are planned to receive pegylated liposomal doxorubicin, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the drug bi 201335 on patients with liver cirrhosis caused by various factors, including hepatitis C, and the eligibility criteria includes factors such as compensated liver disease and negative serological evidence of active HBV, HCV or HIV infection.",
    "The sample is a phase 1 trial for healthy male subjects testing the drugs birt 2584 xx - multiple escalating dose and birt 2584 xx - single dose, along with a placebo, with inclusion criteria including age, BMI, and signed informed consent, and exclusion criteria including various medical conditions, drug use, and smoking.",
    "This phase 1 trial is testing the efficacy of vorinostat, cytarabine, and etoposide in treating various types of relapsed or refractory leukemia, including acute myeloid leukemia, acute lymphoblastic leukemia, and chronic myelogenous leukemia, among others.",
    "This phase 1 trial is testing the efficacy of gemcitabine plus cisplatin or carboplatin in treating advanced/metastatic solid tumors in patients who have not received more than three prior chemotherapeutic regimens and meet certain eligibility criteria.",
    "The sample is a phase 1 trial testing the drug bi 409306 and placebo on healthy male Chinese and Japanese volunteers with specific genotypes, and the eligibility criteria includes age, BMI, and ability to comply with study requirements.",
    "The sample is a phase 1 trial testing the efficacy of retosiban and moxifloxacin in treating premature obstetric labor, with detailed inclusion and exclusion criteria.",
    "This phase 1 trial is testing the use of metformin in patients with histologically documented colorectal cancer who are medically fit for resection or biopsy, with inclusion criteria including age 18-79 years, adequate renal and hepatic function, and exclusion criteria including current use of metformin, significant medical conditions, and pregnancy or lactation.",
    "This phase 1 trial is testing the efficacy of clofarabine, a drug, in treating relapsed or refractory low or intermediate-grade B-cell lymphoma patients who meet specific eligibility criteria.",
    "The sample is a phase 1 trial for patients with neoplasms, testing the efficacy of azd0530, carboplatin, and paclitaxel, with specific inclusion and exclusion criteria listed.",
    "This phase 1 trial is testing the safety and efficacy of oral azacitidine in treating myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia, with inclusion criteria including adequate organ function and negative pregnancy tests, and exclusion criteria including previous treatment with azacitidine or other demethylating agents and uncontrolled systemic fungal, bacterial, or viral infection.",
    "The sample is a phase 1 trial for patients with advanced and/or metastatic solid tumor malignancy, testing the efficacy of the drug rg4733, with inclusion and exclusion criteria listed. The trial focuses on neoplasms and uses a list of icd-10 codes to identify eligible patients.",
    "This is a phase 1/phase 2 trial for a vaccine for influenza, using placebo as the drug, with eligibility criteria including age, health status, and absence of allergies or other medical conditions.",
    "This is a phase 1 clinical trial for patients with non-small cell lung cancer who have failed at least one prior platinum-based chemotherapy regimen, and will test the efficacy of docetaxel as a treatment option. The eligibility criteria includes age, disease type, prior treatments, and various health parameters.",
    "The sample is a phase 1/phase 2 trial for non-small cell lung cancer patients, testing the efficacy of carboplatin, erlotinib hydrochloride, and paclitaxel, with eligibility criteria including specific disease characteristics and patient characteristics, and restrictions on prior concurrent therapy.",
    "This trial is testing the efficacy of chr-2797 (tosedostat), an aminopeptidase inhibitor, in treating acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma patients who have relapsed or are refractory to front line and/or salvage therapy, and who are not candidates for chemotherapy.",
    "This phase 1 trial is testing the drug XL184 on patients with advanced malignancies including lymphoma, cancer, and thyroid carcinoma, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for patients with progressive metastatic prostate cancer, testing the drug odm-201, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 1 trial for patients with locally advanced unresectable or metastatic gastric, gastro-oesophageal or colorectal adenocarcinoma, testing the effects of TKI258 and XELOX drugs on the disease, with eligibility criteria including normal organ and marrow function, age >18 years, and ECOG performance status <2.",
    "This phase 1 trial is testing the efficacy of vandetanib, 5 fluorouracil, carboplatin, and paclitaxel in treating potentially resectable cancer of the esophagus, gastroesophageal junction, or stomach, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 clinical trial for Alzheimer's disease, testing the drugs pf-03654746 and placebo, with inclusion criteria of probable Alzheimer's disease, Mini Mental State Examination score 18-26 inclusive, and aged 55-85, and exclusion criteria of dementia other than Alzheimer's disease, clinically significant cardiovascular disease in the past 6 months prior to screening, and creatinine clearance <30 mL/min.",
    "This phase 1 trial will test the drugs ly2584702, erlotinib, and everolimus on patients with metastatic neoplasms, non-small cell lung carcinoma, renal cell carcinoma, and neuroendocrine tumors, who meet specific eligibility criteria.",
    "This phase 1 trial is testing the drug alisertib on East Asian participants with metastatic and/or advanced solid tumors or lymphomas for which no effective standard treatment is available, with eligibility criteria including expected survival longer than 3 months and radiographically or clinically evaluable tumor.",
    "This trial is for phase 1/phase 2 and focuses on ovarian cancer, using drugs such as carboplatin, cyclophosphamide, etoposide, paclitaxel, and topotecan hydrochloride, with eligibility criteria including histologically proven stage IIIC ovarian epithelial cancer and achieved at least partial response (PR) following six courses of standard dose chemotherapy.",
    "The sample is a phase 1/2 trial for metastatic malignant melanoma using karenitecin and valproic acid as drugs, with inclusion criteria including age, performance status, and hematological function, and exclusion criteria including active infection and uncontrolled CNS metastasis.",
    "This phase 1 trial is testing the efficacy of forodesine hydrochloride in treating refractory cutaneous T-cell lymphoma patients with measurable disease, and the eligibility criteria includes age, performance status, life expectancy, hematopoietic, hepatic, renal, immunologic, and other factors.",
    "This is a phase 1/phase 2 clinical trial for ovarian cancer patients who have relapsed after platinum-based chemotherapy, testing the efficacy of lenvatinib, carboplatin, and gemcitabine, with strict eligibility criteria including age, disease stage, performance status, and various laboratory values.",
    "This early phase 1 trial is testing the drug panobinostat (lbh589) on patients with stage IV tamoxifen-refractory breast cancer, with a list of eligibility criteria including laboratory criteria, cardiac function, and concurrent medication use.",
    "The sample is a phase 1 trial for tumors with the drugs azd1152 part a and azd1152 part b, and eligibility criteria including histological confirmation of a solid, malignant tumor and at least one measurable or non-measurable site of disease as defined by RECIST criteria.",
    "This phase 1 trial is testing the drug bi 6727 on patients with advanced, non-resectable and/or metastatic solid tumors, with a list of inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of raltegravir and emtricitabine/tenofovir disoproxil fumarate in treating HIV infections in antiretroviral treatment naive patients with specific viral load criteria and eligibility criteria, while excluding those with certain allergies, illnesses, or substance abuse issues.",
    "The sample is a phase 1 trial testing rifabutin and rifabutin + atazanavir + ritonavir in healthy subjects with antivirals/hiv, with inclusion criteria of BMI between 18 to 32 kg/m\u00b2 and normal physical and laboratory test findings, and exclusion criteria of any significant acute or chronic medical illness or use of prescription drugs or over-the-counter acid controllers within 4 weeks prior to study drug administration.",
    "This sample is a phase 1/phase 2 trial for patients with hepatocellular carcinoma, testing the efficacy of mapatumumab and sorafenib as compared to placebo, with eligibility criteria including measurable disease and adequate bone marrow, renal and liver function.",
    "The sample is a phase 1 trial for pancreatic neoplasms testing the combination of nelfinavir and gemcitabine, with eligibility criteria of being closed to accrual.",
    "The sample is a phase 1/phase 2 trial for patients with locally advanced or metastatic colorectal cancer, testing the efficacy of bevacizumab and ag-013736 (axitinib) in combination with chemotherapy, with specific inclusion and exclusion criteria.",
    "This trial is testing the effectiveness of sorafenib and topotecan in treating patients with histologically-confirmed epithelial ovarian cancer, primary peritoneal carcinomatosis or fallopian tube cancer who have failed at least one prior platinum based chemotherapeutic regimen.",
    "The sample is a phase 1/phase 2 trial testing the use of smoked cannabis for patients with multiple sclerosis who have moderate or severe spasticity, with inclusion criteria including diagnosis of clinically definite multiple sclerosis and exclusion criteria including preexisting pulmonary and cardiac conditions, recent cannabis use of more than twice per week one month prior to study entry, and inability to provide informed consent.",
    "This phase 1 trial is testing the drug clofarabine on patients with relapsed or refractory acute myelogenous leukemia who meet certain eligibility criteria, including age and performance status, while excluding patients with certain medical histories or conditions.",
    "The sample is a phase 1 trial for the treatment of chronic hepatitis C with the drug SCH 900518, which is being tested on subjects who are treatment-na\u00efve or treatment-experienced, and have acceptable medical history and laboratory evaluations, with a list of inclusion and exclusion criteria.",
    "This trial is testing the drug lenalidomide on patients with urinary bladder neoplasms, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 1 trial is testing the use of topotecan in patients with histologically confirmed rectal cancer who are candidates for preoperative radiotherapy and meet specific eligibility criteria.",
    "This phase 1 trial is testing the drug everolimus (rad001) on Chinese patients with metastatic renal cell carcinoma who have progressed on or are intolerant to VEGF-targeted therapies, and meet certain eligibility criteria.",
    "This is a phase 1 clinical trial for patients with relapsed or refractory multiple myeloma, testing the efficacy of the drugs rad001 and lenalidomide, with eligibility criteria including age, performance status, and negative pregnancy test.",
    "This phase 1 trial is testing the efficacy of vibegron and tolterodine er, along with prophylactic antibiotics, in treating overactive bladder symptoms in participants who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial testing the drug alemtuzumab on patients with ovarian, fallopian tube, or peritoneal cancer that has progressed or recurred, with specific eligibility criteria outlined in the table.",
    "This phase 1 trial is testing the combination of lenalidomide and dacarbazine in patients with metastatic melanoma, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "The sample is a phase 1 trial for chronic hepatitis B, testing the efficacy of gs-7340 and tenofovir disoproxil fumarate, with inclusion criteria including age, HBV DNA levels, and creatinine clearance, and exclusion criteria including co-infection with other viruses, liver disease, and cardiovascular disease.",
    "This phase 1 trial will test the safety and efficacy of qgc001 and placebo in healthy Caucasian males with essential hypertension, who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 1/2 trial for advanced non-small cell lung cancer, testing the efficacy of carboplatin, hydroxychloroquine, and paclitaxel, with eligibility criteria including measurable disease, ECOG performance status 0-1, and no other active malignancy within the past 3 years.",
    "This phase 1 trial is testing the combination of OSI-906 and irinotecan in patients with advanced colorectal cancer who have received and progressed or are intolerable of first-line therapy with an oxaliplatin-containing regimen, and have known Kirsten rat sarcoma (KRAS) mutation status.",
    "The sample is a phase 1/phase 2 trial for acute ischemic stroke, testing the efficacy of mrx-801 and placebo drugs, with inclusion criteria including occlusion demonstrated by transcranial Doppler ultrasound and eligibility for tPA, and exclusion criteria including right to left cardiac shunt, moderate to severe COPD, and uncontrolled hypertension.",
    "This trial is testing the drug lisofylline on adults with type 1 diabetes mellitus who have been on a stable dose of insulin for at least 3 months, with the goal of improving blood glucose control.",
    "The sample is a phase 1/phase 2 trial for recurrent childhood acute lymphoblastic leukemia, testing a combination of drugs including l-asparaginase, doxorubicin hydrochloride, and methotrexate, with eligibility criteria including diagnosis of B lymphoblastic leukemia and certain performance status and laboratory values.",
    "The sample is a phase 1/phase 2 trial for patients with mild bronchial asthma, testing the sensitivity to methacholine with a provocation concentration of methacholine resulting in a 20% fall in FEV1 (PC20 methacholine) of \u2264 8 mg/ml at screening, using active and placebo drugs, and with inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of azacitidine, lenalidomide, and grifola frondosa in treating advanced cancers that are refractory to standard treatment or for which no standard therapy is available, with specific eligibility criteria for patients.",
    "The sample is a phase 1 trial for asthma, testing the drugs gw870086x and placebo, with inclusion criteria including male subjects aged 18-55 with documented history of bronchial asthma and sensitivity to adenosine mono phosphate (AMP), and exclusion criteria including significant illness or disease, history of life threatening asthma, and subjects who take medication for their asthma or other conditions not compatible with the study.",
    "The sample is a phase 1/phase 2 clinical trial testing the drug mln8237 (alisertib) on patients with advanced nonhematological malignancies, non-small cell lung cancer, small cell lung cancer, metastatic breast cancer, head and neck squamous cell carcinoma, and gastroesophageal adenocarcinoma, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for adults with type 2 diabetes mellitus, testing the efficacy of LX4211 and Januvia\u00ae as blood glucose lowering agents, with specific inclusion and exclusion criteria.",
    "This is a phase 1 trial for patients with locally advanced unresectable or metastatic pancreatic adenocarcinoma, testing the drug vandetanib, with inclusion criteria including confirmed diagnosis, ECOG performance status <1, and measurable disease, and exclusion criteria including severe or uncontrolled systemic disease, clinically significant cardiac event, and any concomitant medication that may cause OTc prolongation.",
    "The sample is a phase 1 clinical trial testing the drug pf-00299804 on patients with advanced non-small cell carcinoma and neoplasm metastasis, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 1 trial for type 2 diabetes mellitus, comparing sitagliptin phosphate and placebo, with inclusion criteria for poorly controlled participants not taking more than two oral antidiabetic medications and exclusion criteria for insulin therapy within the prior 8 weeks or TZD use within the prior 12 weeks.",
    "The sample is a phase 1/phase 2 trial for the treatment of intermittent claudication using trans sodium crocetinate (TSC) and 0.9% normal saline, with eligibility criteria including a diagnosis of PAD secondary to atherosclerosis and stable claudication severity, and exclusion criteria including previous treatment with TSC and poorly controlled type 1 or type 2 diabetes.",
    "The sample is a phase 1 trial testing the drug rm-131 and placebo on patients with diabetes mellitus type 1 and 2, gastroparesis, and gastrointestinal motility disorder, with specific eligibility criteria including controlled diabetes and BMI range.",
    "The sample is a phase 1 trial for patients with relapsed or refractory multiple myeloma, testing the efficacy of dexamethasone, sorafenib tosylate, and lenalidomide, with eligibility criteria including measurable disease and specific patient characteristics.",
    "This trial is testing the efficacy of obatoclax mesylate and topotecan hydrochloride in treating recurrent small cell lung cancer and unspecified adult solid tumors, with eligibility criteria including no progressive brain metastases and normal blood counts.",
    "This phase 1 trial will test the safety and efficacy of the drug zygk1 and placebo in male and female volunteers with type 2 diabetes, with inclusion and exclusion criteria specified.",
    "This phase 1 trial is testing the drug vosaroxin on patients with relapsed or refractory leukemia, who meet specific eligibility criteria, and have not been previously exposed to the drug.",
    "The sample is a phase 1/phase 2 trial for metastatic melanoma using mpc-6827 + temozolomide as drugs, with inclusion criteria such as histologically proven melanoma and unresectable melanoma with measurable metastases, and exclusion criteria such as hypersensitivity to Cremophor EL and cardiovascular disease.",
    "The sample is a phase 1/phase 2 trial for chronic myeloid leukemia patients with primary or acquired resistance to imatinib mesylate, testing the efficacy of dasatinib, with inclusion and exclusion criteria specified.",
    "The sample is a phase 1/phase 2 trial for recipients of liver transplantation with hepatitis B core antibody positive grafts, testing the efficacy of adefovir dipivoxil and hepatitis B vaccination in preventing hepatitis B infection, with inclusion and exclusion criteria listed, and diseases including hepatitis B and liver transplantation, and drugs including adefovir dipivoxil and hepatitis B vaccination.",
    "The sample is a phase 1/phase 2 trial testing the drug Torisel on patients with advanced adenocarcinoma or neoplasms, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1/2 trial for patients with advanced non-hematologic malignancy, including brain and central nervous system tumors, melanoma, and solid tumors, testing the efficacy of ps-341 (velcade) and temozolomide, with eligibility criteria including adequate organ system function and completion of prior chemotherapy, and exclusion criteria including peripheral neuropathy and uncontrolled infection.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia, or acute leukemia of ambiguous lineage, testing the efficacy of clofarabine, cytarabine, and methotrexate, with specific eligibility criteria for patients' disease and patient characteristics.",
    "This trial is testing the efficacy of bevacizumab and bortezomib in treating patients with Stage IIIB or Stage IV non-small cell lung cancer who have received one or two prior systemic therapies containing a platinum compound, and have no history of brain metastases, with a set of eligibility criteria that includes having an ECOG Performance Status of 0-2, adequate hepatic function, and no other concurrent anticancer treatment.",
    "The sample is a phase 1/2 trial for HIV infections testing the efficacy of raltegravir poloxamer film coated tablet, raltegravir chewable tablet, and raltegravir oral granules for suspension (20 mg/ml) with inclusion criteria including HIV-1 infection, unchanged therapeutic regimen for at least 12 weeks, and HIV RNA of 1,000 copies/mL or greater at screening.",
    "This phase 1 trial is testing the efficacy of erwinase, vincristine, dexamethasone, doxorubicin, cytarabine, methotrexate, triple intrathecal therapy, and dexrazoxane in treating relapsed acute lymphoblastic leukemia patients with a history of E. coli asparaginase allergy who have had no more than two prior therapeutic attempts.",
    "This trial is for patients with malignant pleural mesothelioma and will test the effectiveness of chemotherapy, with specific eligibility criteria including no previous chemotherapy and adequate organ function.",
    "This phase 1 trial is testing the drug bkm120 on patients with advanced solid tumors who have genetic or molecular alteration of the PI3K pathway, and have not been treated with a PI3K inhibitor before, and the trial has eligibility criteria for patients to be included or excluded. The trial is focused on breast cancer, colon cancer, ovarian cancer, and endometrium cancer.",
    "This phase 1 trial is testing the efficacy of amg 557 and amg 557 placebo in treating subacute cutaneous lupus erythematosus (SCLE) with or without systemic lupus erythematosus (SLE) in patients who are intolerant of anti-malarial therapy or have residual disease activity despite at least 3 months of anti-malarial therapy.",
    "The sample is a phase 1 trial testing the efficacy of brentuximab vedotin, cyclophosphamide, prednisone, doxorubicin, and vincristine in treating CD30-positive mature T-cell and NK-cell neoplasms, including systemic anaplastic large cell lymphoma, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of bortezomib, carboplatin, and docetaxel in treating non-small cell lung cancer patients who meet specific eligibility criteria.",
    "This trial is testing the drug ecopipam on subjects with Tourette's Syndrome who meet specific inclusion criteria, while excluding those with certain medical conditions or who have taken certain medications in the past.",
    "The sample is a phase 1/phase 2 trial for advanced non-small cell lung cancer patients who have progressed after treatment with at least one chemotherapy regimen, testing the efficacy of docetaxel and npi-2358 + docetaxel, with eligibility criteria including ECOG performance status \u2264 1 and exclusion criteria including brain metastases and concurrent, active second malignancy.",
    "This phase 1 trial is testing the efficacy of cisplatin and everolimus in treating advanced solid tumors or recurrent/metastatic solid tumors with measurable disease, while also assessing patient eligibility based on various criteria such as performance status, blood counts, liver function, and gastrointestinal function.",
    "The sample is a phase 1 trial for non-small-cell lung carcinoma, testing the efficacy of azd2171, paclitaxel, and carboplatin, with specific inclusion and exclusion criteria for patients.",
    "This phase 1 trial is testing the combination of vorinostat and decitabine in patients with relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia, chronic myelogenous leukemia in blast crisis, non-Hodgkin's lymphoma, or metastatic or unresectable solid tumors, with eligibility criteria including normal marrow function, ECOG performance status 0-2, and no ongoing or active infection.",
    "The sample is a phase 1 trial for patients with metastatic colorectal adenocarcinoma, testing the efficacy of folfox-4, amg 706, and folfiri, with specific eligibility and exclusion criteria.",
    "This phase 1 trial is testing the drug XL765 (sar245409) on patients with metastatic or unresectable solid tumors, with eligibility criteria including adequate organ function, negative pregnancy test, and no prior malignancy diagnosis.",
    "The sample is a phase 1/phase 2 trial for patients with non-small cell lung cancer, testing the efficacy of everolimus and gefitinib, with eligibility criteria including prior chemotherapy, performance status, and various medical conditions.",
    "This phase 1 trial is testing the drug cnf2024 on patients with solid tumors and lymphoma who have failed standard therapies, and have met certain eligibility criteria.",
    "This phase 1 trial is testing the efficacy of capecitabine, cisplatin, and imatinib mesylate in treating unresectable and/or metastatic gastric cancer patients with confirmed c-kit (CD117) and PDGF-R overexpression, who meet specific eligibility criteria.",
    "The sample is a phase 1 trial for atherosclerotic vascular disease, testing the efficacy of atorvastatin and placebo, with inclusion and exclusion criteria related to age, statin use, HIV/Hepatitis B or C, illegal drug use, Type I diabetes, and claustrophobia.",
    "This phase 1 trial is testing the drug spc5001 on healthy subjects and those with heterozygous Familial Hypercholesterolemia, with the goal of reducing LDL levels, and includes eligibility criteria such as BMI, hematology, and exclusion criteria such as active infections and use of certain medications.",
    "The sample is a phase 1 trial for patients with type 2 diabetes, testing the efficacy of gk activator and ethanol, with inclusion criteria of age, diabetes type, and hepatic function, and exclusion criteria of certain diabetes complications and recent treatment with insulin or PPAR gamma agonist.",
    "The sample is a phase 1/phase 2 trial for patients with relapsed or refractory CD20-positive B-cell non-Hodgkin's lymphoma, testing the efficacy of pegylated liposomal doxorubicin hydrochloride, with eligibility criteria including measurable disease and prior chemotherapy regimens, and patient characteristics such as Karnofsky performance status and hematopoietic, hepatic, renal, and cardiovascular function.",
    "The sample is a phase 1/phase 2 trial for patients with ovarian cancer, peritoneal cancer, fallopian tube cancer, and bowel obstruction, testing the efficacy of cisplatin and paclitaxel, with eligibility criteria including CT findings suggestive of complete bowel obstruction and non-surgical candidacy.",
    "The sample is a phase 1/phase 2 trial for HIV infections testing the safety and efficacy of tipranavir and ritonavir capsules in patients with a documented HIV-1 RNA load and stable ZDV or ABC regimen for at least 6 months.",
    "This phase 1 trial is testing the drugs ly2228820, midazolam, and tamoxifen on patients with advanced cancer who have no higher priority therapy available, and have adequate organ function and performance status, while excluding those with certain medical conditions or who are pregnant or lactating.",
    "This phase 1 trial is testing the drugs ly2090314, pemetrexed, and carboplatin on patients with advanced cancer who meet certain eligibility criteria.",
    "The sample is a phase 1 trial for patients with cancer, testing the drug arq197, with inclusion criteria including refractory to available therapy, KPS \u2265 70%, and adequate organ function, and exclusion criteria including recent anti-cancer therapy and symptomatic brain metastases.",
    "The sample is a phase 1/phase 2 trial testing the drug td-1211 and placebo on healthy subjects and those with opioid-induced constipation, with inclusion and exclusion criteria listed, and diseases identified as \"healthy\" and \"opioid-induced constipation\" with corresponding ICD-10 codes.",
    "This early phase 1 trial is testing the efficacy of vardenafil and carboplatin in treating recurrent malignant glioma or metastatic brain cancer, with eligibility criteria including normal hematologic, renal and liver function, and exclusion criteria including serious concurrent infection or medical illness, pregnancy or breast-feeding, and allergy to 5HT-(3) receptor antagonist including tropisetron, ondansetron.",
    "This phase 1 trial is testing the drugs cs-1008 and folfiri on patients with metastatic colorectal cancer who have progressed after first-line standard therapy that was not irinotecan-based, and have adequate organ and bone marrow function, while also meeting other eligibility criteria.",
    "This phase 1 trial is testing the drugs alvocidib hydrochloride and cyclophosphamide on patients with chronic lymphocytic leukemia and other related diseases, who meet specific eligibility criteria.",
    "The sample is a phase 1 trial for caucasian patients with chronic hepatitis C genotype 1 who are non-responders to previous therapy with peginterferon alfa and ribavirin, and the trial will test the efficacy of four different peginterferon alfa-2a drugs, with specific inclusion and exclusion criteria.",
    "This is a phase 1 trial for the treatment of primary insomnia using the drugs neu-p11 and neu-p11 placebo, with eligibility criteria including sleep latency and total sleep time, medical history, and use of other medications.",
    "The sample is a phase 1 clinical trial testing the safety and efficacy of multiple fentanyl transdermal systems combined with clinical procedures in healthy subjects, with strict inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of sorafenib tosylate and temsirolimus in treating melanoma patients who meet specific eligibility criteria, including having accessible tumors and normal bilirubin and creatinine levels.",
    "The sample is a phase 1 trial for epilepsy, testing the effects of brivaracetam, levetiracetam, and lorazepam on healthy volunteers with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the efficacy of dasatinib in patients with leukemia who are resistant or intolerant to prior imatinib mesylate, and have received and benefitted from \u2265 3 months of prior therapy with dasatinib on protocol UCLA-0303035.",
    "This phase 1 trial is testing the safety and tolerability of the drug azd3839 and its placebo in healthy volunteers, with a focus on blood concentration, and includes eligibility criteria such as age, BMI, and normal creatinine clearance.",
    "This trial is for patients with metastatic prostate cancer who have received prior therapy with docetaxel and will test the efficacy of abt-751, with eligibility criteria including evidence of radiographic progression and adequate hematologic, renal and hepatic function.",
    "This phase 1 trial is testing the drug hydroxyurea on patients with advanced solid tumors who have progressed on standard therapy, and have measurable or evaluable disease, with eligibility criteria including a Karnofsky Performance status of > 70, predicted life expectancy of at least 3 months, and adequate renal, bone marrow, and hepatic function.",
    "The sample is a phase 1/phase 2 trial for primary open-angle glaucoma and ocular hypertension, testing the drugs opa-6566, placebo, and latanoprost, with inclusion and exclusion criteria specified in the eligibility criteria section.",
    "The sample is a phase 1/phase 2 trial for patients with acute myocardial infarction, testing the efficacy of Lovaza\u00ae and a placebo containing corn oil, with eligibility criteria including post-PCI TIMI flow grade = 3 and exclusion criteria including known allergy to fish, fish oil, or aspirin.",
    "The sample is a phase 1 trial for type 1 diabetes using insulin lispro, with inclusion criteria based on age, BMI, and diagnosis, and exclusion criteria including type 2 diabetes, hypersensitivity to study medication, and recent use of investigational drugs or drug/alcohol abuse.",
    "The sample is a phase 1 clinical trial for non-squamous non-small cell lung cancer testing the efficacy of linifanib, carboplatin, and paclitaxel, with eligibility criteria including age, disease confirmation, disease stage, prior treatment, measurable disease, performance score, and adequate organ function.",
    "The sample is a phase 1 trial testing high-dose methotrexate and leucovorin for osteosarcoma, leukemia, and lymphoma patients with specific eligibility criteria, including impaired renal function and delayed MTX elimination.",
    "This phase 1 trial will test the safety and efficacy of the drug srt2379 and placebo in healthy male subjects between 18 and 35 years of age with sepsis, who meet certain inclusion criteria and do not have any exclusion criteria.",
    "This trial is testing the efficacy of docetaxel, cisplatin, and sti571 in treating non-small cell lung cancer patients who meet specific eligibility criteria.",
    "This trial is testing the effectiveness of lo-ovral oral contraceptive pills and placebo in treating aplastic anemia, menorrhagia, and amenorrhea in women aged 12-55 years with a uterus and at least one functioning ovary, who have bone marrow failure and require treatment with chemotherapy or stem cell transplantation.",
    "The sample is a phase 1/phase 2 trial testing the drugs zalutumumab and cisplatin on patients with locoregionally advanced squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx or larynx, with specific inclusion and exclusion criteria, and icd-10 codes for the diseases.",
    "The sample is a phase 1 trial for breast cancer patients with metastatic disease, testing the drugs letrozole and dhea, with eligibility criteria including hormone receptor status, ECOG performance status, and prior concurrent therapy restrictions.",
    "The sample is a phase 1 clinical trial testing the efficacy of pazopanib and ixabepilone in treating advanced non-hematologic solid tumor malignancy, including breast, lung, colon, pancreatic, head and neck, kidney, sarcoma, and hepatocellular cancer, with specific eligibility criteria and exclusion criteria.",
    "This phase 1 trial aims to test the efficacy of different doses of insulin glargine in 12 adults with type 2 diabetes, using a placebo as a control, and with eligibility criteria including HgbA1c levels between 7-12%, age between 18-70 years, and BMI between 27-40 kg/m\u00b2.",
    "This phase 1 trial is testing the efficacy of namilumab and placebo in treating active rheumatoid arthritis in patients who are on stable doses of methotrexate, with specific inclusion and exclusion criteria.",
    "This trial is testing the use of aliskiren, a drug, in patients with type 2 diabetes and nephropathy, with specific inclusion and exclusion criteria.",
    "This trial is testing the effectiveness of mitomycin c and chemophase in treating bladder cancer patients who meet specific eligibility criteria, including having a Karnofsky Performance Status greater than or equal to 80% and acceptable liver and renal function, while excluding those with a history of bladder fibrosis or urinary incontinence that would compromise the ability to retain the study drug.",
    "The sample is a phase 1 trial for a drug called bi 1026706, with a focus on healthy male subjects, and includes both a placebo and the drug being tested.",
    "The sample is a phase 1 trial testing the efficacy of dalotuzumab, mk-0752, ridaforolimus, and mk-2206 in treating metastatic or locally advanced solid tumors, with specific inclusion and exclusion criteria, and requiring gene expression analysis.",
    "This is a phase 1 clinical trial for healthy males testing the safety and tolerability of bi 1744 cl and placebo, with specific inclusion and exclusion criteria, including age, BMI, and medical history.",
    "The sample is a phase 1 clinical trial testing the effects of clopidogrel and placebo on healthy subjects with specific CYP2C19 genotypes and eligibility criteria, with the goal of determining the drug's efficacy and safety.",
    "This trial is testing the efficacy of belinostat, paclitaxel, and carboplatin in treating various types of cancer, including ovarian and bladder cancer, with specific eligibility criteria for patients, such as having no known curative therapy and acceptable liver, renal, and bone marrow function.",
    "The sample is a phase 1/2 trial for pediatric patients with relapsed or refractory acute lymphoblastic leukemia, testing a combination of drugs including abt-751, dexamethasone, and peg-asparaginase, with eligibility criteria including age, prior therapy, and reproductive function.",
    "This sample is a phase 1 trial testing the drug bi 1021958 in healthy individuals and those with mild controlled asthma, with a list of icd-10 codes for asthma, and eligibility criteria including being a non-childbearing potential male or female.",
    "The sample is a phase 1 trial for GSK716155 and placebo in patients with type 2 diabetes mellitus, with inclusion criteria including BMI <=35kg/m2 and age 20-70, and exclusion criteria including clinically significant cardiovascular disease and previous use of insulin as a treatment for diabetes within 3 months.",
    "The sample is a phase 1 trial for chronic lymphocytic leukemia, testing the drugs gx15-070ms, with inclusion criteria including previous chemotherapy and ECOG Performance Status \u22641, and exclusion criteria including patients receiving other investigational agents or with a history of seizure disorders.",
    "The sample is a phase 1/2 trial for patients with various hematologic malignancies, including leukemia, lymphoma, and myeloma, who have failed or are ineligible for autologous transplant, and will receive a transplant of two umbilical cord blood units after conditioning with cyclophosphamide and fludarabine phosphate.",
    "This phase 1 trial is testing the drug NK012 on patients with various types of cancer who have failed conventional therapy, and have recovered from acute adverse effects of prior therapies, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of busulfan, fludarabine phosphate, mycophenolate mofetil, and tacrolimus in treating advanced hematologic malignancies, including leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes, in patients who are not eligible for autologous stem cell transplantation or conventional therapy and have an available umbilical cord blood donor.",
    "The sample is a phase 1 trial for tumors, using dasatinib and ketoconazole as drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This clinical trial is testing the use of fludarabine and treosulfan in combination with allogeneic bone marrow or peripheral blood stem cell transplantation for patients with leukemia or myelodysplastic syndromes, with specific eligibility criteria including donor availability and certain patient characteristics.",
    "This phase 1 trial is testing the drug lenalidomide on patients with wild type metastatic colorectal cancer who have failed on at least two treatment regimens, and have received prior treatment with at least 2 prior regimens of therapy, while adhering to specific eligibility criteria.",
    "The sample is a phase 1 trial for the treatment of schizophrenia, Alzheimer's disease, and cognition disorders using the drug JNJ-39393406 and placebo, with eligibility criteria including a history of schizophrenia, stable treatment for at least 3 months, and a BMI between 18 and 35 kg/m\u00b2.",
    "This phase 1 trial is testing the drug enzastaurin on participants with solid tumors or malignant lymphoma who have no life-prolonging therapy available, and have met certain eligibility criteria.",
    "This is a phase 1 trial testing the drug aliskiren on female subjects with end stage renal disease who have been on intermittent hemodialysis for at least three months and are in relatively good health, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for graft versus host disease, testing the use of rapamycin and tacrolimus as GVHD prophylaxis in patients who received an allogeneic MSD or MUD PBSCT, with specific inclusion and exclusion criteria.",
    "This clinical trial is testing the efficacy of bortezomib and sorafenib in treating relapsed or refractory multiple myeloma patients who have received no more than 2 prior regimens, and meet specific eligibility criteria.",
    "This is a phase 1 trial for a drug called gsk573719, which will be tested on patients with pulmonary disease, chronic obstructive, and the eligibility criteria includes normal spirometry, non-smokers, and no significant abnormality on 12-lead ECG at screening.",
    "This phase 1 trial is testing the efficacy of dacarbazine and bortezomib in treating various types of tumors, including melanoma, soft tissue sarcoma, and carcinoid tumors, with specific eligibility criteria for patients, such as measurable or evaluable disease and ECOG Performance Status 0 or 1.",
    "This phase 1 trial is testing the efficacy of bleselumab and placebo in kidney transplant recipients with specific eligibility criteria, including a post-transplant serum creatinine value decrease and no dialysis requirement, and exclusion criteria such as prior antibody induction therapy and positive T or B cell crossmatch.",
    "This clinical trial is testing the efficacy of dasatinib and docetaxel in treating metastatic prostate cancer patients who have shown evidence of progressive disease, with specific eligibility criteria including a serum testosterone level of \u226450 ng/dL and no prior radioisotope therapy with Strontium-89, Samarium, or similar agents.",
    "This phase 1 trial is testing the efficacy of lenalidomide, liposomal doxorubicin, and bevacizumab in treating platinum-resistant/refractory epithelial ovarian cancer, fallopian tube carcinoma, and primary peritoneal carcinoma, with specific eligibility criteria including no prior anthracycline or lenalidomide use and calculated creatinine clearance > 60ml/min.",
    "The sample is a phase 1 trial testing the drug everolimus on patients with graft versus host disease, with specific inclusion and exclusion criteria listed in the eligibility criteria section.",
    "This phase 1 trial will test the efficacy of clofarabine and cyclophosphamide in treating various types of leukemia and myelodysplastic syndrome, with specific eligibility criteria for patients including normal cardiac function and no recent chemotherapy or major surgery.",
    "This trial is testing the drug tesofensine on overweight to obese subjects with BMI 28-35 kg/m\u00b2 and the eligibility criteria includes exclusion of subjects with specific diseases interfering with their metabolism, mental or psychiatric disorder, and history of cancer within the past 5 years.",
    "This trial is testing the drug temsirolimus on patients with chemotherapy-refractory metastatic castration-resistant prostate cancer who meet specific eligibility criteria.",
    "The sample is a phase 1 trial for advanced solid tumors with breast neoplasms, using lapatinib and docetaxel as drugs, and the eligibility criteria include being able to swallow oral medication.",
    "This is a phase 1 trial for patients with metastatic renal cell carcinoma or advanced refractory solid tumors, testing the association of bevacizumab and pazopanib, with eligibility criteria including age, performance status, and adequate organ function, and exclusion criteria including prior treatment with certain drugs and certain medical conditions.",
    "This trial is testing the drug tbr-652, a CCR5 antagonist, on antiretroviral treatment-experienced individuals with HIV-1 infection, with specific inclusion and exclusion criteria.",
    "This trial is testing the drug RAD001 on patients with unresectable or metastatic hepatocellular carcinoma, with eligibility criteria including prior chemotherapy and biologic regimens, measurable disease, and adequate bone marrow, liver, and renal function.",
    "The sample is a phase 1 clinical trial for patients with advanced, persistent or recurrent squamous cell carcinoma of the uterine cervix, testing the efficacy of carboplatin and docetaxel, with eligibility criteria including age over 18, GOG 0-2 performance status, and no prior severe hypersensitivity reaction to docetaxel or other drugs formulated with polysorbate 80.",
    "This phase 1 trial is testing the drug forodesine on patients with Binet Stage B or C B-cell chronic lymphocytic leukemia who have received up to 2 previous lines of treatment, with specific inclusion and exclusion criteria.",
    "This is a phase 1 trial for patients with locally recurrent breast cancer involving the chest wall and/or its overlying skin, with distant metastasis allowed, testing the efficacy of lyso-thermosensitive liposomal doxorubicin (thermodox) in combination with hyperthermia, with eligibility criteria including prior local radiotherapy, progression on hormonal therapy and chemotherapy, and various patient characteristics and medical history restrictions.",
    "The sample is a phase 1/phase 2 trial for myeloma patients, testing the efficacy of trisenox, velcade, melphalan, and vitamin C, with specific eligibility criteria including refractory disease, age up to 75, and Zubrod performance status of <2.",
    "This phase 1 trial is testing the drugs 7-hydroxystaurosporine and perifosine on patients with various hematologic malignancies, including relapsed or refractory acute myelogenous leukemia and chronic myelogenous leukemia in accelerated or blastic phase that is refractory to imatinib mesylate, who have received or are ineligible for established curative regimens, including stem cell transplantation. The eligibility criteria include various medical and demographic factors, such as age, performance status, and organ function.",
    "The sample is a phase 1/phase 2 trial for patients with advanced malignant solid tumors or ErbB-2-positive breast cancer, testing the efficacy of HKI-272 and vinorelbine as a treatment option, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of temozolomide and vorinostat in treating patients with various types of malignant gliomas, with specific eligibility criteria including a Karnofsky performance status of >= 60, platelet count >= 100,000/mm^3, and a scan performed within 14 days prior to registration.",
    "This phase 1 trial is testing the drugs vintafolide iv bolus and vintafolide iv infusion on patients with cancer, who meet certain eligibility criteria, including having no effective standard therapeutic options and adequate bone marrow reserve, renal, and hepatic function.",
    "This is a phase 1 clinical trial for ulcerative colitis patients who are anti-TNF agent na\u00efve or have lost response to infliximab therapy, and will test the efficacy of adalimumab, with eligibility criteria including a Mayo Clinic Score of 6 to 12 points and exclusion criteria including a history of cancer or lymphoproliferative disease.",
    "This phase 1 trial is testing the drugs ides and placebo on healthy individuals with specific inclusion and exclusion criteria, including BMI and absence of clinically significant disease, HIV, hepatitis B or C, drug abuse, smoking, and use of medication except paracetamol.",
    "The sample is a phase 1 trial for patients with type 2 diabetes, testing the efficacy of bi 10773 at different doses, with inclusion and exclusion criteria based on age, BMI, and antidiabetic treatment, and the primary disease being diabetes mellitus, type 2.",
    "The sample is a phase 1/phase 2 trial for breast cancer patients, testing the efficacy of docetaxel and epirubicin hydrochloride, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This phase 1 trial is testing the efficacy of buthionine sulfoximine and melphalan in treating stage IIIB or IIIC melanoma of the extremity that has been previously treated with melphalan-based regional therapy and had persistent disease at 3 months OR achieved a complete response but disease recurred within 6 months.",
    "The sample is a phase 1 trial for chronic hepatitis B patients using adefovir as a drug, with inclusion criteria such as positive HBsAg and HBeAg, and exclusion criteria such as uncompensated liver disease and positive for Hepatitis C, hepatitis D or HIV infection.",
    "The sample is a phase 1 trial testing the drug fondaparinux on patients with morbid obesity, with specific eligibility criteria and exclusion criteria including medical history and laboratory values.",
    "The sample is a phase 1 trial for children with recurrent or refractory pediatric solid tumors, using a combination of carboplatin, cyclophosphamide, etoposide, thiotepa, and topotecan hydrochloride, with eligibility criteria including age range, performance status, hematopoietic, hepatic, renal, cardiovascular, and neurologic function, and prior concurrent therapy restrictions.",
    "The sample is a phase 1/phase 2 trial for kidney transplantation using the drug aeb071, with inclusion criteria for adult recipients of a functioning kidney within 24 hours post transplant and exclusion criteria for patients with a history of cancer within the last 5 years or significant cardiac disorder.",
    "This sample is a phase 1/phase 2 trial for an experimental vaginal gel containing dapivirine to prevent HIV infections in HIV-negative women who are willing to use two forms of contraception and undergo pelvic examinations, and meet certain inclusion criteria while excluding those who are pregnant or have certain genital abnormalities or infections.",
    "The sample is a phase 1 trial for cancer patients with the drug AEE788, with inclusion criteria such as confirmed solid tumor and adequate hematologic, renal and hepatic function, and exclusion criteria such as active brain metastases and compromised cardiac function.",
    "This trial is testing the combination of vorinostat, carboplatin, and etoposide in chemotherapy-naive patients with small cell lung cancer who meet specific eligibility criteria.",
    "The sample is a phase 1/phase 2 trial for lung cancer patients with inoperable stage IIB or unresectable stage IIIA or IIIB, testing the effectiveness of celecoxib, with eligibility criteria including age, performance status, and medical history.",
    "The sample is a phase 1 trial for patients with solid cancers not responsive to standard therapy, testing the efficacy of sunitinib, pemetrexed, cisplatin, and carboplatin, with inclusion and exclusion criteria listed.",
    "This phase 1 trial is testing the efficacy of velcade, rituximab, ifosfamide, carboplatin, and etoposide in treating aggressive B-cell non-Hodgkin lymphoma, with specific eligibility criteria including age, performance status, and prior treatments.",
    "This phase 1 trial aims to investigate the effects of various oral contraceptives on follicle development and count in premenopausal women, with desogestrel/ethinyl estradiol and ethinyl estradiol, 28-day drospirenone oral contraceptive, and 28-day levonorgestrel oral contraceptive being the drugs tested, and the inclusion and exclusion criteria are specified.",
    "This clinical trial is testing the efficacy of bez235 + trastuzumab and lapatinib + capecitabine in treating HER2-positive invasive breast cancer with inoperable locally advanced or metastatic disease, with eligibility criteria including prior trastuzumab treatment and controlled or asymptomatic CNS metastases.",
    "This trial is for patients with active rheumatoid arthritis and a stable dose of methotrexate, testing the efficacy of a placebo drug, with specific inclusion and exclusion criteria.",
    "This trial is testing the efficacy of eptifibatide and placebo in treating sickle cell disease, with eligibility criteria including confirmed diagnosis of sickle cell anemia or sickle beta zero thalassemia, age between 18 and 55 years, and normal baseline coagulation profile.",
    "This trial is for patients aged 0-18 with relapsed or residual juvenile myelomonocytic leukemia (JMML) who have undergone allogeneic hematopoietic cell transplant (HCT), and will test the efficacy of cyclosporine, cytarabine, filgrastim, methotrexate, methylprednisolone, mitoxantrone hydrochloride, and cis-retinoic acid as treatment options.",
    "The sample is a phase 1 trial for sickle cell disease using propranolol as a drug, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 1/phase 2 clinical trial for patients with multiple myeloma, testing the efficacy of kw-2478 and bortezomib drugs, with eligibility criteria including confirmed diagnosis of multiple myeloma, prior failed or relapsed regimens, and adequate hematologic status, liver and renal function.",
    "This phase 1 trial is testing the use of temsirolimus (torisel) in patients with histologically confirmed supratentorial grade III or IV astrocytoma who require a stereotactic biopsy for confirmation of tumor progression or differentiation of tumor progression from treatment induced effects following radiation therapy \u00b1 chemotherapy.",
    "The sample is a phase 1 trial testing the efficacy of ranibizumab in treating rubeosis iridis and proliferative diabetic retinopathy, with specific inclusion and exclusion criteria for subjects.",
    "The sample is a phase 1 trial for methotrexate in treating rheumatoid arthritis, with inclusion and exclusion criteria listed, and the important values include the drug methotrexate and the disease rheumatoid arthritis.",
    "The sample is a phase 1 trial testing the drugs i5np and placebo on patients undergoing major cardiac or vascular surgery with acute kidney injury risk factors or eGFR <60 mL/min/1.73 m2, with a list of diseases including acute renal failure and acute kidney injury, and eligibility criteria including age, consent, and cancer screening.",
    "This phase 1 trial is testing the drug sunitinib malate on patients with metastatic/unresectable adrenocortical carcinoma or melanoma, with specific eligibility criteria including no history of brain metastases and certain laboratory values within normal limits.",
    "This phase 1 trial is testing the drug px-866 on patients with advanced solid tumors who have failed standard therapy, and have specific eligibility criteria for hematologic, hepatic, and renal function, as well as exclusion criteria for certain medical conditions.",
    "This phase 1 trial is testing the efficacy of zyt1 and placebo tablets on obesity and lipid disorders, with specific inclusion and exclusion criteria for volunteers.",
    "The sample is a phase 1 trial for patients with chronic lymphocytic leukemia and leukemia who have relapsed from or are refractory to at least one fludarabine-based regimen, and the drug being tested is clofarabine.",
    "This trial is testing the efficacy of (folpi) picoplatin with 5-fu and leucovorin, folpi, and folfox in treating metastatic colorectal cancer patients who meet specific eligibility criteria.",
    "The sample is a phase 1/phase 2 trial for primary and inherited erythromelalgia, testing the efficacy of xpf-002 and placebo, with eligibility criteria including BMI, pain flares, and willingness to comply with study procedures and restrictions.",
    "The sample is a phase 1/phase 2 trial for metastatic colorectal cancer testing the efficacy of capecitabine, gefitinib, and oxaliplatin, with eligibility criteria including confirmed colorectal cancer, measurable disease, and specific patient characteristics.",
    "This sample is a phase 1/phase 2 trial for the treatment of irritable bowel syndrome constipation predominant, using the drugs rose-010 and placebo, with eligibility criteria including a previous diagnosis of IBS and constipation predominant type IBS.",
    "This phase 1 trial is testing the efficacy of rad001 in addition to standard radiation and chemotherapy for patients with unresectable stage II, stage III, and Mx non-small cell lung cancer, with eligibility criteria including adequate lung and bone marrow function, and exclusion criteria including prior radiation or chemotherapy for the current diagnosis of NSCLC.",
    "This sample is a phase 1 trial for patients with type 2 diabetes, testing the effectiveness of chromium picolinate as an add-on therapy to metformin, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for metastatic breast cancer patients with ER positive tumors who have relapsed or failed previous treatment, testing the efficacy of icaritin, with eligibility criteria including age, BMI, and ECOG performance status, and exclusion criteria including hypersensitivity to flavonoid drugs and various medical conditions.",
    "This phase 1 trial is testing the drug ly2523355 on participants with acute leukemia, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This phase 1 trial is testing the efficacy of arsenic trioxide, bortezomib, and melphalan in treating multiple myeloma and plasma cell neoplasm, with specific eligibility criteria for patients including disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This is a phase 1 trial for patients with invasive breast cancer with Stage IV disease, testing the efficacy of lapatinib, docetaxel, and trastuzumab or docetaxel and trastuzumab, with eligibility criteria including confirmation of ErbB2 over-expression and adequate haematological, hepatic, and renal function.",
    "This phase 1 trial is testing the efficacy of bevacizumab, sorafenib, and cyclophosphamide in treating refractory solid tumors and leukemia, with specific eligibility criteria including age, organ function, and prior therapy.",
    "The sample is a phase 1 clinical trial for Japanese patients with type 1 diabetes mellitus, testing the efficacy of insulin glargine hoe901 and insulin glargine - new formulation hoe901, with inclusion and exclusion criteria specified.",
    "The sample is a phase 1 trial for patients with metastatic triple negative breast cancer, testing the combination of azd2281 and paclitaxel, with eligibility criteria including normal organ and bone marrow function and availability of a tumor sample for central testing, and exclusion criteria including recent chemotherapy or radiotherapy and certain medications.",
    "The sample is a phase 1 clinical trial for metastatic melanoma with activating V600 BRAF mutation, testing the efficacy of ipilimumab and vemurafenib, with specific inclusion and exclusion criteria.",
    "This trial is testing the use of human secretin in patients with chronic pancreatitis who are using opioid analgesics for pain management, and includes inclusion and exclusion criteria related to age, medical history, and contraceptive use.",
    "The sample is a phase 1 trial testing the drug tki258 (dovitinib) on patients with advanced solid tumors, excluding breast cancer, with specific inclusion and exclusion criteria, and with diseases including neoplasms, cancer, and tumors, identified by icd-10 codes.",
    "The sample is a phase 1 trial for stomach neoplasms using 5-fluorouracil, cisplatin, and sunitinib malate as drugs, with eligibility criteria including confirmed diagnosis of stomach cancer and advanced stage IV, and exclusion criteria including prior chemotherapy for stomach cancer in its advanced stage and pregnancy or breastfeeding patients.",
    "This phase 1 trial is testing the safety and tolerability of bi 207127 na, bi 201335 na, midazolam, and tolbutamide in healthy Caucasian males with a BMI between 19 and 29.9 kg/m2, and includes a list of exclusion criteria.",
    "This sample is a phase 1/2 trial for patients with recurrent or refractory malignant CNS tumors, testing the drug lapatinib ditosylate, and includes eligibility criteria such as histological diagnosis, measurable disease, and adequate general condition.",
    "The sample is a phase 1/phase 2 trial for patients with proliferative diabetic retinopathy, using ranibizumab as the drug, with eligibility criteria including previous treatment with full panretinal photocoagulation and no known sensitivity to ranibizumab, and exclusion criteria including pregnancy and uncontrolled glaucoma.",
    "The sample is a phase 1 trial for Parkinson's disease, testing the drugs mk0657, placebo, levodopa, and carbidopa, with inclusion criteria including levodopa responsiveness and exclusion criteria including intolerance to levodopa or carbidopa.",
    "The sample is a phase 1/phase 2 trial for patients with Stage IV or unresectable Stage III melanoma, testing the efficacy of sunitinib and dacarbazine, with eligibility criteria including adequate organ function and measurable disease by RECIST criteria.",
    "This phase 1 trial is testing the efficacy of perifosine and docetaxel in platinum-resistant or refractory ovarian cancer patients with accessible tumors, and requires compliance with study procedures and eligibility criteria.",
    "This phase 1 trial is testing darinaparsin in patients with advanced solid tumors that are refractory to standard therapies, and the eligibility criteria includes having at least one measurable lesion and adequate bone marrow, liver, and renal function.",
    "This trial is testing the effectiveness of pentostatin, tacrolimus, and methotrexate in treating leukemia and lymphoma patients who are receiving allogeneic hematopoietic transplants from an unrelated donor or one antigen mismatched related donors, and meet specific eligibility criteria.",
    "The sample is a phase 1 trial for breast cancer patients, testing the effects of melatonin and placebo on insomnia, with specific inclusion and exclusion criteria, and a list of icd-10 codes for the disease.",
    "This is a phase 1 trial for cystic fibrosis patients using sodium chloride (7%) as a drug, with eligibility criteria including FEV1 and oxygen saturation levels, and exclusion criteria including recent use of investigational drugs or radiation exposure.",
    "This sample is a phase 1/phase 2 trial for metastatic melanoma using the drug temozolomide, with eligibility criteria including prior systemic therapy and measurable disease, and exclusion criteria including prior temozolomide or dacarbazine and concurrent use of certain medications.",
    "The sample is a phase 1 trial for the treatment of secondary hyperparathyroidism using etelcalcetide and placebo, with inclusion and exclusion criteria for male subjects between 18 and 45 years of age who are in good health, and with a list of icd-10 codes for the disease.",
    "This phase 1 trial is testing the efficacy of decitabine and pegylated interferon-alfa 2b in patients with metastatic or unresectable cancer, with eligibility criteria including measurable disease by RECIST criteria, adequate liver and renal function, and willingness to undergo biopsies, among others.",
    "The sample is a phase 1/phase 2 trial for locally advanced squamous cell carcinoma of the oral cavity, oropharynx, larynx, or hypopharynx, testing the efficacy of carboplatin, rad001, and paclitaxel, with eligibility criteria including various patient characteristics and prior concurrent therapy restrictions.",
    "This phase 1 trial is testing the efficacy of paclitaxel in treating patients with metastatic Her-2 negative breast cancer who meet specific eligibility criteria.",
    "This phase 1 trial is testing the drug vorinostat on patients with high-risk lymphomas who have received autologous stem cell transplantation, and have not been treated with a histone deacetylase inhibitor before.",
    "This trial is for patients with adult glioblastoma or gliosarcoma who have evidence of tumor progression and have received no more than two prior systemic chemotherapy regimens. The trial will test the effectiveness of sorafenib tosylate and temsirolimus as treatment options.",
    "This phase 1 trial is testing the efficacy of tivozanib (av-951) plus temsirolimus in treating renal cell carcinoma patients who have not received prior treatment with temsirolimus or other drugs targeting the mTOR pathway, and meet specific eligibility criteria.",
    "This phase 1 trial is testing the efficacy of bibw 2992 and bibf 1120 in treating advanced, non-resectable and/or metastatic solid tumors in patients who have failed conventional treatment, with eligibility criteria including confirmed diagnosis of neoplasms, age 18 years or older, and Eastern Cooperative Oncology Group performance score 0, 1 or 2.",
    "The sample is a phase 1 trial testing the drug riluzole on patients with metastatic cancer and brain metastases who are eligible for whole-brain radiotherapy, with specific eligibility criteria for disease and patient characteristics, and prior concurrent therapy.",
    "The sample is a phase 1 trial for cancer patients with inadequate standard of care, testing the drug bms-690514, with inclusion criteria of adequate kidney, liver, and cardiac function.",
    "The sample is a phase 1/phase 2 trial for head and neck cancer patients, testing the efficacy of carboplatin, cisplatin, docetaxel, fluorouracil, and lapatinib ditosylate, with eligibility criteria including specific disease characteristics and patient characteristics, and restrictions on prior concurrent therapy.",
    "The sample is a phase 1/phase 2 trial for CCX 354-C in patients with stable rheumatoid arthritis who have been on a stable dose of methotrexate, with inclusion and exclusion criteria listed.",
    "The sample is a phase 1/phase 2 trial for non-small cell lung cancer using etoposide and cisplatin as drugs, with eligibility criteria including confirmed stage II or III NSCLC, inoperable status, measurable disease, and normal organ and marrow function.",
    "This sample is a phase 1/phase 2 trial for multiple sclerosis patients in the Sacramento area, testing the effects of inhaled cannabis, oral THC, and placebos on spasticity, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for metastatic pancreatic cancer, testing the efficacy of ipi-926 plus gemcitabine and placebo plus gemcitabine, with eligibility criteria including confirmed diagnosis, radiologically evaluable metastatic lesion, ECOG 0 or 1, and adequate birth control methods.",
    "This phase 1 trial is testing the efficacy of azd1656 and placebo in male patients aged 20-60 with type 2 diabetes mellitus who have been treated with 1-2 OADs for at least 30 days prior to enrollment and have not been treated with glitazones within 6 months prior to enrollment. The eligibility criteria includes male T2DM patients without known cardiovascular disease, with the exception of Grade 1 hypertension without secondary organ involvement.",
    "This phase 1 trial will test the safety and efficacy of darapladib and diltiazem in healthy individuals with atherosclerosis, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "The sample is a phase 1 trial for patients with kidney cancer, testing the drug sorafenib, with eligibility criteria including measurable disease, good/intermediate Motzer prognostic status, and various medical exclusions.",
    "The sample is a phase 1/phase 2 trial for inoperable stage III or IV malignant melanoma using imexon and dtic drugs, with eligibility criteria including normal blood cell counts and chemistries, and exclusion criteria including prior chemotherapy for stage III or IV disease and brain metastases.",
    "This trial is for patients with leukemia or myelodysplastic syndromes who are unsuitable for intensive chemotherapy and will be treated with cytarabine, and eligibility criteria include ECOG performance status, absence of serious illnesses, and no history of other malignancies.",
    "This phase 1 trial is testing the efficacy of lapatinib and herceptin in treating HER2 overexpressing breast cancer with brain metastases, with specific eligibility criteria including CNS disease progression and normal organ function.",
    "The sample is a phase 1/phase 2 trial for metastatic pancreatic cancer, testing the efficacy of gemcitabine and albumin-bound paclitaxel as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for rheumatoid arthritis, testing the efficacy of ocrelizumab and placebo in patients who have failed one DMARD or biologic, and have been on stable methotrexate treatment for at least 12 weeks, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1/2 trial for patients with persistent or recurrent ovarian epithelial, primary peritoneal, or fallopian tube cancer, testing the efficacy of docetaxel as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of dv-601 and entecavir in treating chronic hepatitis B in subjects who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This is a phase 1/phase 2 trial testing the drug patupilone on patients with unresectable locally advanced or metastatic non-small-cell lung carcinoma who have had prior treatment with a platinum-containing regimen, and meet various eligibility criteria.",
    "This phase 1 trial will test the effects of placebo, insulin, glucose, and glucagon on women with type 2 diabetes mellitus who meet specific inclusion and exclusion criteria.",
    "This trial is testing the effectiveness of carvedilol phosphate, lisinopril, and their combination, as well as placebo, in treating pre-hypertension in patients with additional cardiovascular risk factors, while excluding those with recent cardiac or vascular events, beta blocker or ACE inhibitor therapy, angiotensin receptor blocker therapy, or diabetes.",
    "This phase 1 trial is testing the drug gsk1120212 on male patients with solid tumors and specific eligibility criteria.",
    "The sample is a phase 1/phase 2 trial for allergic asthma, testing the efficacy of qge031 and omalizumab compared to placebo, with specific inclusion and exclusion criteria for patients.",
    "This clinical trial is testing the efficacy of sorafenib tosylate, erlotinib hydrochloride, tipifarnib, and temsirolimus in treating patients with recurrent adult brain tumors, specifically glioblastoma multiforme or gliosarcoma, who meet specific eligibility criteria.",
    "The sample is a phase 1 trial testing the effects of various doses and forms of alo-02 and oxycodone on non-dependent, recreational opioid users with healthy conditions, and the exclusion criteria include substance and/or alcohol dependence, sleep apnea, and positive urine drug screen for other than marijuana.",
    "This phase 1 trial is testing the drug lcl161 on patients with advanced solid tumors who meet certain eligibility criteria.",
    "This trial is testing the efficacy of docetaxel, epirubicin, and bevacizumab in treating metastatic breast adenocarcinoma with specific eligibility criteria, including no previous therapy for metastatic breast cancer and adequate liver, renal, and bone marrow function.",
    "This trial is for patients with extensive or recurrent small cell lung carcinoma and will test the efficacy of carboplatin, cisplatin, etoposide, and sunitinib malate as well as eligibility criteria including measurable disease, no prior chemotherapy for SCLC, and performance status.",
    "This clinical trial is testing the effectiveness of RAD001 and docetaxel in treating non-small cell lung cancer patients who meet specific eligibility criteria.",
    "This phase 1 trial is testing the efficacy of arq 197 and erlotinib in treating advanced/recurrent non-small-cell lung cancer patients who have undergone prior chemotherapy, with specific inclusion and exclusion criteria.",
    "This trial is for patients with Richter's transformation, leukemia, or relapsed/refractory B-cell chronic lymphocytic leukemia, and will test the efficacy of oxaliplatin, fludarabine, cytarabine, rituximab, and pegfilgrastim in treating the diseases. The eligibility criteria include age, performance status, renal and hepatic function, and platelet counts, while exclusion criteria include untreated or uncontrolled life-threatening infection, intolerance to the drugs, pregnancy or lactation, and recent chemotherapy or radiation therapy.",
    "The sample is a phase 1 trial for rosiglitazone maleate in patients with type 2 diabetes mellitus, with inclusion and exclusion criteria listed, and the icd-10 codes for the disease are also provided.",
    "This sample is a phase 1 trial testing the drugs gsk2849466 and placebo for the treatment of cachexia, with specific eligibility criteria for male subjects between 18 and 50 years of age, and various exclusion criteria based on medical history and laboratory tests.",
    "This sample is a phase 1 clinical trial testing the drug lenalidomide in patients with CD20+ B-cell non-Hodgkin lymphoma who have received high-dose chemotherapy with autologous stem cell transplantation, and the study will evaluate the safety and efficacy of the drug.",
    "This phase 1 trial is testing the safety and tolerability of dabigatran etexilate capsules, quinidine sulfate tablets, and fexofenadine tablets in healthy individuals who meet specific inclusion criteria and do not have any exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for esophagus cancer using oxaliplatin, docetaxel, and capecitabine, with eligibility criteria including adenocarcinoma or squamous cell carcinoma of the esophagus or G/E junction, surgical candidacy, and no previous treatment for esophageal cancer.",
    "The sample is a phase 1/phase 2 trial for patients with relapsed or refractory B- or T-cell non-Hodgkin's lymphoma, testing the efficacy of bortezomib and gemcitabine hydrochloride as a therapeutic regimen, with eligibility criteria including prior therapeutic regimens, ECOG performance status, and various medical and psychiatric conditions.",
    "The sample is a phase 1 trial for patients with myelodysplastic syndromes or chronic myelomonocytic leukemia, testing the efficacy of cyclophosphamide as a treatment option for those who have failed or are ineligible for azacitidine, with specific eligibility criteria for donors and patients.",
    "This trial is for patients with chronic lymphocytic leukemia and will test the efficacy of bendamustine, rituximab, and lenalidomide as a treatment option, with specific eligibility criteria including prior treatment regimens and liver function.",
    "This is a phase 1 trial for combination therapy using decitabine and midostaurin in patients with newly diagnosed or relapsed/refractory acute myeloid leukemia who meet specific eligibility criteria, with a list of exclusion criteria, and no prior midostaurin treatment.",
    "This phase 1 trial is testing the drug cc-5013 in patients with active multiple myeloma who have relapsed or progressed after at least 2 cycles of anti-myeloma treatment, and have measurable myeloma paraprotein levels in serum or urine, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 1 clinical trial for non-small cell lung cancer patients with recurrent or persistent disease, testing the efficacy of gefitinib as a treatment option, with specific eligibility and exclusion criteria listed.",
    "This is a phase 1 trial for patients with non-small cell lung cancer, testing the combination of lapatinib and pemetrexed, with specific eligibility criteria including stage IIIB or IV NSCLC, ECOG performance status 0-2, and no prior exposure to pemetrexed or an EGFR inhibitor in combination with 5-FU or a 5FU prodrug.",
    "This phase 1 trial is testing the drug pemetrexed disodium on patients with pancreatic cancer who meet specific eligibility criteria.",
    "This phase 1 trial is testing the efficacy of AMG 386, paclitaxel and carboplatin in treating high-risk FIGO Stage I or Stages II-IV epithelial ovarian, primary peritoneal and fallopian tube cancer, with eligibility criteria including specific laboratory values and exclusion criteria such as prior use of anticancer therapy or experimental therapy for these cancers.",
    "This phase 1 trial is testing the efficacy of sb-485232 and pegylated liposomal doxorubicin in treating advanced stage ovarian cancer, with eligibility criteria including confirmed diagnosis of epithelial ovarian, fallopian tube, or primary peritoneal carcinoma, measurable lesions, and predicted life expectancy of \u22654 months.",
    "This phase 1 trial will test the efficacy of otelixizumab, a monoclonal antibody, in treating rheumatoid arthritis patients who have not responded to other treatments, and the eligibility criteria includes specific disease criteria, drug history, and medical conditions.",
    "The sample is a phase 1 trial testing the efficacy of fondaparinux, an anticoagulant, in treating thrombosis and heparin-induced thrombocytopenia in children between 1 and 18 years of age, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the drug cudc-101 on patients with advanced breast, gastric, head and neck, liver, and non-small cell lung cancer who have no further standard of care options or have refused standard therapy, and meet other eligibility criteria.",
    "The sample is a phase 1/2 trial for kidney transplant recipients, testing the efficacy of daclizumab, mycophenolate mofetil, prednisone, tacrolimus, ganciclovir, valganciclovir, and trimethoprim and sulfamethoxazole, with eligibility criteria including PRA of 20% or less and exclusion criteria including previous steroid treatment within 6 months prior to transplantation and HIV infection.",
    "This trial is testing the efficacy of chr-2797 and erlotinib in treating non-small-cell lung carcinoma patients who have failed platinum-based chemotherapy, with eligibility criteria including specific disease stage, performance status, and laboratory values.",
    "The sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the efficacy of canagliflozin and placebo, with inclusion criteria including stable anti-hyperglycemic agent regimen and fasting plasma glucose concentrations between 7.8 mM and 15 mM.",
    "This clinical trial is testing the combination of ixazomib, lenalidomide, and dexamethasone for previously untreated multiple myeloma patients who meet specific eligibility criteria.",
    "The sample is a phase 1 trial for patients with hepatitis C, testing the efficacy of the drugs imo-2125 and saline placebo, with eligibility criteria including non-responsiveness to standard treatment and exclusion criteria including HIV or hepatitis B, inadequate organ function, recent antiviral therapy, significant medical diseases, and substance abuse.",
    "This trial is a phase 1/phase 2 study testing the drug ro5024048 on patients diagnosed with chronic hepatitis C infection, genotype-1, for at least 6 months, who are HCV treatment-naive, with no history of exposure to interferon, ribavirin, or direct antivirals, and have at least one measurement of serum HCV RNA of \u2265 100,000 IU/mL measured during Screening by the COBAS AmpliPrep/COBAS TaqMan HCV.",
    "The sample is a phase 1 trial for Autistic Disorder, testing the efficacy of ro5028442 and placebo drugs, with inclusion criteria including male adults aged 18-45 with IQ > 70 and BMI 18-35 kg/m2, and exclusion criteria including positive urine test for drugs of abuse and clinically relevant cardiovascular, renal, hepatic or hematologic disease or disorder.",
    "This trial is a phase 1/2 study testing the combination of vorinostat and paclitaxel in patients with male or stage IIIB/IIIC/IV breast cancer, with specific eligibility criteria including disease accessibility to biopsy and consent to serial biopsy, and exclusion criteria including recent chemotherapy or radiotherapy and ongoing or active infection.",
    "The sample is a phase 1/phase 2 trial for Friedreich ataxia, testing the drug resveratrol, with inclusion criteria of homozygosity for the GAA repeat expansion in intron 1 of the FXN gene and functional stage on the Ataxia subscale of the FARS of 1 or higher, and exclusion criteria including pregnancy or lactation, active arrhythmias or significant cardiac insufficiency, and use of idebenone, Coenzyme Q or vitamin E within 30 days prior to enrollment or other medications which may have clinically significant drug interactions that cannot be safely monitored.",
    "This trial is for patients with untreated childhood brain stem glioma and will test the drug tipifarnib, with eligibility criteria including no prior chemo or radiation therapy, certain blood counts, and negative pregnancy test.",
    "This trial is testing the efficacy of docetaxel and imatinib mesylate in treating hormone-refractory prostate cancer patients who have progressed after at least two prior hormonal manipulations, with specific eligibility criteria outlined.",
    "This sample is a phase 1/phase 2 trial for hypertension and renal transplant patients, testing the effectiveness of allopurinol and placebo drugs, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for rectal and colorectal cancer using cetuximab, oxaliplatin, capecitabine, and diphenhydramine hydrochloride (hcl) as drugs, with eligibility criteria including histologically-confirmed adenocarcinoma of the rectum, age \u2265 18, and ability to swallow pills without difficulty.",
    "This sample is a phase 1/phase 2 trial for patients with anaplastic or poorly differentiated variant thyroid carcinoma, testing the efficacy of cisplatin, doxorubicin hydrochloride, and fosbretabulin disodium, with eligibility criteria including specific disease characteristics and patient characteristics.",
    "This phase 1 trial is testing the efficacy of azd6244 and cediranib in treating locally advanced rectal cancer, with eligibility criteria including confirmed rectal adenocarcinoma, no previous chemotherapy or radiotherapy for rectal cancer, and adequate bone marrow, hepatobiliary, and renal function.",
    "The sample is a phase 1/phase 2 trial for breakthrough nausea and vomiting and unspecified adult solid tumor patients receiving inpatient chemotherapy containing at least moderately emetogenic agents, with eligibility criteria including self-report of at least mild nausea, scheduled 5-HT3 receptor antagonist antiemetic, and no history of chronic nausea and/or vomiting, with study drugs fosaprepitant dimeglumine and systemic chemotherapy.",
    "The sample is a phase 1 trial for type 2 diabetes mellitus, testing the efficacy of mk-0941, placebo, and lantus insulin, with inclusion criteria including being diagnosed with type 2 diabetes and currently being treated with basal insulin, and exclusion criteria including history of type 1 diabetes and allergy to insulin.",
    "The sample is a phase 1 trial for chronic hepatitis C infection, testing the drugs ach-0143102 and ribavirin, with eligibility criteria including genotype CC and HCV RNA > 10000 IU/mL, and exclusion criteria including BMI>36 and previous participation in a clinical trial with protease inhibitor and/or NS5A inhibitor.",
    "This phase 1 trial is testing the combination of sunitinib and rapamycin in patients with non-small cell lung cancer who have completed prior therapy, with eligibility criteria including age \u226518 years, ECOG 0-2, and adequate bone marrow, liver, and renal function.",
    "The sample is a phase 1 trial for patients with metastatic renal cell carcinoma, testing the drugs cp-675,206 and su011248, with inclusion criteria of histologically proven renal cell carcinoma with metastases and Eastern Cooperative Oncology Group (ECOG) PS of 0 or 1.",
    "The sample is a phase 1 trial for a drug called pf-05161704 or placebo in patients with type 2 diabetes mellitus, with inclusion criteria including BMI of 24.5 to 35.5 kg/m2 and total body weight >50 kg, and exclusion criteria including evidence or history of clinically significant diseases and habitual use of tobacco or nicotine containing products within 3 months of screening.",
    "The sample is a phase 1 trial for healthy individuals, testing the efficacy of darifenacin and tolterodine compared to placebo for urinary incontinence, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial testing the safety and efficacy of amifostine trihydrate and melphalan in treating multiple myeloma and plasma cell neoplasm, with eligibility criteria including age 18-70, ECOG 0-1 performance status, and no prior radiotherapy for amyloidosis.",
    "This trial is for patients with stage IV pancreatic cancer and will test the effectiveness of erlotinib hydrochloride and gemcitabine hydrochloride as treatment options. The eligibility criteria includes various medical conditions and excludes patients who have received certain types of prior treatments.",
    "The sample is a phase 1 trial for liraglutide and placebo in patients with type 1 diabetes mellitus, with inclusion criteria of a BMI between 20.0 and 28.0 kg/m^2 and exclusion criteria of recent use of liraglutide or exenatide, recurrent severe hypoglycaemia, and recent blood or plasma donation.",
    "This phase 1 trial is testing the efficacy of pazopanib, erlotinib, and pemetrexed in treating advanced non-small cell lung cancer patients who have failed standard therapy or for whom there is no standard therapy, and have adequate organ system function and measurable disease on CT scan.",
    "This phase 1 trial is testing the efficacy of insulin degludec in Japanese patients with type 2 diabetes mellitus who have been treated with insulin for at least 3 months and have a maximum BMI of 33.0 kg/m^2 and maximum HbA1c of 10.0%, and the exclusion criteria include recent use of oral antidiabetic drugs and/or GLP-1 receptor agonists.",
    "This is a phase 1/phase 2 trial for ovarian cancer patients who have progressed following chemotherapy with platinum and paclitaxel, and will test the efficacy of cc-5013 and topotecan as treatment options. The eligibility criteria includes measurable metastatic advanced ovarian or primary peritoneal carcinoma, ECOG performance status of 0 or 1, and exclusion criteria includes prior use of lenalidomide and any standard or experimental anti-cancer drug therapy within 28 days of the initiation of study drug therapy.",
    "This trial is testing the effectiveness of various drugs, including ciclosporin and betamethasone, on chronic plaque type psoriasis, with specific inclusion and exclusion criteria.",
    "This trial is testing the drug erlotinib hydrochloride on patients with various types of brain tumors, who meet specific eligibility criteria, including having measurable or evaluable disease and a performance status of Karnofsky 60-100%.",
    "This phase 1 trial is testing the efficacy of gabapentin at different doses and donepezil for neuropathic pain in male subjects who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 1/phase 2 clinical trial for patients with relapsed and/or refractory multiple myeloma, testing the efficacy of cci-779 and bortezomib drugs, with eligibility criteria including age, prior therapy, ECOG performance status, and laboratory values, and exclusion criteria including uncontrolled infection, recent chemotherapy or biologic therapy, pregnancy or nursing, and serious medical or psychiatric illness likely to interfere with participation.",
    "The sample is a phase 1 trial for soft tissue sarcoma using chemotherapy as the drug, with eligibility criteria including biopsy-proven sarcoma of the extremity and certain patient characteristics, such as WBC and platelet counts, and no concurrent disease that renders the patient unable to tolerate treatment.",
    "This phase 1 trial is testing the efficacy of cyclophosphamide and imatinib in treating advanced or metastatic solid tumors, with specific eligibility criteria for patients, including ECOG performance status 0-1 and no uncontrolled hypertension or cardiovascular disease.",
    "This phase 1 trial is testing the drug dacomitinib on healthy volunteers and those with mild or moderate hepatic dysfunction, with specific inclusion and exclusion criteria, and the trial will involve multiple doses of the drug.",
    "The sample is a phase 1 trial testing cetuximab on patients with non-small-cell lung carcinoma and metastatic neoplasms, with inclusion criteria of measurable disease tumor available for biopsies and life expectancy of at least 3 months, and exclusion criteria of known or documented brain metastases prior to Cetuximab therapy.",
    "The sample is a phase 1/phase 2 trial for non-Hodgkin's lymphoma, testing the efficacy of bortezomib, chop, and rituximab, with eligibility criteria including confirmed diagnosis, no prior anti-cancer therapy, measurable disease, and certain blood counts, while exclusion criteria include CNS involvement, HIV, pregnancy or nursing, major surgery within the last 3 weeks, and known peripheral neuropathy > Grade 2.",
    "This phase 1 trial is testing the use of lithium carbonate in patients with brain metastases and primary malignancy, with specific eligibility criteria and exclusion criteria.",
    "This phase 1 trial is testing the drug kx2-391 on patients with advanced solid tumors or lymphoma, who have exhausted standard treatment options, and meet specific eligibility criteria.",
    "This phase 1 trial is testing the efficacy of sar341402 and insulin aspart in male or female subjects with type 1 diabetes who meet specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the drug fruquintinib on patients with solid malignant tumors who have failed standard treatment, with eligibility criteria including age, performance status, and adequate organ function.",
    "This phase 1 trial is testing the drug ati-1123 (active drug = docetaxel) on patients with various solid tumors, including breast, ovarian, pancreatic, and non-small cell lung cancer, who have progressive disease following standard chemotherapy or have no appropriate alternative therapy available, and meet certain eligibility criteria.",
    "The sample is a phase 1 trial for patients with refractory solid tumors, testing the drug gefitinib, with inclusion criteria including confirmed tumors, life expectancy of >12 weeks, and WHO performance status of <2, and exclusion criteria including severe hypersensitivity to gefitinib and incomplete healing from previous surgery.",
    "The sample is a phase 1/phase 2 trial for patients with metastatic or unresectable malignancy or melanoma, testing the drug imatinib mesylate, with eligibility criteria including various medical conditions and restrictions.",
    "This trial is testing the efficacy of Arikayce and its placebos in treating cystic fibrosis patients with chronic P.aeruginosa infection, with eligibility criteria including confirmed diagnosis of CF and FEV1 \u226540% of predicted at Screening.",
    "This trial is testing the effectiveness of obatoclax mesylate and bortezomib in treating refractory multiple myeloma, with specific eligibility criteria including prior treatment with bortezomib and absence of certain medical conditions.",
    "The sample is a phase 1/phase 2 trial for the treatment of Fanconi anemia and severe aplastic anemia using fludarabine, with eligibility criteria including diagnosis confirmation, HLA matching, and certain health conditions, while exclusion criteria include cardiac disease, severe infection, and mental illness.",
    "This phase 1 trial is testing the combination of erlotinib and hydroxychloroquine in patients with non-small cell lung cancer who have previously received EGFR small molecule TKI agents, and the eligibility criteria includes measurable disease, adequate organ function, and approval for HCQ treatment by an eye doctor.",
    "This trial is for patients with end-stage renal disease who are highly-HLA sensitized and a candidate for transplantation after desensitization, and will test the efficacy of Immune Globulin Intravenous 10%/Rituximab or C1 INH, along with placebos, as therapy.",
    "The sample is a phase 1 trial for patients with advanced solid tumors, testing the combination of temsirolimus and capecitabine, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 1 trial for pancreatic cancer patients who have undergone complete resection, with gemcitabine and bosutinib as the drugs being tested, and the eligibility criteria includes various medical and age-related factors.",
    "The sample is a phase 1 trial testing the efficacy of romosozumab and placebo in postmenopausal women with osteopenia, with inclusion and exclusion criteria related to bone health and vitamin D levels.",
    "This clinical trial is testing the drugs pci-32765 and ofatumumab on patients with chronic lymphocytic leukemia, small lymphocytic lymphoma, prolymphocytic leukemia, or Richter's transformation, who have failed prior therapies and meet certain eligibility criteria.",
    "The sample is a phase 1/phase 2 trial for rheumatoid arthritis testing the drug he3286 in combination with methotrexate, with eligibility criteria including stable disease and normal thyroid levels, and exclusion criteria including previous use of certain immunosuppressive drugs and clinically significant abnormalities in laboratory results.",
    "This phase 1 trial is testing the drugs erlotinib hydrochloride and isotretinoin on patients with various types of malignant glioma, and eligibility criteria includes a Karnofsky performance status of >= 60%, recovery from prior therapy, and meeting iPLEDGE requirements.",
    "This phase 1 trial is testing the drug lbh589 for patients with active multiple myeloma who have received at least one prior line of therapy and meet specific eligibility criteria.",
    "This phase 1 trial is testing the efficacy of pazopanib and vinorelbine in treating metastatic non small cell lung cancer and metastatic breast cancer, with eligibility criteria including age over 18, diagnosis of breast cancer or non small cell lung cancer, and no prior exposure to vinorelbine or other VEGF inhibitors as treatment for metastatic disease.",
    "This phase 1 trial is testing the drug px-478 on patients with advanced solid tumors or lymphoma who have failed or are intolerant of standard therapy, and have met certain eligibility criteria.",
    "This phase 1 trial is testing the effectiveness of bicalutamide and cp-675,206 (tremelimumab) on patients with prostate cancer who have completed surgery or radiation, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for patients with \u03b2-thalassemia and transfusional iron overload, testing the drug deferasirox as a treatment option, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the drug bibw 2992 on patients with advanced, non-resectable and/or metastatic solid tumors historically known to express EGFR and/or HER2, who have failed conventional treatment, or for whom no therapy of proven efficacy exists, or who are not amenable to established forms of treatment, and have measurable tumor deposits or recognized tumor markers, with certain exclusion criteria.",
    "This phase 1 trial is testing the effectiveness of il-2, okt3, cyclophosphamide, fludarabine, and mesna in treating metastatic renal cell cancer, with specific eligibility criteria for patients to be included in the trial.",
    "This phase 1 trial is testing the efficacy of bevacizumab, everolimus, and lbh589 in treating advanced solid tumors that are refractory to standard therapies, with eligibility criteria including measurable disease sites, adequate bone marrow and liver function, and negative pregnancy test for women of childbearing potential.",
    "The sample is a phase 1/phase 2 trial for chronic hepatitis C, testing the efficacy of daclatasvir and placebo drugs, with specific eligibility criteria including genotype 1 infection, treatment-naive or non-responders/intolerant, and BMI 18 to 35 kg/m\u00b2.",
    "The sample is a phase 1/phase 2 trial for Crohn's disease, testing delayed release 6mp or calcitriol vs. purinethol, with inclusion criteria including moderate Crohn's Disease and exclusion criteria including previous bowel resection and evidence of other serious diseases.",
    "This phase 1 trial is testing the combination of paclitaxel and neratinib in patients with HER2-positive metastatic breast cancer, with eligibility criteria including confirmation of diagnosis, adequate organ function, and absence of certain comorbidities or conditions.",
    "The sample is a phase 1/phase 2 trial for AUY922 in postmenopausal women with metastatic or resistant locally advanced HER2+ and ER+ breast cancer, with eligibility criteria including laboratory values, disease stage, prior treatment, and measurable lesions, and exclusion criteria including cardiac function and HIV status.",
    "The sample is a phase 1 trial testing the efficacy of methadone hydrochloride in treating chronic neuropathic pain syndrome related to cancer or its treatment, with eligibility criteria including a minimum pain score and specific patient characteristics, and excluding patients with certain medical conditions or substance abuse history.",
    "The sample is a phase 1/phase 2 trial for rheumatoid arthritis, testing the efficacy of ask8007 and placebo drugs in patients who meet specific inclusion criteria, including having active poly-arthritis and being treated with MTX, leflunomide, or sulfasalazine for at least 4 months prior to baseline.",
    "This trial is testing the use of rituximab in patients with hematological malignancies who have undergone allogeneic stem cell transplantation, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of docetaxel and idronoxil in treating recurrent advanced ovarian, fallopian tube, and primary peritoneal cavity cancer, with eligibility criteria including prior platinum and taxane combination chemotherapy and no active CNS metastases.",
    "This is a phase 1 trial for asthma patients testing the safety and efficacy of the drug gsk2269557 and its matching placebo, with inclusion and exclusion criteria including age, weight, medical history, and medication use.",
    "The sample is a phase 1/phase 2 trial for kidney diseases, testing the efficacy of yspsl and placebo drugs for primary cadaver renal transplants, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for Alzheimer's disease, testing the efficacy of various drugs including active and placebo comparators, with specific inclusion and exclusion criteria for subjects.",
    "This phase 1 trial is testing the drug gefitinib on patients with non-small-cell lung cancer who require low dose palliative thoracic irradiation, and have not had previous thoracic radiotherapy or known hypersensitivity to the drug.",
    "The sample is a phase 1 clinical trial for ulcerative colitis using mesalamine as part of the treatment, with eligibility criteria including age, weight, and ability to swallow tablets, and exclusion criteria including history of cancer or renal insufficiency.",
    "This phase 1 trial is testing the efficacy of different concentrations of shape (shp-141) in treating lymphoma, T-cell, cutaneous, with eligibility criteria including histopathologically confirmed CTCL, clinical Stage IA, IB, or IIA CTCL, and ECOG performance status of 0-2.",
    "This phase 1 trial is testing the effectiveness of rituximab, cyclophosphamide, fludarabine, mesna, and sirolimus in treating patients with persistent or progressive follicular lymphoma, mantle cell lymphoma, chronic lymphocyte leukemia/small lymphocytic lymphoma, or multiple myeloma who have achieved a partial or complete response to their most recent chemotherapy and have an HLA matched related donor who is seropositive against Epstein Barr virus and capable of donating peripheral blood mononuclear cells and peripheral blood progenitor cells.",
    "This phase 1 trial is testing the drugs gsk1322888 and placebo for the treatment of gastroparesis, with specific eligibility criteria including age, weight, and liver function.",
    "The sample is a phase 1/phase 2 trial for non-small-cell lung carcinoma using the drugs entinostat, sndx-275, and erlotinib, with eligibility criteria including confirmed NSCLC of stage IIIb or IV, prior chemotherapy or chemoradiotherapy regimens, and measurable lesions.",
    "The sample is a phase 1 trial for chronic hepatitis C patients who are non-responders or relapsers, testing the efficacy of betaine, peginterferon alpha 2a, and ribavirin, with eligibility criteria including liver biopsy confirmation, hematologic and biochemical criteria, and exclusion criteria including pregnancy, hypersensitivity to interferon or ribavirin, and history of substance abuse.",
    "This trial is testing the efficacy of bibf + paclitaxel and paclitaxel in treating HER2-negative localized breast cancer with primary tumor over 2 cm, with specific eligibility criteria for patients.",
    "This trial is testing the use of aliskiren, a drug, in patients with type 2 diabetes and incipient or overt diabetic nephropathy, with specific eligibility criteria including stable hypoglycemic medications and discontinuation of certain medications, and exclusion criteria such as severe hypertension and history of malignancy.",
    "This sample is a phase 1/phase 2 trial for pancreatic cancer patients who have undergone surgery and have no grossly positive surgical margins, and will test the efficacy of gemcitabine hydrochloride as a treatment option.",
    "The sample is a phase 1/phase 2 trial for metastatic breast cancer patients with HER2-positive tumors, testing the combination of lapatinib and docetaxel, with eligibility criteria including age, ECOG performance status, prior treatment history, and cardiac and organ function.",
    "The sample is a phase 1 trial for a malaria vaccine, using placebo as the drug, with eligibility criteria including age, health status, and absence of prior malaria exposure, and exclusion criteria including history of malaria infection, hypersensitivity to vaccine components, and various medical conditions.",
    "This trial is testing the drug Velcade on patients with peripheral T-cell lymphomas and non-Hodgkin lymphoma, with specific eligibility criteria including age, performance status, and laboratory values.",
    "This phase 1 trial is testing the drug osi-906 on patients with advanced solid tumors that are refractory to established forms of therapy, with eligibility criteria including prior treatment recovery, normal electrolyte levels, and accessible for repeat dosing and follow-up.",
    "This phase 1 trial is testing the efficacy of aliskerin/valsartan and rampiril in African American patients with hypertension and metabolic syndrome, with strict inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for relapsed malignant melanoma, testing the efficacy of busulfan, cyclophosphamide, cyclosporine, and methotrexate, with eligibility criteria including HLA-matched or related bone marrow donor and no history of CNS metastases.",
    "The sample is a phase 1/phase 2 trial for multiple myeloma, testing the effectiveness of lenalidomide, bortezomib, dexamethasone, and doxil, with eligibility criteria including age, measurable disease, and LVEF, and exclusion criteria including peripheral neuropathy, renal insufficiency, and other medical conditions.",
    "The sample is a phase 1/phase 2 trial for patients with non-small-cell lung cancer, testing the efficacy of abt-751 and pemetrexed compared to placebo, with eligibility criteria including prior treatment and measurable disease, and exclusion criteria including allergy to study drugs and significant systemic disease.",
    "The sample is a phase 1 clinical trial for prostate cancer using dasatinib as a drug, with eligibility criteria including specific disease stages, no prior radiation or chemotherapy, and required laboratory parameters, among others.",
    "This clinical trial is testing the effectiveness of hydroxychloroquine and ixabepilone in treating metastatic breast cancer that is resistant to anthracycline and taxane, and patients must meet specific eligibility criteria.",
    "The sample is a phase 1 clinical trial for patients with relapsed or refractory multiple myeloma or other plasma cell disorders, testing the efficacy of paricalcitol and zoledronic acid, with eligibility criteria including performance status, life expectancy, and absence of certain medical conditions.",
    "This phase 1 trial is testing the efficacy of anecortave acetate in patients with uveitis and glaucoma who have had recent implantation of the Retisert implant, with eligibility criteria including age, medical history, and willingness to participate.",
    "The sample is a phase 1/phase 2 trial for non-Hodgkin's lymphoma using rituximab, dhap, tec, and autologous stem cell transplantation as drugs, with eligibility criteria including first relapse or primary refractory disease of aggressive Non-Hodgkin's lymphoma stage I-IV, pretreatment with systemic therapy, and age between 18-65 years.",
    "This clinical trial is testing the effectiveness of paclitaxel, carboplatin, and vorinostat in treating stage IIIA, IIIB, and IV non-small cell lung cancer patients who have not received prior chemotherapy, and meet specific eligibility criteria.",
    "This phase 1 trial is testing the drug JNJ-38877605 on patients with advanced or refractory solid tumors, with inclusion and exclusion criteria specified, and the disease being targeted is neoplasms.",
    "This sample is a phase 1/phase 2 trial for heart failure and asymptomatic systolic dysfunction, testing the effectiveness of nesiritide and placebo, with specific inclusion and exclusion criteria for subjects.",
    "This phase 1 trial is testing the drug rdea119 on patients with advanced cancer who have no proven effective therapy available, and have met the eligibility criteria.",
    "This phase 1 trial is testing the drug txa127 for patients with myelodysplastic syndrome (MDS) who meet certain eligibility criteria.",
    "This phase 1 trial is testing the drug SGX523 capsules on patients with advanced cancer who have failed standard therapy, and have evidence of phospho-MET expression on tumor material, with eligibility criteria including laboratory values and exclusion criteria including allergies to SGX523 formulation or its excipients and patients receiving anti-coagulant therapy.",
    "The sample is a phase 1 trial for non-small cell lung cancer patients with EGFR mutations, testing the efficacy of cetuximab and bibw 2992, with eligibility criteria including previous treatment with EGFR TKIs and availability of tumor-derived material for mutation analysis.",
    "This phase 1 trial is testing the efficacy of bendamustine, lenalidomide, dexamethasone, aspirin, prophylaxis, and antibiotic drugs in treating symptomatic multiple myeloma patients who have previously received at least one cycle of specific therapy and meet certain measurable disease parameters.",
    "This is a phase 1/phase 2 trial for patients with clinical stage T4 or recurrent adenocarcinoma of the rectum, using capecitabine as the drug, and with specific eligibility criteria including confirmed histology and no distant metastatic disease.",
    "The sample is a phase 1/phase 2 trial for locally advanced or metastatic, unresectable soft tissue sarcoma, testing the drugs amg 655 and doxorubicin, with inclusion criteria including confirmed soft tissue sarcoma, measurable disease, and adequate organ function, and exclusion criteria including prior treatment with anthracyclines and uncontrolled cardiovascular disease.",
    "This phase 1 trial is testing the efficacy of semaglutide versus placebo in male subjects with diabetes or healthy individuals with a BMI below 35.0 kg/m^2, with strict inclusion and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for patients with relapsed or refractory acute lymphoblastic leukemia, testing the efficacy of clofarabine, with eligibility criteria including CD52 expression on at least 10% of lymphoblasts and adequate renal and hepatic functions.",
    "This phase 1 trial is testing the drug g-202 on patients with advanced solid tumors, who meet specific eligibility criteria related to liver, renal, hematologic, and coagulation function, and have not received chemotherapy or surgery in the past 4 weeks.",
    "This phase 1 trial is testing the drug E7107 on patients with solid tumors who have progressed after receiving approved therapies, and have no effective therapies available, with eligibility criteria including a performance status score of 0 or 1, and a life expectancy of over three months.",
    "The sample is a phase 1 clinical trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the efficacy of pur0200 and active comparator drugs, with specific eligibility criteria and exclusion criteria.",
    "This trial is testing the efficacy of tivantinib, placebo, cetuximab, and irinotecan in treating metastatic colorectal cancer patients who have received one prior line of chemotherapy and express the wild-type form of the gene KRAS.",
    "This is a phase 1 trial for multiple sclerosis patients on beta-interferon therapy, testing the efficacy of ACTH and methylprednisolone as treatment options, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of nnc0215-0384, a drug, versus placebo in treating inflammation and rheumatoid arthritis in patients who are also taking MTX, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for the drug zgn-433 in obese, post-menopausal or infertile females with a BMI between 32 and 45 kg/m2 and exclusion criteria including a history of diabetes or other endocrine disorder, and the trial will test the drug's efficacy in treating obesity.",
    "This trial is testing the combination of gefitinib and gemcitabine for patients with pancreatic cancer, with specific eligibility criteria and exclusion criteria listed.",
    "The sample is a phase 1 trial testing the drugs ro5323441 and sorafenib on patients with advanced or metastatic hepatocellular carcinoma, with specific inclusion and exclusion criteria listed in the eligibility criteria section.",
    "The sample is a phase 1 trial for healthy Caucasian individuals, testing the drugs Advagraf\u00ae and Prograf\u00ae with eligibility criteria including no history of certain diseases, normal ECG, and non-smoking within 3 months prior to screening.",
    "This phase 1 trial will test the drug batracylin on patients with metastatic or unresectable solid tumor malignancy or lymphoma, who meet specific eligibility criteria, and have a slow acetylator NAT2 genotype.",
    "This phase 1 trial is testing the drug pazopanib (gw786034) on patients with relapsed or refractory solid tumors, including sarcoma, neuroblastoma, and osteosarcoma, with specific eligibility criteria based on age, disease type, and performance score.",
    "The sample is a phase 1/2 trial for patients with non-small-cell lung carcinoma who have failed standard chemotherapy and will test the drug pt-523 for injection, with eligibility criteria including age \u2265 18 years, ECOG performance status 0-2, and adequate organ function and bone marrow reserve.",
    "This phase 1 trial is testing the efficacy of cyclophosphamide & zyc300 in treating advanced stage malignancies including breast, ovarian, prostate, colon, and renal cancer, with specific eligibility criteria for patients, such as measurable disease and adequate hematological and renal function.",
    "The sample is a phase 1/phase 2 trial for patients with chronic lymphocytic leukemia, testing the efficacy of gleevec and chlorambucil as a treatment option, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for multiple types of cancer, using cyclophosphamide and fludarabine phosphate as drugs, with eligibility criteria including confirmed malignancy, CEA-positive tumor, and various patient characteristics and prior concurrent therapies.",
    "This phase 1 trial is testing the efficacy of recombinant fowlpox-cea(6d)/tricom vaccine, recombinant vaccinia-cea(6d)-tricom vaccine, docetaxel, and sargramostim in treating patients with incurable metastatic lung or colorectal cancer who have exhausted standard treatment options and meet a variety of eligibility criteria.",
    "This phase 1 trial is testing the effectiveness of temozolomide on patients with central nervous system neoplasms and neoplasm metastasis who have not responded to prior chemotherapy or radiation therapy and are candidates for high dose chemotherapy and autologous stem cell transplant.",
    "This phase 1 trial is testing the drug lbh589 on patients with metastatic melanoma, with specific eligibility criteria and exclusion criteria listed.",
    "The sample is a phase 1/2 trial testing the drug mgcd0103 on patients with high-risk myelodysplastic syndrome or acute myelogenous leukemia, with specific eligibility criteria and exclusion criteria listed.",
    "The sample is a phase 1/phase 2 trial for metastatic and/or locally advanced colorectal cancer using bevacizumab, oxaliplatin, and capecitabine as drugs, with eligibility criteria including age, histologically confirmed colorectal cancer, and measurable lesion according to RECIST.",
    "The sample is a phase 1 trial for drugs nnc 0070-0002-0453 and placebo on overweight/obese males with metabolism and nutrition disorder and obesity, with eligibility criteria including BMI between 27.0 to 39.0 kg/m2 and good general health, and exclusion criteria including aggressive diet attempts within the last 3 months and history of eating disorders.",
    "This phase 1 trial is testing the efficacy of bortezomib and cisplatin in treating previously untreated stage IV squamous cell carcinoma of the head and neck, with eligibility criteria including ECOG performance status 0-1, normal total bilirubin, and no prior bortezomib or systemic EGFR inhibitors.",
    "This trial is testing the effectiveness of samarium sm-153 lexidronam + docetaxel in treating castrate metastatic prostate cancer patients with at least 3 bone metastases, who have shown progression of disease following withdrawal of anti-androgen therapy, and meet other eligibility criteria.",
    "This phase 1 trial is testing the efficacy of multiple drugs, including mapracorat and calcipotriene, on stable plaque-type psoriasis in subjects aged 18 to 65, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1/2 trial testing the drug gefitinib on Asian patients with non-small cell lung cancer, with specific eligibility criteria including EGFR mutational status and never/light smoking history.",
    "This phase 1 trial is testing the efficacy of pramlintide acetate, a drug for type 1 diabetes, on patients who have not achieved glycemic goals while on MDI of insulin, and have an HbA1c between 7.0% and 9.0%.",
    "The sample is a phase 1/phase 2 trial for essential tremor, testing the efficacy of levetiracetam and placebo drugs, with inclusion and exclusion criteria related to neurological and renal diseases, and pregnancy.",
    "This phase 1 trial is testing the efficacy of different combinations of amlodipine and losartan in treating hypertension, with specific eligibility criteria and exclusion criteria listed.",
    "The sample is a phase 1 trial testing the drug brivanib on patients with advanced or metastatic solid tumors, including colorectal, hepatocellular, or renal cancer, with specific eligibility criteria, and the trial includes a list of diseases and their corresponding icd-10 codes.",
    "This phase 1 trial is testing the drug aflibercept on patients with non-Hodgkin B-cell lymphoma who have not been previously treated, and the eligibility criteria includes exclusion of patients with contraindications to the R-CHOP drug combination and other medical conditions that could impair participation or interpretation of study results.",
    "This is a phase 1/2 trial for patients with metastatic colorectal cancer who have received prior cetuximab-containing regimens, and will test the efficacy of irinotecan hydrochloride as a treatment option. The eligibility criteria includes specific disease and medical history requirements, as well as laboratory values and performance status.",
    "The sample is a phase 1/phase 2 trial for patients with rheumatoid arthritis, testing the efficacy of cdp 6038 sc and methotrexate, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for healthy subjects testing the efficacy of pf-03654764 and fexofenadine in different doses compared to placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 1/phase 2 trial for relapsing multiple sclerosis, testing the drugs cdp323 and placebo, with inclusion criteria including age, disease type, and EDSS score, and exclusion criteria including concomitant treatment with MS disease modifying drugs.",
    "The sample is a phase 1/phase 2 trial for ta-7284 and placebo in clinically stable type 2 diabetes mellitus patients with specific inclusion and exclusion criteria, including BMI, hemoglobin A1c levels, fasting blood glucose levels, blood pressure, and medication history.",
    "This phase 1 trial is testing the safety and efficacy of vasomera and 0.9% sodium chloride in treating essential hypertension in subjects who are not currently on antihypertensive therapy or who could be safely withdrawn from it, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for patients with metastatic prostate cancer, testing the efficacy of ODM-201 capsule or tablet formulations, with eligibility criteria including ongoing androgen deprivation therapy and exclusion criteria including previous chemotherapy and known brain metastases.",
    "This is a phase 1 trial for cancer patients with the drug npi-2358, with eligibility criteria including confirmed solid tumor malignancy, adequate bone marrow reserve, hepatic and renal function, and exclusion criteria including prior treatment with vascular disruptive agents, brain metastases, and active uncontrolled bacterial, viral, or fungal infection.",
    "This phase 1 trial is testing the efficacy of temsirolimus, temozolomide, and irinotecan hydrochloride in treating patients with unspecified childhood solid tumors, who have no known curative therapy or therapy proven to prolong survival with an acceptable quality of life, and meet various eligibility criteria.",
    "This sample is a phase 1/phase 2 trial for patients with multiple myeloma, testing the efficacy of depsipeptide, bortezomib, and dexamethasone as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This phase 1 trial is testing the efficacy of a placebo drug on patients with migraine who meet specific inclusion criteria, including a history of migraine for at least 12 months and use of acute migraine medications for no more than 14 days per 28 day period.",
    "This phase 1 trial is testing the efficacy of ppc-5650 and placebo in treating pain in postmenopausal women or women who have undergone hysterectomy, and males between 18 and 70 years of age, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial testing LY573636-sodium on participants with relapsed or refractory essential thrombocythemia or acute myeloid leukemia, with eligibility criteria including adequate hepatic and renal function, previous therapy discontinuation, and negative pregnancy test, while exclusion criteria include myeloproliferative disorders, stem cell transplant within a certain time frame, and serious preexisting medical conditions.",
    "The sample is a phase 1 trial testing the use of dabigatran etexilate in patients with chronic renal insufficiency and either aspirin or Vitamin K Antagonist use, with specific inclusion and exclusion criteria listed.",
    "This phase 1 trial is testing the efficacy of topotecan and sorafenib in treating small cell carcinoma and lung cancer patients who have received one course of systemic chemotherapy and have radiographically documented disease recurrence or progression, with specific eligibility criteria for organ function, brain metastases, and contraception.",
    "This phase 1 trial is testing the safety and efficacy of BIA 9-1067, levodopa/carbidopa, and levodopa/benserazide in treating Parkinson's disease, with inclusion criteria including being between 18 and 45 years old, having a BMI between 18 and 30 kg/m2, and being healthy as determined by medical history, physical examination, and laboratory tests.",
    "The sample is a phase 1 trial for ischemic stroke patients with cervicocephalic arterial dissection, testing the efficacy of aspirin and warfarin as drugs, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the drugs mk0683 and vorinostat on chemotherapy-naive patients with NSCLC and normal organ function, with inclusion and exclusion criteria specified.",
    "This phase 1 trial is testing the safety and efficacy of pf-04991532, a drug for type 2 diabetes, compared to placebo, in patients with stable metformin treatment and specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial testing the drug glpg0778 and placebo on healthy males with specific inclusion and exclusion criteria, and the trial includes the disease \"healthy\" and icd-10 codes Z76.3 and Z76.2.",
    "This phase 1 trial is testing the drug decitabine on patients with an unspecified adult solid tumor, with specific eligibility criteria including measurable disease, performance status, and various laboratory values.",
    "The sample is a phase 1 trial testing the effectiveness of oral zinc and vitamin c supplements on children aged 3-8 years with autism spectrum disorder and a serum copper/zinc ratio greater than 2.0, with exclusion criteria of known chromosomal disorder or neurological disorders other than autism.",
    "This phase 1 trial is testing the drugs mk-3281 and placebo to mk-3281 on participants with chronic hepatitis C infection, with inclusion and exclusion criteria listed.",
    "This phase 1 trial is testing the effectiveness of inotuzumab ozogamicin and rituximab in treating CD20 and CD22-positive, B-cell NHL that has progressed after 1 or 2 prior therapies, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for patients with advanced non-small cell lung cancer, testing the drug irinotecan, with eligibility criteria including prior chemotherapy, high ISG15 levels, and adequate bone marrow, hepatic, and renal function.",
    "The sample is a phase 1 trial for neoplasms, testing the efficacy of afatinib and vinorelbine iv, with specific eligibility criteria and exclusion criteria.",
    "This phase 1 trial is testing the drug pralatrexate on patients with relapsed or refractory cutaneous T-cell lymphoma who have no curative treatment options and meet certain eligibility criteria.",
    "This phase 1 trial is testing the efficacy of as703569/gemcitabine in treating pancreatic cancer patients who have not responded to standard treatments and have a life expectancy of at least 3 months. The eligibility criteria includes having no more than 3 prior chemotherapy regimens, adequate renal, hepatic and bone marrow functions, and an ECOG Performance Status < 2.",
    "This phase 1 trial is testing the efficacy of interleukin-2, gm-csf, and growth hormone in HIV-1 positive patients who are stable on HAART and have a CD4 T cell count of >400 cells/ul, with exclusion criteria including prior therapeutic vaccination and prior immunomodulatory therapy.",
    "The sample is a clinical trial for patients with traumatic injuries and shock, testing the effectiveness of normal saline control and vasopressin drugs, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for metastatic melanoma using the drug raf265, with eligibility criteria including confirmed diagnosis of melanoma, measurable disease, and ECOG performance status of 0 or 1.",
    "The sample is a phase 1/phase 2 trial for HIV infections, testing the efficacy of tenofovir df and tenofovir alafenamide, with inclusion and exclusion criteria listed.",
    "This phase 1 trial is testing the use of psilocybin to treat anxiety in advanced-stage cancer patients, with specific inclusion and exclusion criteria, and treatment sessions scheduled in Los Angeles, California.",
    "The sample is a phase 1/phase 2 trial for patients with clinically refractory or resistant prostate cancer, testing the efficacy of abiraterone acetate, abiraterone acetate mtd, and dexamethasone, with eligibility criteria including histologically documented adenocarcinoma of the prostate and PSA evidence for progressive prostate cancer.",
    "The sample is a phase 1/phase 2 trial for locally advanced or metastatic pancreatic cancer, testing the efficacy of gemcitabine, capecitabine, erlotinib, and bevacizumab, with eligibility criteria including confirmed adenocarcinoma of the pancreas, measurable disease, and no invasion of adjacent organs, among other requirements.",
    "The sample is a phase 1/2 clinical trial for small cell lung cancer, testing the efficacy of at-101 and topotecan as second-line treatment, with specific eligibility criteria including prior chemotherapy regimen and ECOG performance status.",
    "This is a phase 1 clinical trial for patients with advanced solid tumors, testing the drug tki258, with specific eligibility criteria and exclusion criteria.",
    "This phase 1 trial is testing the safety and efficacy of MN-221, a beta-agonist drug, in treating chronic obstructive pulmonary disease (COPD) in patients who meet specific eligibility criteria.",
    "The sample is a phase 1/phase 2 trial for non-small-cell lung cancer patients who have failed prior treatment, using the drugs vorinostat and erlotinib, with inclusion and exclusion criteria listed.",
    "This phase 1 trial is testing the drug cep-18770 on patients with relapsed or refractory solid tumors or non-Hodgkin's lymphoma, with specific eligibility criteria including previous treatments and health requirements.",
    "The sample is a phase 1 trial for acute coronary syndrome, testing lc23-1306, placebo, and ticagrelor as drugs, with eligibility criteria including healthy male subjects between 20 and 50 years old with a BMI between 18.0 and 27.0 kg/m2 and laboratory results within the reference ranges.",
    "This phase 1 trial is testing the efficacy of tiotropium bromide and placebo in patients with cystic fibrosis who meet specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of ranibizumab in treating predominantly hemorrhagic subfoveal choroidal neovascularization resulting from age-related macular degeneration, with inclusion criteria including age over 50 and ability to comply with study assessments, and exclusion criteria including previous participation in a clinical trial involving anti-angiogenic drugs within the last 6 months and history of stroke within 6 months of study entry.",
    "The sample is a phase 1 trial testing the drug nnc0114-0000-0005 and placebo on subjects with inflammation, rheumatoid arthritis, or healthy, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of vemurafenib, a drug used to treat metastatic melanoma, on Chinese patients with positive BRAF V600 mutation results, who are treatment-na\u00efve or have received prior systemic treatments for metastatic melanoma, and meet other eligibility criteria.",
    "The sample is a phase 1/phase 2 trial for patients with stage IV non-small cell lung cancer, testing the efficacy of paclitaxel albumin-stabilized nanoparticle formulation, with eligibility criteria including measurable disease, specific performance status, and no prior chemotherapy for metastatic disease.",
    "The sample is a phase 1 trial for asthma patients, testing the efficacy of gw805858 and placebo drugs, with eligibility criteria including non-smoking, stable asthma, and BMI within 19.0-30.0 kg/m2, and exclusion criteria including history of allergy to inhaler ingredients and use of steroids within 4 weeks.",
    "This phase 1 trial is testing the efficacy of the drugs mk-4827 and temozolomide in treating advanced solid tumors, recurrent glioblastoma multiforme, and metastatic melanoma, with specific eligibility criteria and exclusion criteria.",
    "This trial is testing the effectiveness of docetaxel and pemetrexed in treating non-small cell lung cancer in patients who have not previously been treated with these drugs, and have met certain eligibility criteria.",
    "This phase 1 trial is testing the efficacy of sorafenib tosylate in treating patients with progressive or recurrent malignant glioma, with specific eligibility criteria including a Karnofsky performance status >= 60%, measurable progressive or recurrent malignant glioma by MRI or CT imaging, and recovery from toxicity of prior therapy.",
    "This phase 1 trial is testing the safety and efficacy of asp1941, a glucose-lowering medication, in subjects with type 2 diabetes mellitus who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 1 clinical trial for knee osteoarthritis, testing the efficacy of sar113945 and placebo drugs, with inclusion and exclusion criteria based on disease diagnosis, age, gender, and other factors.",
    "This phase 1 trial is testing the drug th-302 on patients with various types of relapsed or refractory leukemias, myelodysplastic syndrome, myelofibrosis, and chronic lymphocytic leukemia, who are not eligible for standard therapy options, and have met the eligibility criteria.",
    "The sample is a phase 1 trial for patients with unresectable hepatocellular carcinoma, testing the efficacy of lenalidomide and sorafenib, with specific eligibility criteria including liver function, performance status, and prior cancer therapy.",
    "This trial is for patients with primary refractory or relapsed acute myeloid leukemia, who have not received high-dose cytarabine within 3 months prior to registration, and are not pregnant or nursing. The treatment includes cytarabine and lovastatin.",
    "This phase 1 trial is testing the safety and efficacy of dcvax-001 and poly-iclc compared to placebo in healthy volunteers and those with HIV-1 infection, with strict inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of arsenic trioxide, ascorbic acid, and bortezomib in treating relapsed/refractory multiple myeloma, with eligibility criteria including measurable disease and adequate organ function.",
    "This phase 1 trial is testing the drugs bicalutamide, docetaxel, and gnrh analog on patients with prostate cancer who meet specific eligibility criteria, including having no prior radiation or chemotherapy for prostate cancer and no history of severe hypersensitivity reaction to docetaxel or other drugs formulated with Polysorbate 80.",
    "This phase 1 trial will test the safety and eligibility criteria of GSK1265744, a drug for HIV infection, in healthy male and female subjects between 18 and 55 years of age, with a BMI within the range of 18.5-31.0 kg/m2, and with a CD4 cell count >/ 200 cells/mm3 and plasma HIV-1 RNA >/ 5,000 copies/mL for HIV-infected cohort only.",
    "The sample is a phase 1/phase 2 clinical trial for the drug abt-263 in patients with small cell lung cancer or small cell lung carcinoma who have experienced disease progression or are refractory to prior chemotherapy treatment regimens, with eligibility criteria including age, disease diagnosis, prior treatment history, ECOG performance score, and adequate bone marrow, renal, and hepatic function.",
    "This trial is testing the efficacy of Alks 5461 and placebo in treating major depressive disorder in patients who have had an inadequate response to SSRI or SNRI treatment, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the drugs cnf2024 and cnf2024 + trastuzumab on patients with advanced HER2 adenocarcinoma of the breast who have had disease progression on at least one standard hormonal or chemotherapy regimen.",
    "This phase 1 trial is testing the drugs ALS-002158 and placebo on subjects with chronic hepatitis C, with specific inclusion and exclusion criteria, and requires written consent and good health.",
    "The sample is a phase 1/phase 2 trial for patients with various hematologic diseases, testing the efficacy of a combination of drugs including campath, busulfan, fludarabine, and fk-506, with eligibility criteria including age, performance status, and availability of a healthy donor.",
    "This phase 1 trial is testing the efficacy of the combination of osi-930 and erlotinib in treating advanced solid tumors, with eligibility criteria including prior chemotherapy and hormonal therapy, adequate hematopoietic, hepatic, and renal function, and written informed consent.",
    "The sample is a phase 1/2 trial testing the efficacy of capecitabine, irinotecan hydrochloride, and oxaliplatin in treating metastatic or locally advanced unresectable colorectal cancer, with eligibility criteria including Karnofsky performance status 70-100%, life expectancy \u2265 12 weeks, and various laboratory values within normal limits.",
    "This phase 1 trial is testing the efficacy of XL147 (sar245408) in treating metastatic or unresectable solid tumors and relapsed or refractory lymphoma, with eligibility criteria including prior chemotherapy regimens and adequate organ function.",
    "The sample is a phase 1 trial for patients with advanced, non-resectable and/or metastatic solid tumors, testing the efficacy of bi 6727 and bibf 1120 drugs, with eligibility criteria including age > or = 18 years, ECOG performance status < or = 2, and recovery from grade 2-4 therapy-related toxicities from previous systemic anti-cancer therapies or radiotherapy.",
    "This trial is for phase 1/phase 2 of oligog cf-5/20 and saline in treating cystic fibrosis patients with Pseudomonas aeruginosa, with specific inclusion and exclusion criteria.",
    "This phase 1 trial will test the drug varespladib methyl on subjects with renal impairment, using inclusion and exclusion criteria based on age, BMI, renal function, and other health conditions.",
    "This phase 1 trial is testing the investigational drug yh4808 and placebo on healthy male volunteers, with eligibility criteria including age, weight, and medical history, and the trial will measure the effects of the drugs on pH levels in the stomach.",
    "This phase 1 trial is testing the efficacy of vorinostat and temozolomide in treating various childhood CNS malignancies, with specific eligibility criteria including measurable or evaluable disease, no known curative therapy, and stable neurological deficits.",
    "This phase 1 trial is testing the efficacy of nevirapine, amprenavir, and abacavir in treating HIV infections, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 1 trial is testing the efficacy of radium-223 dichloride in treating castration-resistant metastatic prostate cancer patients with at least 2 bone metastases, who have failed initial hormonal therapy, and have a castrate level of testosterone, while also listing the eligibility and exclusion criteria.",
    "This trial is for patients with relapsed or refractory acute myeloid leukemia and acute promyelocytic leukemia, and will test the efficacy of clofarabine and cytarabine as treatment options.",
    "This trial is testing the efficacy of bilb 1941 zw and placebo in treating chronic hepatitis C in adult males with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for Alzheimer's disease testing the drug e2609 and placebo, with inclusion criteria of healthy males and females aged 30 to 55 years or 65 to 85 years with a BMI of 18 to 32kg/m^2, and exclusion criteria of females of child-bearing potential, personal or family history of neurological or cardiac abnormalities, and thyroid abnormalities.",
    "This phase 1 trial is testing the efficacy of intraventricular rituximab plus mtx in treating relapsed, refractory CNS lymphoma, ocular lymphoma, and lymphomatous meningitis, with eligibility criteria including CD20+ tumors and the presence of an Ommaya reservoir.",
    "The sample is a phase 1/phase 2 trial for small cell lung cancer using pemetrexed and cisplatin as drugs, with inclusion criteria including measurable disease and a performance status of 0 to 1, and exclusion criteria including prior chemotherapy and/or thoracic radiotherapy and concurrent administration of any other antitumor therapy.",
    "The sample is a phase 1 trial for healthy adult males testing the safety and tolerability of trv130a and dextrose in water, with inclusion and exclusion criteria listed, and the diseases are listed as 'healthy'.",
    "This phase 1 trial is testing the efficacy of capecitabine (xeloda) in treating unresectable hepatocellular carcinoma, liver mets with no evidence of extrahepatic disease, or cholangiocarcinoma, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for patients with advanced solid tumor cancers, medulloblastoma, and basal cell carcinoma, testing the drug lde225, with specific inclusion and exclusion criteria.",
    "This is a phase 1/phase 2 trial for non-small-cell lung carcinoma using cisplatinum and docetaxel as drugs, with eligibility criteria including confirmed NSCLC, stage III unresectable LA-NSCLC, and adequate cardiac function.",
    "This phase 1 trial is testing the efficacy of carfilzomib, lenalidomide, and dexamethasone in treating relapsed multiple myeloma patients who have had up to three prior therapeutic treatments, with specific eligibility criteria outlined.",
    "This is a phase 1 trial for hypertension testing the efficacy of mk-7145 and hydrochlorothiazide (hctz) against placebo, with eligibility criteria including a diagnosis of essential hypertension, BMI \u226435 kg/m^2, and treatment-na\u00efve or taking up to 2 antihypertensive therapeutic agents.",
    "This phase 1 trial is testing the efficacy of belinostat and azacitidine in treating various types of leukemia, myelodysplastic syndrome, and chronic myeloproliferative disorders, with specific eligibility criteria and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of MN-221 and placebo in treating chronic obstructive pulmonary disease (COPD) in patients aged 40-75 with a history of physician-diagnosed COPD, with inclusion criteria including FEV1 \u2265 30% and < 80% predicted and FEV1/FVC ratio < 0.7, and exclusion criteria including uncontrolled hypertension and patients with home oxygen requirements.",
    "This phase 1 trial will test the safety and efficacy of GSK1322322, a drug for bacterial infections, and its placebo, in Japanese males with specific inclusion and exclusion criteria.",
    "This trial is testing the efficacy of lenalidomide, pioglitazone, dexamethasone, and treosulfan in treating multiple myeloma patients who have relapsed after at least two different anti-myeloma treatments, and have been previously treated with lenalidomide for the phase II part.",
    "The sample is a phase 1/phase 2 trial for patients with hepatocellular carcinoma, testing the drug denspm, with eligibility criteria including measurable disease, renal and hepatic function, and exclusion criteria including prior therapy within certain time frames and unstable medical conditions.",
    "This phase 1 trial is testing the efficacy of imatinib mesylate and sunitinib malate in treating gastrointestinal stromal tumor, with specific eligibility criteria for patients including measurable lesions by RECIST and ECOG performance status 0-2.",
    "The sample is a phase 1 clinical trial testing the drug ombrabulin for advanced neoplastic diseases with specific inclusion and exclusion criteria, and the diseases are listed as 'neoplasms' with corresponding ICD-10 codes.",
    "The sample is a phase 1 trial for extended-release bupropion hydrochloride in patients with Major Depressive Disorder (MDD) with a seasonal pattern, with a list of inclusion and exclusion criteria, and a list of icd-10 codes for MDD.",
    "This phase 1 trial is testing the combination therapy of irinotecan, levofolinate, and 5-fluorouracil (5-fu) for Japanese patients with metastatic colorectal carcinoma who have received no more than 2 prior systemic chemotherapy regimens and have experienced disease progression during first-line therapy, or disease progression within 6 months after the last dose of first-line therapy, or discontinued part or all of first-line therapy due to toxicity and experienced disease progression within 6 months after the last dose of first-line therapy.",
    "This sample is a phase 1/phase 2 trial testing the drug Proellex on healthy adult females with excessive menstrual bleeding, menstrual pain, uterine fibroids, or endometriosis, who meet certain eligibility criteria and do not have any exclusion criteria.",
    "This phase 1 trial is testing the drug mln4924 on patients with relapsed and/or refractory lymphoma or multiple myeloma, with specific subtypes required for the expansion cohort, and eligibility criteria including ECOG performance status 0-2 and evaluable tumor.",
    "The sample is a phase 1/phase 2 trial for patients with vision-threatening autoimmune uveitis, using the drug apremilast, with inclusion criteria of failure to respond to prednisone and at least one other systemic immunosuppressive, or intolerance to such medications due to side effects, and exclusion criteria of serious concomitant illness, previous or current use of an alkylating agent, use of CYP3A4 inhibitors during the trial, and TNF blocker use within the 8 weeks prior to enrollment.",
    "The sample is a phase 1/phase 2 trial for the drug arn-509 in patients with non-metastatic or metastatic castration-resistant prostate cancer, with specific eligibility criteria and exclusion criteria.",
    "This clinical trial is for patients with Malignant Pleural Mesothelioma and will test the effectiveness of carboplatin, bevacizumab, and pemetrexed as a treatment, with specific eligibility criteria and exclusion criteria.",
    "This trial is a phase 1/2 study testing erlotinib hcl, a drug used to inhibit epidermal growth factor receptor (EGFR), in patients with non-small cell lung cancer who have received at least one chemotherapy regimen for advanced or metastatic NSCLC, and have measurable disease on computed tomography (CT) and at least one detectable lesion on FDG-PET scan and/or FLT-PET scan that is measurable on CT.",
    "This phase 1 trial is testing the drug ridaforolimus on patients with unresectable or metastatic cancer that is refractory to standard therapies or for which no standard therapy exists, and the eligibility criteria includes measurable or nonmeasurable lesions, adequate renal and hepatic function, and an anticipated life expectancy of \u2265 3 months.",
    "The sample is a phase 1 trial for hepatitis C, testing the drugs pf-00868554 and placebo, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 1/phase 2 trial for prostate cancer using the drugs tak-700, docetaxel, and prednisone, with eligibility criteria including confirmed diagnosis of prostate adenocarcinoma, radiograph-documented metastatic disease, and prior surgical castration or concurrent use of an agent for medical castration.",
    "The sample is a phase 1/phase 2 trial for metastatic or relapsed locally advanced breast cancer with HER2-positive by FISH, using bevacizumab and herceptin as drugs, and with specific eligibility and exclusion criteria.",
    "The sample is a phase 1 trial for locally advanced and surgically resectable esophageal or gastroesophageal junction cancer, testing the drug capecitabine (xeloda), with inclusion and exclusion criteria listed.",
    "The sample is a phase 1/phase 2 trial for glioblastoma multiforme using the drug aee788, with inclusion criteria including confirmed GBM in first or second recurrence or relapse, adequate hematologic, hepatic and renal function, age \u2265 18 years, Karnofsky performance status score \u2265 70%, and life expectancy \u2265 12 weeks, and exclusion criteria including peripheral neuropathy > grade 1, diarrhea > grade 1, gastrointestinal dysfunction, compromised cardiac function, and concurrent severe and/or uncontrolled medical conditions.",
    "This phase 1 trial is testing the efficacy of bibw 2992 in patients with non-resectable and/or metastatic cancer, with squamous cell carcinomas of head and neck, esophagus, lung or cervix, who have recovered from previous therapies, have an ECOG performance score less than or equal to 2, and meet other eligibility criteria.",
    "This trial is for patients with symptomatic multiple myeloma requiring treatment, who have been approved for single or tandem autologous transplant, and will test the efficacy of busulfan in combination with DT-PACE.",
    "The sample is a phase 1/phase 2 trial for osteoarthritis, testing the efficacy of normal saline as a treatment, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 1/2 trial for the drug tmc278la in HIV-infected individuals, with inclusion and exclusion criteria listed, and the value is the potential efficacy of tmc278la in treating HIV.",
    "This sample is a phase 1/phase 2 clinical trial for patients with mantle cell lymphoma, testing the efficacy of temsirolimus and bendamustine in patients who have relapsed or progressed during therapy, with specific eligibility criteria and exclusion criteria.",
    "This phase 1 trial is testing the effectiveness of RNS60, normal saline, and budesonide in treating mild to moderate asthma in non-smokers aged 18-65, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for glaucoma and ocular hypertension, testing the drugs ino-8875 and placebo, with inclusion criteria based on age and mean intraocular pressure, and exclusion criteria based on visual field loss, cup-to-disc ratio, central corneal thickness, and medical history.",
    "The sample is a phase 1 trial for breast cancer patients using ixabepilone and capecitabine, with inclusion criteria of women over 20 years old with adenocarcinoma originating in the breast and exclusion criteria of having received three or more prior chemotherapy lines of treatment in the metastatic setting.",
    "This phase 1 trial is testing the efficacy of axitinib plus everolimus in treating advanced solid tumors, including renal cell carcinoma, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 1 trial for patients with advanced non-small cell lung cancer, testing the combination of pazopanib, gemcitabine, and cisplatin, with eligibility criteria including prior failed standard therapy, measurable or evaluable disease, and adequate organ function.",
    "This phase 1 trial is testing the efficacy of cyclosporine, etoposide, and vincristine sulfate in treating newly diagnosed diffuse intrinsic brain stem glioma in patients aged 3 to 21 with specific eligibility criteria.",
    "The sample is a phase 1/phase 2 clinical trial for the treatment of anterior cruciate ligament injury and osteoarthritis using hyaluronan, with eligibility criteria including ACL reconstruction surgery within six months, autograft use, and willingness to participate in follow-up for 24 months.",
    "This is a phase 1 trial for Parkinson's disease testing the drug rotigotine, with eligibility criteria including being healthy, of normal body weight, and having no history of drug or alcohol abuse within the last 2 years.",
    "This phase 1 trial is testing a malaria vaccine on males and non-pregnant, non-lactating females between the ages of 18 and 45 years in Burkina Faso, using a placebo drug and a set of inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for peripheral vascular diseases, testing the drugs mk-0736 and placebo, with specific eligibility criteria and exclusion criteria listed.",
    "The sample is a phase 1 trial testing brentuximab vedotin on patients with relapsed or refractory CD30-positive malignancy, with inclusion criteria including adequate organ function and ECOG performance status <2, and exclusion criteria including cardiac abnormalities and prior hematopoietic stem cell transplant.",
    "This clinical trial is testing the drug radotinib on patients with Ph+ CML who are resistant or intolerant to imatinib or other targeted anticancer agents, with specific inclusion and exclusion criteria based on disease phase, performance status, laboratory values, and medical history.",
    "The sample is a phase 1/phase 2 trial for relapsed or refractory multiple myeloma patients using the drug Revlimid, with eligibility criteria including measurable levels of myeloma paraprotein, ECOG performance status score of 0, 1 or 2, and exclusion criteria including prior use of Revlimid and history of cardiac disease.",
    "The sample is a phase 1/phase 2 trial testing the safety and efficacy of ibi-20089/Lucentis in treating active, subfoveal choroidal neovascular membranes due to age-related macular degeneration, with specific inclusion and exclusion criteria for subjects.",
    "The sample is a phase 1 trial for cancer patients with specific ICD-10 codes, testing the efficacy of ic83/ly2603618 and pemetrexed drugs, with inclusion and exclusion criteria related to pregnancy, brain metastases, and active infection.",
    "The sample is a phase 1 trial for healthy non-smoking adults testing the effects of IV dihydroergotamine mesylate (DHE) and other drugs on cardiac status, with inclusion and exclusion criteria listed, and the diseases column indicating 'healthy'.",
    "This trial is testing the drug panobinostat on HIV patients who meet specific eligibility criteria.",
    "This phase 1 trial is testing the efficacy of DepoCyt and temozolomide in treating neoplastic meningitis, with eligibility criteria including a histologic diagnosis of systemic malignancy, a Karnofsky performance status of >/=60%, and adequate liver and renal function.",
    "The sample is a phase 1/phase 2 trial for patients with hermansky-pudlak syndrome, pulmonary fibrosis, oculocutaneous albinism, platelet storage pool deficiency, and metabolic disease, testing the efficacy of losartan, zileuton, n-acetylcysteine, pravastatin, and erythromycin, with specific eligibility and exclusion criteria.",
    "The sample is a phase 1 trial for patients with advanced solid tumors, testing the drug ixabepilone (oral formulation), with inclusion criteria including confirmed diagnosis of solid tumor malignancy, measurable or non-measurable disease, and KPS of 70-100, and exclusion criteria including inadequate hepatic and renal function and prior exposure to any epothilone.",
    "This early phase 1 trial will test the effectiveness of haloperidol and placebo in treating nausea and vomiting, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 1 trial aims to investigate the effect of mangosteen juice and placebo juice on patients with atrial fibrillation who are undergoing cardioversion, with inclusion criteria including age >18 years, documented atrial fibrillation, and anticoagulation with therapeutic INR or PTT, while exclusion criteria include bleeding diathesis, known atrial thrombus, and current use of corticosteroids.",
    "This trial is testing the efficacy of capecitabine, epirubicin, amg 102, cisplatin, and placebo in treating unresectable locally advanced or metastatic gastric or esophagogastric junction adenocarcinoma, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of zoledronate in treating cervical cancer and precancerous conditions, with eligibility criteria including normal creatinine levels, no known hypersensitivity to bisphosphonates, and no concurrent use of loop diuretics, aminoglycosides, immunosuppressive drugs, or other investigational agents.",
    "This is a phase 1/phase 2 trial for patients with progressive, metastatic prostate cancer, testing the efficacy of docetaxel, prednisone, and vatalanib, with eligibility criteria including castrate levels of testosterone, Karnofsky performance status \u2265 60%, and no pre-existing grade 3 or 4 clinical peripheral neuropathy.",
    "The sample is a phase 1/phase 2 trial for kidney transplantation, testing the drugs aeb071 and mycophenolic acid, with inclusion criteria including adult recipients of a functioning kidney transplant and exclusion criteria including patients with a history of cancer or severe systemic infections.",
    "This phase 1 trial is testing the safety and efficacy of the drug gm-csf in HIV-uninfected individuals with specific MHC alleles and negative hepatitis B and C status, with a list of exclusion criteria, for a 15-month study period.",
    "This phase 1 trial is testing the efficacy of cisplatin and pazopanib in treating metastatic solid tumors, with eligibility criteria including measurable or evaluable disease, WHO performance status \u2264 1, and corrected QT interval (QTc) \u2264 480 msecs using Bazett's formula.",
    "The sample is a phase 1/phase 2 trial for metastatic colorectal cancer, colon cancer, colorectal cancer, and rectal cancer, testing the efficacy of placebo, amg 655, modified folfox6, and bevacizumab, with specific eligibility criteria and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of carfilzomib and dexamethasone in treating patients with refractory or relapsed hematologic malignancies, including multiple myeloma, non-Hodgkin's lymphoma, Hodgkin's disease, and Waldenstrom's macroglobulinemia, with specific eligibility criteria and exclusion criteria.",
    "This trial is testing the efficacy of idarubicin, sorafenib, and ara-c in treating AML and high risk MDS in patients aged 15 to 60 years who meet specific eligibility criteria.",
    "The sample is a phase 1 trial for advanced breast cancer patients, testing the efficacy of cyclophosphamide, docetaxel, and doxorubicin hydrochloride, with eligibility criteria including age, sex, performance status, and various medical conditions.",
    "This phase 1 trial is testing the drug osi-906 on patients with advanced solid tumors who are refractory to established forms of therapy or for which no effective therapy exists.",
    "This phase 1 trial is testing the effectiveness of HAART, a drug used to treat HIV infection, on patients who meet specific eligibility criteria.",
    "The sample is a phase 1/phase 2 trial for locally advanced pancreatic ductal adenocarcinoma, testing the efficacy of bevacizumab, 5-fluorouracil, oxaliplatin, and gemcitabine, with specific eligibility criteria and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of cyclophosphamide, cyclosporine, and mycophenolate mofetil in treating life-threatening marrow failure of nonmalignant etiology, specifically aplastic anemia, with eligibility criteria including granulocytes < 500/mm^3, a corrected reticulocyte count < 1%, and platelet count < 20,000/mm^3.",
    "This phase 1 trial is testing the drug SGX523 capsules on patients with advanced cancer who have failed standard therapy, and have evidence of phospho-MET expression on tumor material, with eligibility criteria including laboratory values and exclusion criteria including patients receiving anti-coagulant therapy.",
    "This phase 1 trial is testing the drug clofarabine on patients with hematologic malignancies, including AML, ALL, myelodysplasia, CML, and aggressive NHL, who have failed previous treatments and have an HLA-matched donor, with specific eligibility criteria including age, performance status, and baseline laboratory values.",
    "The sample is a phase 1 trial testing the drugs vorinostat and velcade on patients with relapsed or refractory solid tumors, including lymphomas, with specific eligibility criteria based on age, disease state, performance score, and organ function.",
    "This trial is testing the drug camptothecin (cpt) conjugated to a linear, cyclodextrin-based polymer on patients with advanced, histologically-confirmed solid tumors refractory to standard therapy or for which no standard therapy exists, with measurable or evaluable disease, and who have not received prior chemotherapy or radiation for >/= 4 weeks prior to first dose of study drug, among other eligibility criteria.",
    "This is a phase 1 trial for cystic fibrosis testing the efficacy of recombinant human igf-1 and placebo, with eligibility criteria including a diagnosis of cystic fibrosis and age >= 18 years.",
    "This trial is for patients with relapsed or primary refractory lymphoid malignancy, and the treatment involves chemotherapy with the drugs vorinostat, ifosfamide, carboplatin, and etoposide, with specific eligibility criteria including measurable disease and a SWOG performance status of 0, 1, or 2.",
    "This phase 1 trial is testing the drug ipilimumab on previously untreated urothelial carcinoma patients who are ineligible for chemotherapy and have adequate hematologic, kidney, and liver function, with inclusion and exclusion criteria listed.",
    "The sample is a phase 1/phase 2 trial for non-small cell lung cancer using tlk286, carboplatin, and paclitaxel as drugs, with eligibility criteria including confirmed NSCLC, measurable disease, and adequate liver and renal function.",
    "This clinical trial is testing the efficacy of AVE1642, sorafenib, and erlotinib in treating liver carcinoma patients who are not eligible for surgical resection, liver transplantation, local ablation techniques or chemoembolisation, and have histologically proven liver carcinoma or a combination of radiologically documented hypervascular liver tumour and \u03b1 foeto protein level \u2265 400 ng/ml.",
    "The sample is a phase 1 trial testing the efficacy of canagliflozin and placebo in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy, with inclusion and exclusion criteria specified.",
    "The sample is a phase 1 trial for non-small cell lung cancer using cetuximab as the drug, with specific eligibility criteria including histologically confirmed cancer, inoperable stage III, and adequate organ function.",
    "This trial is testing the combination of pemetrexed, cisplatin, and LY2603618 for the treatment of non-small cell lung cancer and malignant mesothelioma in Phase 1 and NSCLC in Phase 2, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 1 trial testing the drug azd4877 on patients with lymphoma and non-Hodgkin lymphoma, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 1 trial for cancer patients with the drug snx-5422, with inclusion criteria of refractory solid tumor malignancy and exclusion criteria of CNS malignancy and significant GI disease.",
    "This phase 1 trial is testing the drug MLN8054 on patients with metastatic and/or advanced solid tumors, including breast, colon, pancreatic, and bladder neoplasms, who have exhausted standard treatment options and meet specific eligibility criteria.",
    "The sample is a phase 1/phase 2 trial for metastatic colorectal cancer testing the efficacy of pimasertib, placebo, and folfiri as treatment options for patients who have progressed during or after first-line treatment with oxaliplatin and fluoropyrimidines based chemotherapy with or without bevacizumab, with eligibility criteria including K-Ras mutated colon/rectum cancer and measurable metastatic disease, and exclusion criteria including bone marrow impairment, renal impairment, and history of CNS metastases.",
    "The sample is a phase 1/phase 2 trial for psoriasis vulgaris using hat1 topical solution and calcipotriol as drugs, with inclusion criteria including a PASI score >3 and <12, and exclusion criteria including systemic treatment with immunosuppressive drugs or corticosteroids within 4 weeks prior to enrollment.",
    "This phase 1 trial is testing the drug cudc-101 on subjects with advanced, refractory solid tumors and a histopathologically confirmed diagnosis, who have no further standard of care options or have refused standard therapy, and meet other eligibility criteria.",
    "The sample is a phase 1 trial for tumors using the drug bms-275183, with eligibility criteria including non-hematologic malignancy, ECOG performance status 0-1, and no more than 3 prior chemotherapy regimens.",
    "The sample is a phase 1/phase 2 trial for patients with locally advanced non-small cell lung cancer, testing the efficacy of bortezomib, paclitaxel, and carboplatin in combination with radiotherapy, with strict eligibility criteria including performance status, blood counts, liver and kidney function, and exclusion of prior chemotherapy or radiation to the chest.",
    "This phase 1 trial is testing the efficacy of bevacizumab, capecitabine, and erlotinib in treating rectal cancer patients who meet specific eligibility criteria.",
    "This phase 1 trial is testing the drug AXL1717 in combination with chemotherapy for locally advanced or metastatic squamous non-small-cell lung cancer, with eligibility criteria including preserved major organ functions and signed written informed consent.",
    "This phase 1 trial is testing the combination of mk-2206, paclitaxel, and trastuzumab in patients with metastatic or locally advanced, unresectable HER2+ cancer who meet certain eligibility criteria.",
    "This phase 1 trial is testing the efficacy of fluticasone and placebo in patients with mild to moderate persistent allergic asthma who have a positive response to house dust mite allergen challenge and meet other inclusion criteria, while excluding patients with certain medical histories or who take certain medications.",
    "The sample is a phase 1 clinical trial testing the safety and tolerability of bibr 796 bs, a drug for treating diseases, in healthy male and female subjects with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the drug dinaciclib on patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have received at least one prior therapy, and have an ECOG performance status \u2264 2, while excluding patients with certain medical conditions or who have previously been treated with a cyclin dependent kinase inhibitor.",
    "This phase 1 trial is testing the drug cdki at7519 on patients with advanced and/or metastatic solid tumors or refractory non-Hodgkin's lymphoma, with specific eligibility criteria for patient characteristics and prior concurrent therapy.",
    "The sample is a phase 1 trial for locally advanced pancreatic cancer patients who have not undergone surgery, testing the effectiveness of gemcitabine hydrochloride, with eligibility criteria including Karnofsky performance status, blood count, bilirubin, and comorbid conditions.",
    "The sample is a phase 1 trial for patients with esophageal cancer, testing the effectiveness of capecitabine, [18-f] fluorodeoxyglucose, 5-fluorouracil, and carboplatin, with eligibility criteria including confirmed diagnosis of adenocarcinoma or squamous cell carcinoma of the esophagus and no prior chemotherapy for esophageal cancer.",
    "This trial is testing the efficacy of entinostat and imatinib mesylate in treating Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia patients who have failed primary induction therapy or relapsed after achieving complete remission, and meet specific eligibility criteria.",
    "This phase 1 trial is testing the efficacy of cetuximab and lapatinib in patients with colorectal cancer, lung cancer, and head and neck cancer who have progressed after standard therapy, and have measurable lesions, adequate organ function, and meet other eligibility criteria.",
    "The sample is a phase 1/phase 2 trial for systemic sclerosis, testing the efficacy of rapamycin and methotrexate as treatment options, with specific inclusion and exclusion criteria.",
    "This trial is testing the efficacy of pemetrexed, cisplatin and cbp501, and pemetrexed and cisplatin in treating malignant pleural mesothelioma and solid tumors in patients who meet specific eligibility criteria.",
    "The sample is a phase 1 trial for pancreatic cancer patients with measurable or evaluable disease, testing the efficacy of gemcitabine and imatinib mesylate, with eligibility criteria including ECOG performance status, blood counts, liver and kidney function, and exclusion of other medical conditions or malignancies.",
    "This phase 1 trial is testing the combination of azacitidine and temozolomide in patients with soft tissue sarcoma or mesothelioma who have received prior chemotherapy, and have measurable disease, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for patients with refractory solid tumors or lymphomas, testing the drugs tanespimycin and bortezomib, with eligibility criteria including performance status, blood counts, cardiac and pulmonary function, and no prior radiotherapy or concurrent investigational therapy.",
    "This is a phase 1 trial for patients with severe peripheral arterial disease, testing the efficacy of biwh 3 and placebo drugs, with eligibility criteria including Fontaine class III or IV and a life expectancy of at least six months.",
    "This phase 1 trial is testing the efficacy of rad001, cetuximab, and irinotecan in treating metastatic colorectal cancer patients who have progressed despite prior therapy with FOLFOX plus bevacizumab or XELOX plus bevacizumab, and have at least one measurable lesion by RECIST, while meeting other inclusion/exclusion criteria.",
    "This phase 1 trial is testing the drug enmd-2076 on patients with advanced cancer who have no standard therapy available, and the eligibility criteria includes meeting modified RECIST criteria, having an ECOG performance status of 0 or 1, and agreeing to use effective contraceptive methods.",
    "This trial is for patients with relapsed or refractory acute lymphoblastic leukemia and will test the efficacy of a combination therapy including bortezomib, dexamethasone, peg-asparaginase, doxorubicin, cytarabine, methotrexate, vincristine, and triple it therapy, with specific eligibility criteria for patients' age, prior therapy, and reproductive function.",
    "This clinical trial is testing the efficacy of placebo, palifermin, and cisplatin in treating mucositis and head and neck cancer patients who meet specific eligibility criteria, including having newly diagnosed squamous cell carcinoma and receiving adjuvant concurrent chemoradiation treatment within 12 weeks of surgery. The trial is in phase 1/phase 2 and includes patients with various ICD-10 codes.",
    "The sample is a phase 1 trial testing the drug bi 660848 and placebo on healthy males with various pain-related icd-10 codes and diseases, with strict inclusion and exclusion criteria.",
    "This trial is testing the efficacy of paclitaxel, nanoparticle albumin-bound in treating patients with recurrent bladder cancer refractory to standard intravesical therapy, with specific eligibility criteria including confirmed diagnosis of transitional cell carcinoma, high-grade histology, and exclusion of muscle invasion.",
    "This sample is a phase 1/phase 2 trial for patients with unresectable pancreatic cancer, testing the efficacy of oxaliplatin, 5fu, and folfox 6, with eligibility criteria including no prior chemotherapy or radiation therapy, ECOG performance status 0-1, and adequate organ function.",
    "This phase 1 trial is testing the safety and efficacy of losmapimod and moxifloxacin in treating acute coronary syndrome, with strict inclusion and exclusion criteria for participants.",
    "The sample is a phase 1/phase 2 trial for squamous cell cancer, testing the efficacy of cilengitide, cetuximab, 5-fluorouracil, and cisplatin, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for patients with refractory/relapsed AML, testing the effectiveness of vorinostat and decitabine, with eligibility criteria including age, prior treatment, liver/kidney function, and willingness to practice birth control during the study.",
    "The sample is a phase 1 trial testing the drug bay86-9766 on Japanese patients with advanced or refractory solid tumors, excluding primary brain or spinal tumors, and with specific eligibility criteria.",
    "This is a phase 1 trial for locally advanced or metastatic colorectal cancer patients with K-ras wildtype tumors, testing the efficacy of zd6474, cetuximab, and irinotecan, with specific eligibility and exclusion criteria.",
    "This trial is testing the drug pd-0325901 on patients with metastatic or inoperable breast cancer, colon cancer, or melanoma, with eligibility criteria including age, prior treatment, and adequate organ function.",
    "This phase 1 trial is testing the efficacy of sorafenib, a drug, in previously untreated or systemically treated poor prognosis NSCLC patients for whom palliative thoracic irradiation is the treatment of choice per standard of care.",
    "The sample is a phase 1 trial for patients with rheumatoid arthritis, testing the effectiveness of cp-690,550 or placebo drugs, with inclusion criteria based on ACR classification and inadequate response to DMARDs, and exclusion criteria including pregnancy, severe allergies, and serious medical conditions.",
    "This clinical trial is testing the efficacy of carboplatin, paclitaxel, and medi-575 in treating inoperable Stage IIIB or Stage IV non-small cell lung cancer patients with squamous cell carcinoma, who meet specific eligibility criteria.",
    "This phase 1 trial is testing the efficacy of fludarabine, melphalan, and campath in treating preleukemia, myeloproliferative disorders, lymphoma, myeloma, and graft versus host disease, with specific eligibility criteria for patients.",
    "The sample is a phase 1/phase 2 trial for metastatic breast cancer, testing the drugs ct-p6, herceptin, and paclitaxel, with eligibility criteria including Her 2 over-expression and ECOG 0 or 1.",
    "This trial is testing the efficacy of carboplatin, cetuximab, and rad001 in treating patients with recurrent, refractory or metastatic squamous cell carcinoma of the head and neck who failed to respond to prior chemoradiotherapy, and the eligibility criteria includes various medical conditions and laboratory values.",
    "The sample is a phase 1 trial with healthy participants testing the safety and tolerability of glpg1205 and placebo oral suspensions, with inclusion criteria of healthy males aged 18-50 years and BMI between 18-30 kg/m2, and exclusion criteria of any condition that might interfere with the study procedures or tests, drug or alcohol abuse, and smoking.",
    "This clinical trial is testing the combination of bay86-9766 and gemcitabine for patients with locally advanced, inoperable or metastatic pancreatic adenocarcinoma, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of amg 706, gemcitabine, and cisplatin in treating lung, pancreatic, and esophageal cancer patients who meet specific eligibility criteria.",
    "This phase 1 trial is testing the efficacy of anti-IL-20 and placebo drugs on patients with moderate to severe chronic plaque psoriasis and inflammation, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the drug rad001 (everolimus) on untreated or relapsed/refractory acute myeloid leukemia patients over the age of 18, with specific eligibility criteria including normal electrolyte levels and adequate hepatic and renal function.",
    "This sample is a phase 1/phase 2 trial for Friedreich's ataxia, testing the efficacy of deferiprone and placebo drugs, with inclusion and exclusion criteria for eligibility.",
    "This phase 1 trial is testing the efficacy of ebi-005-1 and ebi-005-1 placebo in treating dry eye, with inclusion criteria including healthy adults between 18 and 65 years old with best correction vision of greater than or equal to 20/40 in each eye, and exclusion criteria including a history of laser refractive surgery, use of contact lenses currently or within the past one year, and positive urine drug/alcohol or cotinine testing.",
    "The sample is a phase 1 trial for indolent B cell Non-Hodgkin's lymphoma patients using bendamustine hydrochloride as the drug, with eligibility criteria including prior therapy, age range, and written consent.",
    "The sample is a phase 1/phase 2 trial for lung cancer using the drug ipi-504, with inclusion criteria of Stage IIIb or Stage IV NSCLC and measurable disease by RECIST criteria, and exclusion criteria of previous treatment with 17-AAG, DMAG or other known Hsp90 inhibitor.",
    "This phase 1 trial is testing the drug tki258 on patients with acute myeloid leukemia, with inclusion criteria including confirmed diagnosis of the disease and exclusion criteria including clinically significant cardiac disease and uncontrolled diabetes mellitus.",
    "This trial is testing the efficacy of trastuzumab and rad001 in patients with HER-2-overexpressing breast cancer and metastatic disease who have previously received trastuzumab-based therapy, with eligibility criteria including measurable disease, performance status, and laboratory values within certain ranges.",
    "The sample is a phase 1/phase 2 trial for patients with advanced metastatic or recurrent gastric cancer, testing the effectiveness of paclitaxel, with specific eligibility criteria including proper bone marrow, kidney, and liver function, and exclusion criteria such as blood tumors or uncontrolled infectious disease.",
    "This phase 1 trial is testing the efficacy of rad001 and sorafenib in treating metastatic or unresectable renal cell carcinoma, with eligibility criteria including clear cell histology, RECIST-defined measurable disease, and adequate bone marrow, hepatic, and renal function.",
    "This phase 1 trial is testing the efficacy of aprepitant and cyclophosphamide in treating breast cancer patients with nausea and vomiting, with specific eligibility criteria including ANC, platelet count, hemoglobin, serum creatinine, and AST/ALT levels.",
    "The sample is a phase 1/phase 2 trial for patients with idiopathic cardiomyopathy, testing the use of allopurinol and dobutamine, with inclusion and exclusion criteria listed.",
    "The sample is a phase 1 trial testing the drug tki258 on patients with advanced solid tumors that have progressed despite standard therapy, with a list of diseases including neoplasm, cancer, and tumors, and a list of icd-10 codes, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for patients with metastatic pancreatic cancer, testing the combination of cp-675,206 and gemcitabine, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 1 clinical trial for hypercholesterolemia, testing the efficacy of alirocumab, ezetimibe, ezetimibe placebo, and fenofibrate in reducing LDL-C levels in healthy subjects aged 18 to 65 years old, with exclusion criteria including those currently taking lipid-lowering therapy or with clinically relevant illness.",
    "The sample is a phase 1/phase 2 trial for hormone refractory prostate cancer using docetaxel and gemcitabine as drugs, with eligibility criteria including PSA > 10 microgram/l and stage IV disease.",
    "This phase 1 trial is testing the efficacy of anti-IL-20 drug and placebo in treating rheumatoid arthritis patients who have been on stable methotrexate treatment for at least 4 weeks, with specific inclusion and exclusion criteria.",
    "This phase 1 trial will test the efficacy of sumatriptan, a drug used to treat migraines, in healthy men and women ages 18 to 55 with a BMI of 18-32 kg/m2, inclusive, and a body weight of not less than 50 kg, who have no clinically relevant abnormalities and meet other eligibility criteria.",
    "This phase 1 trial is testing the drugs arry-520 and filgrastim on patients with advanced solid tumors that have recurred or progressed following standard therapy, with specific eligibility and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of dinaciclib and epirubicin hydrochloride in treating metastatic or unresectable triple-negative breast carcinoma patients who have no more than two prior chemotherapy regimens, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the efficacy of dapagliflozin, with specific inclusion and exclusion criteria.",
    "This trial is testing the effectiveness of rituximab in treating Sjogren's syndrome, with inclusion criteria including positive autoantibodies and a parotid gland biopsy, and exclusion criteria including previous treatment with anti-TNF or other monoclonal antibodies and underlying medical conditions that place the patient at an unacceptable risk for participation in the study.",
    "This phase 1 trial is testing the efficacy of enzastaurin hydrochloride, a drug, on patients with locally advanced or metastatic cancer for which no preferable therapy exists, and the eligibility criteria includes various patient characteristics and prior concurrent therapy restrictions.",
    "This phase 1 trial is testing the drug fondaparinux on patients with ovarian carcinoma who meet specific eligibility criteria, including being at high risk of clinical relapse and having adequate end organ function, while excluding patients with certain medical conditions or lab abnormalities.",
    "This is a phase 1 trial for patients with metastatic or unresectable solid tumors, specifically differentiated thyroid cancer and renal cell carcinoma, testing the efficacy of rosiglitazone and xl184 drugs with eligibility criteria including BMI, organ and marrow function, and performance status.",
    "This is a phase 1 trial for patients with non-Hodgkin lymphoma, testing the efficacy of SB-485232 and rituximab as treatment options, with eligibility criteria including confirmed diagnosis of CD20+ B cell NHL, measurable or evaluable disease, and predicted life expectancy of at least 12 weeks.",
    "This phase 1 trial is testing the combination of pazopanib and lapatinib in patients with advanced solid tumors, who meet certain eligibility criteria, including having adequate bone marrow reserve and hepato-renal function, and excluding those with prior treatment with pazopanib or lapatinib, or poorly controlled hypertension. The trial is focused on patients with carcinoma, renal cell, and the icd-10 codes associated with the disease.",
    "This phase 1 trial is testing the efficacy of fludarabine, obinutuzumab, bendamustine, and cyclophosphamide in treating CD20-positive B-CLL with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of disulfiram and arsenic trioxide in treating metastatic melanoma patients who have progressed after at least one prior systemic therapy, and have normal ECG and performance status of 0-2.",
    "This trial is testing the effectiveness of sunitinib malate, docetaxel, and prednisone in treating metastatic prostate cancer that is unresponsive to hormone therapy, with eligibility criteria including a histological diagnosis of adenocarcinoma of the prostate, adequate hepatic and renal function, and an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.",
    "This phase 1 trial is testing the drug lenvatinib on patients with solid tumors or lymphoma who are resistant/refractory to approved therapies or for whom no appropriate therapies are available, and have met specific eligibility criteria.",
    "This phase 1 trial is testing the efficacy of rituximab and alemtuzumab in treating relapsed chronic lymphocytic leukemia patients who have received at least one prior fludarabine-containing regimen and meet specific eligibility criteria.",
    "The sample is a phase 1/phase 2 clinical trial for Crohn's disease, testing the effectiveness of chondroitin sulfate as a treatment option, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 1 trial is testing the efficacy of belinostat and 5-fluorouracil in treating advanced colorectal cancer and other adenocarcinomas, with eligibility criteria including confirmed solid tumors, measurable lesions, and acceptable liver, renal, hematologic, and coagulation function.",
    "The sample is a phase 1/phase 2 trial for non-small cell lung cancer patients with a list of eligible drugs including bevacizumab, erlotinib, and pemetrexed, and eligibility criteria including age, disease stage, performance status, and adequate organ function.",
    "The sample is a phase 1/phase 2 trial for patients with chronic lymphocytic leukemia, testing the efficacy of a combination of drugs including busulfan, cyclophosphamide, and fludarabine phosphate, with eligibility criteria including poor prognostic features and the availability of an HLA-identical sibling or unrelated donor.",
    "The sample is a phase 1/phase 2 trial for castration-resistant prostate cancer using the drug mdv3100, with inclusion criteria including confirmed adenocarcinoma of the prostate and ongoing androgen deprivation therapy, and exclusion criteria including metastases in the brain and use of bicalutamide within 6 weeks prior to the study.",
    "The sample is a phase 1/phase 2 clinical trial for relapsed or refractory acute myeloid leukemia, testing the efficacy of voreloxin injection and cytarabine, with eligibility criteria including at least 10% blasts by BM biopsy or aspirate and exclusion criteria including allogenic bone marrow transplant/stem cell transplant and prior exposure to vosaroxin.",
    "The sample is a phase 1/phase 2 clinical trial for the drug pci-32765 in the treatment of b-cell chronic lymphocytic leukemia and small lymphocytic lymphoma, with specific eligibility criteria for different patient groups based on their previous treatments and disease progression.",
    "This trial is testing the efficacy of cyclophosphamide, doxorubicin hydrochloride, fludarabine phosphate, paclitaxel, and mesna in treating metastatic infiltrating carcinoma of the breast, with specific eligibility criteria including Karnofsky performance status, ejection fraction, and normal liver function.",
    "The sample is a phase 1/phase 2 trial for women with Her-2 positive and ER-negative or ER-low breast cancer, testing the effectiveness of trastuzumab (herceptin\u00ae) and including eligibility criteria such as not having received prior treatment and not having a BRCA mutation.",
    "The sample is a phase 1/phase 2 trial for infertility in females, using drugs g-csf and saline, with inclusion criteria related to endometrial growth and exclusion criteria related to sickle cell disease, renal insufficiency, respiratory infection, chronic neutropenia, and malignancy.",
    "This phase 1 trial is testing the efficacy of lapatinib ditosylate and doxil in treating metastatic breast cancer patients with measurable disease, and the eligibility criteria includes various patient characteristics and prior concurrent therapies.",
    "This phase 1 trial is testing the combination of pr-104, docetaxel, and gemcitabine hydrochloride in patients with solid tumor malignancy who meet specific eligibility criteria.",
    "The sample is a phase 1/phase 2 trial testing the drugs ji-101 and everolimus on patients with refractory solid tumors, including ovarian and colon cancer, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for chronic hepatitis C, testing the drugs bms-791325 and placebo, with inclusion criteria including HCV genotype 1, treatment-naive or non-responders/intolerant, and BMI 18-35 kg/m\u00b2.",
    "The sample is a phase 1 trial testing the efficacy of amifostine trihydrate, busulfan, filgrastim, melphalan, and thiotepa in treating high-risk or relapsed solid tumors or brain tumors, including Ewing's sarcoma, neuroblastoma, and hepatoblastoma, among others, with specific eligibility criteria for patients.",
    "This early phase 1 trial is testing the drug Nexavar on patients with Hepato Cellular Carcinoma (HCC) who meet specific eligibility criteria, including age, diagnosis confirmation, performance status, and adequate bone marrow, liver, and renal function, while excluding patients with certain cardiac diseases, prior use of sorafenib, and other conditions that impair swallowing whole pills.",
    "This early phase 1 trial is testing the effectiveness of inhaled iloprost for asthma patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This trial is for patients with metastatic prostate cancer who have failed at least one taxane regimen or are chemotherapy-nai\u0308ve, and will test the drug he3235, with eligibility criteria including confirmed adenocarcinoma of the prostate and progression of disease despite adequate hormone therapy.",
    "This trial is testing the combination of temsirolimus and sunitinib for the treatment of advanced renal cell carcinoma, with specific inclusion and exclusion criteria for the dose escalation and expanded cohort phases.",
    "The sample is a phase 1 trial for patients with advanced solid tumors or lymphoma, testing the combination of gemcitabine hydrochloride and triapine, with specific eligibility criteria including normal organ function and no prior use of the drugs being tested.",
    "This phase 1 trial is testing the safety and efficacy of GSK679586 and placebo in treating asthma patients who meet specific inclusion criteria, including having a positive skin prick test for an allergen appropriate for nasal challenge and a pre-bronchodilator FEV1 >70% but <90% of predicted at screening with \u226512% reversibility after short-acting beta2-agonist.",
    "The sample is a phase 1 trial for the drug maraviroc in HIV patients with specific eligibility criteria, including having at least 3 active drugs other than maraviroc in their regimen, and exclusion criteria such as severe hepatic impairment or end stage renal disease.",
    "The sample is a phase 1/phase 2 trial for glioblastoma and gliosarcoma using the drugs enzastaurin and temozolomide, with specific eligibility criteria including recent biopsy or resection and no prior drug therapy for brain tumors.",
    "The sample is a phase 1 trial for a respiratory syncytial virus vaccine, testing the drugs rv568 and placebo, with eligibility criteria including age, health status, and absence of certain medical conditions or medication use.",
    "This phase 1 trial is testing the drug regorafenib for advanced solid tumors that are refractory to standard treatment or have no standard therapy available, with inclusion criteria including adequate bone marrow, liver and renal function, and exclusion criteria including symptomatic metastatic brain or meningeal tumors and clinically significant bleeding.",
    "The sample is a phase 1/phase 2 trial for non-Hodgkin's lymphoma, testing the efficacy of vincristine sulfate liposome injection plus rituximab, with eligibility criteria including prior chemotherapy regimens, measurable disease, and confirmation of CD20 expression on lymphoma cells.",
    "This trial is for patients with relapsed CD20-positive B-cell non-Hodgkin's lymphoma and will test the efficacy of a combination of drugs including y zevalin, in zevalin, rituxan, bcnu, vp -16, ara-c, melphalan, and g-csf. The eligibility criteria include having a prestudy performance status of 0, 1, or 2, and acceptable hematologic status with absolute neutrophil count and platelet counts meeting certain thresholds.",
    "The sample is a phase 1 clinical trial for patients with advanced cancer, solid tumors, or neoplasms, testing the drug rigosertib sodium, with eligibility criteria including ECOG performance status < 2, Hgb > 10 gm/dl, and platelets >100,000 per microliter.",
    "This phase 1 trial is testing the drug bavituximab on adults with chronic hepatitis C and HIV infections, who meet specific eligibility criteria and do not have any exclusion criteria.",
    "The sample is a phase 1 trial testing the efficacy of temsirolimus and vinorelbine ditartrate in treating various metastatic or unresectable solid tumors, with specific eligibility criteria and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of erlotinib and rad001 in treating metastatic breast cancer patients who have failed previous taxane therapy and anthracycline therapy, with specific eligibility criteria for disease and patient characteristics.",
    "This phase 1 trial is testing the efficacy of intravenous ezn-2968, an anti-HIF-1\u03b1 LNA AS-ODN, in treating advanced and/or metastatic solid tumors or lymphomas that have failed standard therapy, with measurable or evaluable disease, and patients who are 18 years or older. The diseases being targeted are carcinoma and lymphoma, with corresponding ICD-10 codes provided. The eligibility criteria include having a tumor amenable to biopsy and no known effective therapy available, while exclusion criteria include concurrent serious medical illness and prior chemotherapy or immunotherapy within 4 weeks of scheduled administration of EZN-2968.",
    "The sample is a phase 1/phase 2 clinical trial for melanoma treatment using Normothermic Isolated Limb Infusion (ILI) of melphalan and ADH-1, with inclusion criteria including measurable disease and availability for immunohistochemical testing of N-cadherin expression tumor tissue, and exclusion criteria including stage IV melanoma and history of tumors that have shown clinically significant evidence of active bleeding within 12 weeks before study entry.",
    "This phase 1 trial is testing the drug bi10773 and placebo in Chinese patients with type 2 diabetes mellitus who are on a maximum of two oral antidiabetic agents, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of cisplatin and vinorelbine in treating non-small cell lung cancer patients who have undergone surgery and meet specific eligibility criteria.",
    "This is a phase 1 trial for HIV patients who have not been exposed to rilpivirine, and are currently receiving a stable antiretroviral regimen comprising of TDF/FTC with nevirapine, to test the safety and efficacy of rilpivirine; the eligibility criteria includes having plasma HIV RNA < 50 copies/mL, no clinically-significant resistance documented on any prior HIV-1 genotypic resistance testing, and BMI above or equal to 18 and below 32.",
    "The sample is a phase 1 trial for dapagliflozin in patients with type 2 diabetes mellitus, with inclusion criteria based on diagnosis, therapy, glucose and HbA1C levels, eGFR, urinary albumin excretion, BMI, and age, and exclusion criteria based on type of diabetes, glucose and HbA1C levels, and age.",
    "The sample is a phase 1 trial testing the drug azd4877 on patients with lymphoma, AML, certain types of ALL, NHL, and MM, with inclusion and exclusion criteria listed.",
    "The sample is a phase 1 trial for insulin degludec in patients with type 2 diabetes mellitus, with inclusion criteria of clinical diagnosis of diabetes for at least 12 months and BMI below or equal to 35.0 kg/m2, and exclusion criteria of recent blood or plasma donation, smoking, and use of nicotine gum or patches during the inpatient period.",
    "The sample is a phase 1/phase 2 trial for chronic myelogenous leukemia and philadelphia chromosome positive acute lymphoblastic leukemia, testing the drug dasatinib, with eligibility criteria including completion of a previous study and exclusion criteria including pregnancy or breastfeeding.",
    "The sample is a phase 1/phase 2 trial for previously untreated aggressive non-Hodgkin's Lymphoma, using cyclophosphamide, doxorubicin, vincristine and prednisone as drugs, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of liposomal doxorubicin hydrochloride and decitabine in treating relapsed epithelial ovarian cancer, with eligibility criteria including up to four previous lines of chemotherapy, a Karnofsky performance status of > 70%, and hematology and biochemistry laboratory results within the limits normally expected for the patient population.",
    "This phase 1 trial is testing the drug GSK933776 and its placebo in male and female subjects with mild Alzheimer's disease, with a list of inclusion and exclusion criteria.",
    "The sample is a phase 1 clinical trial testing the safety and tolerability of hm10560a, a drug, and placebo in healthy male volunteers, with specific inclusion and exclusion criteria.",
    "This trial is testing the effectiveness of ptk787 and trastuzumab in treating breast cancer patients with HER2 gene amplification and specific eligibility criteria.",
    "The sample is a phase 1 trial for a drug combination of sam-531 and donepezil on healthy adults with specific inclusion and exclusion criteria, and the trial will use icd-10 codes Z76.3 and Z76.2 to identify eligible participants.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic or locally recurrent colorectal cancer who failed prior therapy with fluorouracil, leucovorin calcium, and irinotecan given either sequentially or in combination, and will test the efficacy of zd1839 and oxaliplatin as drugs.",
    "This is a phase 1 trial for breast cancer patients with high-risk criteria, testing the efficacy of paclitaxel, docetaxel, and capecitabine as neoadjuvant therapy, with eligibility criteria including histologic confirmation of invasive breast cancer, adequate bone marrow and liver function, and exclusion criteria including N2 or N3 nodal disease, inflammatory breast cancer, or metastatic disease.",
    "This phase 1 trial is testing the efficacy of genasense\u00ae, abraxane\u00ae, and temodar\u00ae in treating progressive, unresectable, or advanced melanoma patients who have not previously received cytotoxic chemotherapy, and have measurable disease, an Eastern Cooperative Oncology Group Performance Status less than or equal to 2, and serum LDH less than or equal to 1.1 times the upper limit of normal.",
    "This is a phase 1 trial for HCV infection testing the drugs VCH 916 and placebo, with eligibility criteria including detectable plasma HCV-RNA, documented HCV genotype 1, and no evidence of cirrhosis or liver fibrosis.",
    "This phase 1 trial is testing the efficacy of intravenous docetaxel with intraperitoneal oxaliplatin and intravenous oxaliplatin with intraperitoneal docetaxel in treating recurrent platinum-sensitive or platinum-resistant ovarian, primary peritoneal, or fallopian tube cancer, with specific eligibility criteria for patients.",
    "This sample is a phase 1/phase 2 trial testing the effectiveness of bumetanide in treating neonatal seizures in term babies with specific inclusion and exclusion criteria, including EEG monitoring and written informed consent.",
    "This phase 1 trial is testing the drugs gsk1120212 and gsk2110183 on patients with various solid tumor malignancies, including breast cancer, pancreatic cancer, and non-small cell lung cancer, who have not responded to standard therapies or for whom there is no approved or curative therapy, and have met certain eligibility criteria.",
    "This phase 1 trial is testing the efficacy of insulin glargine and insulin glargine-new formulation in Japanese patients with type 1 diabetes mellitus who are on basal-bolus insulin treatment, with specific inclusion and exclusion criteria.",
    "This is a phase I trial for breast cancer patients with measurable disease, testing the combination of lapatinib ditosylate and paclitaxel albumin-stabilized nanoparticle formulation, with eligibility criteria including HER2/neu 3+ or positive by fluorescent in situ hybridization, and no prior chemotherapy, immunotherapy, radiotherapy, or hormonal therapy for breast cancer.",
    "This phase 1 trial is testing the efficacy of various drug combinations, including donepezil and mk-3134, in treating dementia, with eligibility criteria including male participants between 18 and 40 years of age who are non-smokers and in good health."
]